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Summary 
 
The study of adaptation in microorganisms has led to a significant 
expansion in knowledge at many biological levels, ranging from biochemistry and 
genetics, to ecology and demography. Experimental evolution, in particular, has 
been invaluable at elucidating how complex the adaptive dynamics in microbial 
populations can be. One of the most fundamental characteristics of these 
dynamics is the distribution of beneficial mutations driving the adaptive process. 
How often do microorganisms acquire these mutations? And what are their 
expected effects? These questions have been at the heart of evolutionary biology 
from the very beginning, and the studies that have tackled these difficult issues 
have been tremendously enlightening about adaptive processes. However, the 
increasing awareness of the complexity of the environment where microorganisms 
live requires constant development of new approaches to answer these 
fundamental questions about their evolution. Large population sizes lead to 
increased levels of clonal interference, and thus to a deviation from the expected 
outcome in classical regimes of periodic selection. Genetic variation within an 
evolving population, which is now easily detected by sequencing technologies, can 
create complex interactions between phenotypes. Environments with antagonistic 
biotic interactions, pose very different selective pressures from the ones 
experienced when a species grows alone. All these factors influence adaptation in 
microorganisms and, importantly, drive the pathogenicity traits that create severe 
clinical and epidemiological problems. 
 
The main goal of the research presented in this thesis is to address some 
of these outstanding questions by experimentally evolving the bacterium 
Escherichia coli, in scenarios that are closer to clinically relevant conditions. We 
study a particular pathogenic trait, antibiotic resistance, by first addressing 
compensatory adaptation in multiple resistant backgrounds. By performing whole 
genome sequencing of the evolved populations, we were able to uncover, for the 
first time, the genetic basis for compensation in bacteria resistant to both 
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rifampicin and streptomycin. Moreover, we showed that the paths taken for 
compensating resistance costs in multiple resistant strains differ substantially from 
the ones observed in the corresponding individual resistant alleles.  We also 
studied compensatory adaptation in populations with standing genetic variation for 
resistance, a scenario closer to the that found in clinical infections, showing that 
the relative fitness difference between the different resistances is not predictive of 
their long-term maintenance in the population. Instead, the fate of resistances is 
highly dependent on their potential for adaptation. We also investigate the 
adaptation of a commensal E. coli in a biotic environment where antagonistic 
interactions with cells of the immune system play a crucial role in driving the 
transition into pathogenicity. We identified potential pathoadaptive targets, 
observing the existence of antagonistic pleiotropy and clonal interference as main 
drivers in the transition from commensalism to pathogenicity. Across these 
studies, we use and develop new theoretical methods to estimate important 
evolutionary parameters from experimental data and study the dynamics of 
individual mutations in evolving populations in the context of Fisher Geometric 
Model. 
 
Using an integrative approach involving experimental evolution, theoretical 
modelling and next generation sequencing, we studied the adaptive dynamics of 
evolving microorganisms, in the hope that these sort of studies may contribute to 
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Resumo 
 
O estudo da adaptação em microrganismos levou a importantes 
desenvolvimentos no conhecimento a vários níveis biológicos, desde bioquímica e 
genética, até ecologia e demografia. A contribuição da evolução experimental, em 
particular, tem sido inestimável ao elucidar a complexidade envolvida nas 
dinâmicas de adaptação em populações microbianas. Uma das questões mais 
fundamentais destas dinâmicas é a distribuição de mutações que impele o 
processo adaptativo. Com que frequência são estas mutações adquiridas pelos 
microrganismos? E quais são os seus efeitos esperados? Estas questões têm 
sido centrais à biologia evolutiva desde a sua génese, e os vários estudos que 
abordam estes assuntos complexos têm sido tremendamente instrutivos acerca 
do processo adaptativo. No entanto, há uma consciência crescente de que o nível 
de complexidade do ambiente onde habitam os microrganismos requer o 
desenvolvimento constante de novas abordagens de modo a responder a estas 
questões fundamentais acerca da sua evolução. Populações de grande tamanho 
levam à presença de interferência clonal e, portanto, a desvios das observações 
esperadas em regimes clássicos de seleção periódica. A variação genética 
gerada nas populações em evolução,  que é agora facilmente detectada através 
de tecnologias de sequenciação, leva a interações complexas entre os fenótipos. 
Ambientes com interações antagonistas bióticas colocam diferentes pressões 
selectivas daquelas encontradas quando uma espécie cresce em isolamento. 
Todos estes factores influenciam a adaptação de microrganismos sendo muito 
importantes no desenvolvimento de características patogénicas que criam sérios 
problemas clínicos e epidemiológicos. 
 
O objectivo principal  da investigação apresentada nesta tese é responder 
a algumas destas questões prementes através da evolução experimental de 
Escherichia coli, em cenários que se aproximam de condições clinicamente 
relevantes. Estudámos uma característica patogénica específica, a resistência 
antibióticos, investigando a adaptação compensatória em genomas bacterianos 
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com múltiplas mutações de resistências. Através de sequenciação completa do 
genoma das populações evoluídas, descobrimos, pela primeira vez, a base 
genética de compensação em bactérias resistentes a rifampicina e streptomicina. 
Adicionalmente, mostrámos que os caminhos que levam à compensação de 
resistências custosas em estirpes com resistências múltiplas diferem 
substancialmente daquelas observadas com as correspondentes resistências 
individuais. Estudámos também adaptação compensatória em populações com 
variação genética para a resistência, um cenário mais próximo daquele 
encontrado em infecções bacterianas na clínica, mostrando que as diferenças 
relativas de fitness entre as resistências não prevê a sua manutenção a longo 
termo na população. Em vez disso, o destino das resistências é altamente 
dependente do seu potencial adaptativo. Investigámos também a adaptação de 
uma estirpe comensal de E. coli a um ambiente biótico, onde interações 
antagonistas com células do sistema imunitário são um factor crucial na transição 
para a patogenicidade. Identificámos potenciais alvos genéticos patoadaptativos, 
observando a existência de pleiotropia antagonista e interferência clonal como 
alguns dos principais impulsionadores na transição entre comensalismo e 
patogenicidade. Ao longo destes estudos, usámos e desenvolvemos novos 
métodos teóricos para estimar importantes parâmetros evolutivos a partir de 
dados experimentais, e estudamos as dinâmicas de mutações individuais em 
populações em evolução no contexto do Modelo Geométrico de Fisher. 
 
Ao usar uma abordagem integrativa, envolvendo evolução experimental, 
modelação teórica e sequenciação de nova geração, estudámos as dinâmicas de 
adaptação durante a evolução de organismos, na esperança que este tipo de 
estudos possa contribuir para potenciais caminhos que levem a meios mais 
eficientes de prever, prevenir e inverter diversas patologias microbianas. 
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Thesis Outline 
 
The main and unifying purpose of this thesis, and the main driver of the 
work performed during these last years, is to better understand how adaptation 
occurs across increasingly complex adaptive environments, from simple and 
monoclonal populations, to polymicrobial populations, and finally in an 
environment where strong antagonistic interactions occur. We start by developing 
theoretical methods and simulations to infer key evolutionary parameters from 
biological observations. We then use antibiotic resistance as a trait to understand 
compensatory evolution and the role of epistasis in compensation under strong 
clonal interference, both in single and multiple antibiotic resistant backgrounds. 
Next, we explore the evolutionary parameters underlying adaptation in populations 
initially composed of different antibiotic resistance alleles, as observed in 
polymicrobial infections. Finally, we use a biotic environment that includes 
macrophages to understand the adaptive processes in the transition of a 
commensal into a pathogen, and how clonal interference might generate dynamics 
that strongly influence this process.  
First, Chapter I introduces some fundamental concepts in evolutionary 
biology, with a focus on experimental evolution of microbial organisms, as well as 
antibiotic resistance and the interaction of bacteria with the innate immune system. 
Chapter II presents and discusses a computational method to infer the 
beneficial mutation rate and the distribution of arising beneficial mutations, from 
populations undergoing experimental evolution tracked by neutral markers. 
Then, in Chapter III, we use Fisher’s Geometric Model to study the 
dynamics of individual mutations and their aggregation in cohorts, under scenarios 
of intense clonal interference.  
We move away from purely theoretical scenarios in Chapter IV, where we 
study the compensatory process of antibiotic resistant Eschericha coli, and try to 
understand whether the compensatory process is shaped by epistatic interactions 
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between different resistances. We characterize this process in terms of adaptive 
dynamics and fitness increase, both of which we use to infer evolutionary 
parameters, and we describe the genetic basis of compensation of double 
resistant bacteria.  
In Chapter V we study a similar compensation process, but with E. coli 
populations that are composed of different antibiotic resistant clones to begin with. 
We ask if the initial relative fitness difference between these resistant mutants can 
predict the outcome of composition of the population, or if their different 
evolvability determines adaptation. 
Chapter VI explores a more complex biotic environment, where we study 
the initial steps of E. coli adapting to the intracellular environment of macrophages. 
We describe this adaptation in phenotypic terms and provide the genetic basis for 
this transition. 
In Chapter VII, we discuss the ability of clonal interference to generate 
genetic variation that explains morphologic and phenotypic dynamics in the 
adaptation of E. coli coexisting with macrophages. 
Finally, Chapter VIII summarizes and discusses the investigation 
presented in the previous chapters, contextualizing the results in the current and 
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Microbial adaptation and experimental evolution  
 
Evolution, the change in heritable traits over time, is a unifying principle 
that holds information on why something is or behaves in a certain way. This 
variation in traits within a population, however, is not random, and it is observed 
across many biological levels of organization, from molecules to interactions 
between individuals. Therefore, understanding why certain traits are selected over 
others – that is, why they are adaptive – is fundamental in order to understand life 
itself. The primary mechanism of evolution is the generation of mutations, random 
changes in the genome of an organism. Most importantly, the emergence of these 
genetic variants means there is variation on the phenotype of an organism (be it 
how many offspring it can generate or the color of its fur) over which natural 
selection can then act. Most of these changes are neutral or even detrimental to 
an individual, but there is also a chance for a mutation to confer a beneficial effect, 
either by optimizing a given trait or by creating a novel adaptive one. Whenever 
such an event occurs, this new variant should increase in frequency in the 
population, replacing the worse variants. This fundamental principle drives 
adaptation in a population, through the emergence of new adapted phenotypes.  
One way to better understand adaptation is by studying microbial evolution. 
Microbes are incredibly diverse and inhabit a vast multitude of habitats, from the 
depths of oceans (DeLong 2005) to the mammalian digestive system (Jeffrey I 
Gordon 2012). This microbial diversity is likely to be due to the tremendous 
adaptive potential of microorganisms. Their large population sizes and fast 
generation times, with some microorganisms dividing within minutes (Sezonov et 
al. 2007), allow adaptation to occur and be observed in a matter of a few days 
(Lenski et al. 1991; Novella et al. 1995). The rapid generation of diversity from a 
single microbial genotype leads to the coexistence of multiple clonal variants, 
which can then either compete for resources (Fredrickson & Stephanopoulos 
1981; Orr 1998; Hibbing et al. 2010) or interact cooperatively (Deborah M Gordon 




from motility (Zhang et al. 2009) to biofilm formation (Xavier & Foster 2007). 
Competition between microbes has been, however, the most frequently used 
scenario for studying adaptive dynamics (Gerrish & Lenski 1998; Sniegowski & 
Gerrish 2010). A wide and well-established set of molecular, genetic and 
technological tools facilitates the study of microorganisms. While the genetic 
manipulation of microbial genomes allows putting forward hypothesis regarding 
the role and effect of particular mutations on the phenotype of an organism, 
advances in genomic sequencing technology allow the observation of genetic 
changes that underlie adaptation (Lee et al. 2012; Chedom et al. 2015). 
Another significant advantage in studying microbial adaptation concerns 
the clinical relevance of microorganisms to human hosts. Microbes can be a 
vicious pathogenic foe, but also a powerful commensal ally, and often the same 
organism can display both these characteristics, depending on environmental 
conditions (Littman & Pamer 2011). Phenotypic changes allowing a commensal to 
become a pathogen (Ebert & Bull 2008; Leimbach et al. 2013), or a microbial 
invader to acquire resistance to an antibiotic (Paulsen et al. 2003; O'Neill et al. 
2001), can occur very quickly. Moreover, certain microbial genomes have mobile 
DNA, such as plasmids (Touchon et al. 2012) or other mobile genetic elements 
(Touchon et al. 2014), which can cause horizontal gene transfer of pathogenic 
traits to occur (Iwasaki & Takagi 2009; Gluck-Thaler & Slot 2015), enhancing their 
ability to adapt under strong selective pressures. Thus, investigating how 
adaptation occurs in microbes can not only lead to useful insights on the key 
principles of adaptation, but also to increase our knowledge on pathologies and 
the evolution of infectious diseases. The information gathered in microbial 
adaptation studies can help to exploit their weaknesses and curb their effects on 
human health. 
A very useful tool for studying the adaptation of microbial populations in 
real time is experimental evolution, where evolutionary scenarios can be created 
by starting from a common ancestral genotype and controlling the conditions 
experienced by the organisms, such as the size of populations, temperature or 
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resource availability (Kawecki et al. 2012; Adams & Rosenzweig 2014). It usually 
consists on several independent replicate populations evolving in parallel, which 
are then analyzed for traits that have changed during adaptation. Phenotypic 
changes, such as the growth rate or the ability to consume a given resource, as 
well as genomic changes, can be tracked over time. Asking how these 
modifications have occurred across replicate populations can assess the spectrum 
of adaptive mutations arising under specific conditions (Lang & Desai 2014) or the 
even how predictable is adaptation (Blank et al. 2014; Barroso-Batista et al. 2014). 
Experimental evolution has therefore been used to estimate evolutionary 
parameters (Hegreness 2006) and test evolutionary hypothesis (Perfeito et al. 
2007; Fitzpatrick et al. 2007). A wide range of organisms have been studied under 
this framework, including Drosophila melanogaster (Simões et al. 2008) or 
Arabidopsis thaliana (Kolodynska & Pigliucci 2003). However, many studies that 
use this tool focus on microorganisms (for instance, virus (Bull et al. 2003), 
bacteria (Barrick et al. 2009), yeast (Ratcliff et al. 2015) or nematodes (Denver et 
al. 2012)), due to their easy manipulation and storage. In what is arguably the 
most famous foray into an experimental evolution study, Richard Lenski’s research 
group has been propagating several replicate Escherichia coli populations in 
minimal media supplemented with glucose for more than 25 years, having now 
surpassed 64000 generations (Lenski et al. 1991; Maddamsetti et al. 2015). While 
the initial response of interest was the change in mean fitness of populations over 
time, it has now spawned a myriad of interesting observations, from the genetic 
constraints to evolvability (Woods et al. 2011), to selection in mutation rates 
(Sniegowski et al. 1997) and adaptation involving the cross-feeding between 
individuals (Rozen et al. 2009). Because populations are frozen and stored every 
500 generations, it is even possible to go back to a previous point and replay 
evolution to understand its contingency (Woods et al. 2011) or the reasons for the 
extinction of ecotypes (Turner et al. 2015). This hallmark study from Lenski, as 
many others that followed, focuses on how microorganisms improve in a given 
environment, but the reverse question is also being explored using a similar 




population bottlenecks (usually a single individual or colony), study how the 
accumulation of mutations in the absence of selection impacts the fitness of 
organisms over time (Kibota & Lynch 1996; Perfeito et al. 2014). Clinically, 
experimental evolution has somewhat played an ancient role in the creation of 
vaccines (Woo & Reifman 2014), which consists in the serial passage of 
pathogens until their disease causing traits were severely impaired. Nowadays, 
however, experimental evolution can be used to assess, for instance, the speed 
and types of mutations associated with drug resistance to a certain antibiotic, by 
evolving bacteria in media supplemented with the drug (Perron et al. 2006; Palmer 
& Kishony 2013). 
Although based on simple principles, adaptive processes occurring in 
evolving populations are complex and can sometimes display cryptic properties. 
They are also fairly difficult to analyze quantitatively and comparatively. 
Theoretical models, by making certain explicit evolutionary assumptions, allow the 
interpretation and quantification of adaptive processes, putting forward testable 
predictions (Smith & Haigh 1974; Wahl & Gerrish 2001). Furthermore, they allow 
inferring key parameters from experimental observations. For instance, the rates 
and effects of mutations can be inferred from marker dynamics in an experimental 
evolution setup (Hegreness 2006; Barrick et al. 2010). Historically, mathematical 
modeling provided, for instance, a crucial intellectual convergence by conciliating 
Mendelian genetics with the effect of natural selection on the change in gene 
frequencies, mainly through the work of Ronald A. Fisher, Sewall Wright and 
J.B.S. Haldane (Ronald Aylmer Fisher 1930; S Wright 1932; Haldane 1927). 
Theoretical models have since then been very useful in untangling adaptive 
processes and explaining certain evolutionary observations, be it at the level of 
linkage between genes (Desai & D S Fisher 2007), changes in fitness along time 
(Wiser et al. 2013), organism complexity (Wang et al. 2010), or social interactions 
in meta-populations (Bucci & Xavier 2014). Developing a useful model, however, 
requires careful identification of the relevant processes for the particular question 
one proposes to tackle. As John H. Holland put it, model building can be an art, 
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because it stems from a process of induction in choosing the relevant parameters 
(Holland 1995). Therefore, it is crucial to identify and understand what are the key 
evolutionary processes that underlie the dynamics observed in bacterial evolution. 
 
Patterns and dynamics in bacterial evolution 
Generation of bacterial variants 
The spontaneous mutation rate in bacteria is estimated to be in the order of 
10-3 mutations per cell per generation (Lee et al. 2012). This rate, combined with 
the large population sizes of bacteria, results in a fast generation of genetic 
diversity within a population. From all these mutations, the vast majority will have a 
deleterious or neutral effect on an organism (Drake et al. 1998; Eyre-Walker & 
Keightley 2007), but beneficial mutations, although rare, are the drivers of long-
term adaptation (Sniegowski & Gerrish 2010; Frenkel et al. 2014). The fraction of 
beneficial mutations is strongly dependent on the initial level of adaptation of an 
organism to a given environment, and the true distribution of effects of these 
arising beneficial mutations is very hard to determine experimentally (Hietpas et al. 
2011). Once a beneficial mutation appears, because it is initially rare in the 
population, it has to survive stochastic fluctuations in the production of offspring, a 
process known as genetic drift (Orr 1998). Indeed, many arising beneficial 
mutations are lost due to drift. Since the probability of a mutation not being lost 





, where N and Ne are the total and effect population, 
respectively) (Kimura 1962), mutations of stronger beneficial effects have a lower 
likelihood of being lost due to this process. Natural selection is less effective in 
smaller populations, as these are more susceptible to these stochastic fluctuations 
(Lanfear et al. 2013). A mutation that is able to overcome drift will start to increase 
in frequency and, if no other beneficial variant of a similar or higher effect appears, 




Figure 1. Dynamics in regimes of periodic selection and clonal interference. 
Different colors represent alleles emerging and segregating through time, with grey 
being the ancestral genotype. In panel A, the successional mutation regime is 
represented, where the periodic sweep of each beneficial allele. Panel B represents 
a regime of clonal interference, where multiple mutations segregate simultaneously 
and interfere with the other variants. Adapted from (Marx 2013). 
successional accumulation of mutations, and is typically observed when 
populations are small and beneficial mutations are rare (Atwood et al. 1951). 
However, larger populations with a higher influx of beneficial variants will lead to 
alternative regimes (Desai & D S Fisher 2007).  
Competition between beneficial variants – Clonal Interference 
Beneficial alleles that survive loss by drift and start increasing in frequency 
in the populations are considered contending, or competing, mutations (Gerrish & 
Lenski 1998). In regimes of large population sizes and high frequency of beneficial 
mutations, it is expectable that, contrary to the successional regime, multiple 
beneficial variants arise and segregate simultaneously. Because microbes 
reproduce mainly asexually, the emergence, through recombination, of clones with 
multiple beneficial mutations (Ronald Aylmer Fisher 1930; Felsenstein 1974) in the 
same individual is rare. As a consequence, individual mutations compete against 
each other for increase in frequency and, ultimately, for fixation. This is a process 
that is known as clonal interference (Gerrish & Lenski 1998). 
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While in the successional regime any mutation that survives drift can reach 
fixation, regardless of its fitness advantage, in regimes of clonal interference there 
is an enrichment of mutations with stronger effects, since these are the ones that 
are able to outcompete the other beneficial variants. Moreover, because mutations 
interfere with each other’s segregation, the fixation of single alleles is less 
common than expected if such interference did not occur. Fixations take a longer 
time to occur, and there is higher likelihood for observing genetic diversity within a 
population (Comeron & Kreitman 2002; de Visser 2005). These predictions have 
been observed across experimental evolution studies that use large population 
sizes (de Visser 2005; Lang et al. 2013). Moreover, clonal interference has also 
been observed in clinical settings, notably in persistent infections of antibiotic 
resistant pathogens (Navarro et al. 2011) or viral evolution (Chedom et al. 2015; 
Zanini et al. 2016). For instance, temporal analysis of tuberculosis infections has 
show that clonal interference is prevalent (Eldholm et al. 2014), and can even 
occur within the same host (Al-Hajoj et al. 2010). The Influenza virus has also 
been shown to evolve under strong clonal interference, with selection for viral 
strains of increasingly stronger beneficial mutations (Strelkowa & Lässig 2012). 
Other biological processes that rely on clonal reproduction have also been 
observed to be under the influence of clonal interference. Namely, in cancer 
development and progression (Ding et al. 2012), where fast division times and 
high mutation rate of deregulated cells originates genetic diversity and competition 
between different cancer lineages (Greaves & Maley 2012). Across all these 
systems, one important consequence of the longer fixation times caused by clonal 
interference is that there is time, before the fixation of an allele, for a genetic 
background to acquire subsequent mutations. 
Interactions between mutations – Epistasis 
If the effect of a mutation depends on whether another mutation is present 
in the genome, that is, if it depends on the genetic background where it occurs, 
there is epistasis between these mutations (Bateson 1910; Phillips 2008). The 




depends on the connectedness of the processes that are affected. For instance, 
mutations that affect a similar biosynthetic pathway or cellular process are more 
likely to conflict than functionally distinct mutations (Phillips 2008). There are two 
main types of epistasis: magnitude and sign. For magnitude epistasis, two 
mutations can interact antagonistically, if the combined effect of the mutations is 
smaller than predicted by their individual effects, or synergistically, if it is bigger 
than expected. An extreme case of this latter type of epistasis is synthetic lethality, 
where a specific mutation becomes lethal if it co-occurs with another one (St Onge 
et al. 2007). Sign epistasis occurs if the sign of the effect of a mutation changes: 
e.g., a beneficial mutation becomes deleterious in the presence of another 
mutation. The extreme version of this type of interaction is called reciprocal sign 
epistasis, and it occurs if two deleterious mutations result in increased fitness 
when put together (Kvitek & Sherlock 2011). 
Evolutionarily, the concept of epistasis is crucial because it can effectively 
constrain the adaptive paths an organism can follow (Fenster et al. 1997), since a 
modified allele might have a different spectrum of subsequent mutations that 
become deleterious in that background. Therefore, it has an important role in the 
predictability of evolution (Weinreich et al. 2006) and can also constrain the 
evolution of genetic architecture (Kondrashov 1988; Gros et al. 2009). Epistasis 
ultimately defines the ruggedness of the adaptive landscape of organisms 
(Kauffman & S Levin 1987; Martin et al. 2007). Fitness landscapes (S Wright 
1932) were once discussed purely in conceptual terms, but this is now changing, 
as real genetic landscapes, built by constructing genotypes with the different 
possible mutations are being explored (Jacquier et al. 2013). By performing 
combinations between the mutations, it is possible to clearly map the landscape 
with types of combinations that are viable (Khan et al. 2011). The role of epistasis 
in health is also very important. One particular example is regarding the 
emergence of multiple drug resistances (Chakrabarti & Gorini 1977; Hall & 
MacLean 2011), where it is important to understand the likelihood of multiple 
mutations that confer resistance to different drugs to accumulate in a genetic 
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background. Understanding an epistatic interaction between two resistance alleles 
could predict a given cost of resistance, and the correspondent likelihood for 
certain resistance alleles to co-occur together (Trindade et al. 2009).  
Segregation and competition of haplotypes 
Once multiple mutations accumulate in a genome, and unless their 
epistatic interactions are completely known, it is difficult to disentangle the effects 
of single alleles. Instead of referring to a beneficial variant, the term haplotype is 
used, denominating the group of polymorphisms that are inherited together. 
Haplotypes can be composed entirely by beneficial mutations, but might also 
include neutral, or even slightly deleterious alleles, which hitchhike with the ones 
that are positively selected (Smith & Haigh 1974; Desai & D S Fisher 2007). 
Experimental evolution studies, coupled with sequencing technologies, allow the 
observation of the dynamics of individual mutations in evolving populations (Lang 
et al. 2013; Zanini et al. 2016). The general observation is that there is an 
impressive level of polymorphism in populations and that selective sweeps of a 
single mutation are rare. Instead, multiple mutations are usually seen in 
aggregates – cohorts – that change in frequency together, competing with other 
groups of mutations and eventually fixing as a group (Lang et al. 2013). Similar 
observations come from the analysis of bacterial infections, where a mutation that 
provides resistance to an antibiotic segregates with other additional mutations that 
might improve their otherwise costly fitness effect (Comas et al. 2012). 
 
Antibiotic resistance and compensatory adaptation 
The history and ecology of antibiotics 
One of the most important medical advances of the past century is the 
discovery and development of drugs to treat bacterial infections. Recognized as a 
clinical threat in late 19th century, the first therapeutic agent developed against 




penicillin by Alexander Fleming in 1929, and the development of its antibiotic in 
1942. Fleming left plates cultured with Staphylococcus aureus for a long time in 
the laboratory, and upon his return from summer holidays he realized that the 
fungi that had contaminated his petri dishes were inhibiting the growth of S. aureus 
(Hare 1982). This marked the beginning of a golden era for clinicians and humans 
in general. For the first time in history, infections were manageable by therapeutics 
and even invasive surgery was possible. The discovery of antibiotics provided 
several clinical breakthroughs and, since then, millions of deaths have been 
prevented each year, with the consequent increase in the average life expectancy 
of humans. Perhaps overly optimistic by the success of antibiotic treatments, 
society started to overuse these drugs, which may have played an important role 
in directing us back to a state of increasing powerlessness against these 
pathogens (World Health Organization 2014). 
An antibiotic treatment imposes a very strong selection for bacteria that 
survive exposure to the drugs. This strong selective pressure, together with the 
ability of microbes to quickly adapt, lead to the emergence of bacteria that are 
resistant against the treatment of antibiotics (Abraham & Chain 1940; J Davies & 
D Davies 2010). The full extent of this ability was only fairly recently realized, since 
microbiologists thought that the frequency of resistance mutations was too low to 
be an actual threat (J Davies 1994). However, the potential dangers that come 
with the misuse of antibiotics were identified as soon as after the discovery of 
penicillin, when Fleming himself realized that some bacteria had the ability to 
become resistant to the treatment. In his own words, “the time may come when 
penicillin can be bought by anyone in the shops. Then there is the danger that the 
ignorant man may easily underdose himself and by exposing his microbes to non-
lethal quantities of the drug make them resistant” (Fleming 1945). The first 
identified acquisition of resistance to an antibiotic treatment marked the beginning 
of an arms race between scientists and the ever-adaptable microbes, where the 
discovery of new treatments was – and is – soon counteracted by the evolution of 
resistance mechanisms (Hede 2014).  
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Figure 2. Timeline of antibiotic clinical introduction and emergence of 
resistance. Upward arrows indicate when the drug was introduced as therapeutic 
treatment; downward arrows indicate when resistance was first detected. Retrieved 
from (Hede 2014). 
 
 
Despite this recent (from a human standpoint) competition between drug 
development and resistance, one has to keep in mind that this process has been 
occurring for far longer than humans even existed (Brown & Gerard D Wright 
2016). Both antibiotic production and mechanisms of resistance are ancient tools 
that microorganisms have been evolving for millions of years, using these secreted 
weapons competitively against other strains and species, but also as means of 




clinically, like the case of penicillin, are identified and isolated from 
microorganisms themselves (e.g., vancomycin (Levine 2006)). When surveying 
microorganisms in various environments, either from the soil (Forsberg et al. 2012) 
or isolated bacterial communities (Bhullar et al. 2012), several studies have 
realized that the resistome (Gerard D Wright 2010), a global collection of genes 
conferring resistance, is genetically diverse, environmentally widespread and 
predates by far the clinical use of antibiotics (Brown & Gerard D Wright 2016). 
While the evolutionary and ecological aspects of antibiotic production and 
resistance are far from being completely understood, the unrestrained use of 
antibiotics by humans applied a tremendous selective pressure for the selection 
and dissemination of these resistance genes (Gullberg et al. 2011; World Health 
Organization 2014). 
Types of antibiotics and mechanisms of action and resistance 
Antibiotics fall into three main categories: natural antibiotics, which are 
isolated from living organisms (e.g., aminoglycosides); others are semi-synthetic 
modifications of natural compounds (e.g., beta-lactam or carbapenems); the 
remaining ones are completely synthetic (e.g., sulfonamides and quinolones). 
Streptomycin, for instance, is a naturally isolated aminoglycoside that binds to the 
ribosome and inhibits elongation of protein synthesis (Luzzatto et al. 1968), and 
the resulting misfolding of proteins produces many toxic and pleiotropic effects 
(Abad & Amils 1994). It is a drug that has been paramount in controlling infections 
of tuberculosis, and, according to the WHO, is one essential medicinal compound. 
Another example of a semi-synthetic antibiotic is rifampicin, which was derived 
from the naturally isolated rifamycin. This drug inhibits the RNA polymerase, 
impairing the synthesis of RNA (Wehrli 1983), causing cell death, and it is also one 
of the most widely used drugs to treat many different bacterial infections, such as 
tuberculosis and MRSA. 
The main function of antibiotics is to perturb important biochemical processes, 
therefore disrupting the normal functioning and the survival ability of cell. 
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Antibiotics can have bactericidal properties, meaning that they actively kill bacteria 
by targeting the cell wall, membranes or essential enzymes and functions; or they 
can be bacteriostatic, meaning that bacterial reproduction is prevented by 
targeting protein synthesis (Yamori et al. 1992). Although these are the two 
classical means of describing an antibiotic, whether they actively kill a cell or 
simply stop its reproduction is strongly dependent on the concentration of the 
compound, as protein synthesis are also required for cell survival (Pankey & 
Sabath 2004). 
Resistance to the action of an antibiotic can be of different types (Tenover 
2006; Blair et al. 2014): 1) inactivation or modification of drug compound, by the 
production of additional residues that are added to the antibiotic molecule and 
prevent binding its target; 2) modification of the target site, by conformational 
changes; 3) reduction of levels of the drugs, for instance through efflux pumps 
located in the cell wall that export antibiotics out of the bacterial cell; and 4) 
modification of the metabolic pathway affected by a drug, by relocating the 
metabolic functions through other means. Many of these mechanisms are not 
readily at the dispose of a bacterial cell. Resistance can often be obtained through 
the exchange of DNA from one bacteria to another, through conjugation or plasmid 
mediation (Maiden 1998; van Hoek et al. 2011). Genomic islands with entire 
collections of antibiotic resistance genes can be transmitted through horizontal 
gene transfer, which has been shown to play a crucial role in the spread of 
resistance in bacteria populations, particularly for MRSA (Kriegeskorte & Peters 
2012). Other means of acquisition of resistance involve modifications in the 
essential proteins and mechanisms targeted by antibiotics (Jacoby & Archer 1991; 
Spratt 1994; Blair et al. 2014). For instance, in Mycobacterium Tuberculosis, drug 
resistance arises almost exclusively through chromosomal mutations in genes that 
are required for antibiotic action, i.e., genes that encode the proteins targeted by 
the drugs or the enzymes required for drug activation (Sun et al. 2012; Farhat et 
al. 2013; Zhang et al. 2013). This is the case for mutations in a gene coding for the 




rifampicin (Telenti et al. 1993). Similarly, mutations in genes coding for ribosomal 
proteins (for instance, rpsL (Kurland et al. 1996)), allow bacterial cells to survive 
exposure to streptomycin. These chromosomal mutations can occur at relatively 
high rates. Resistance to rifampicin, for instance, can spontaneously arise at 
frequencies higher than 10-8 in E. coli (M R Baquero et al. 2004). How these 
resistances spread in bacterial communities depend also on demographic 
parameters such as the population size and bottlenecks (Schrag et al. 1997; 
Andersson & Hughes 2011).  
Polymorphism in antibiotic resistant populations 
Given both the high rate of generation of resistant mutants and the multiple 
targets that confer resistance to an antibiotic, the emergence, competition and co-
existence between different resistance alleles are to be expected. Clonal 
interference plays an important role in clinical infections (Miralles et al. 1999; 
Mariam et al. 2011), since it can select for the most fit resistant clones (Hughes & 
Andersson 2015). This has been observed in several studies that sampled clones 
from infections at multiple time points, where diverse segregating resistant 
backgrounds are observed (Al-Hajoj et al. 2010; Navarro et al. 2011). As an 
example, in a study where 3 patients infected with M. tuberculosis were followed 
along time, 4 different resistant clones were detected to be segregating 
simultaneously, while no resistance had been previously detected (Sun et al. 
2012). At the last time point sampled, 94% of the population had a single resistant 
allele, whilst the remaining 6% had other resistance mutations. Another study 
followed a single tuberculosis patient for 42 months, a period over which 12 drug 
resistance mutations where detected above a frequency of 25% in the population. 
Over this time period, only 7 of these mutations reached fixation status (Eldholm et 
al. 2014). Clonal interference and cohort fixation were also shown to be involved in 
virus evolution, where each selective sweep detected in influenza A was inferred 
to be composed of 3 or 4 mutations on average (Strelkowa & Lässig 2012). The 
observations that there are complex dynamics occurring within an infection point to 
the importance of detecting these clinical cases early, in order to avoid selection 
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Figure 3. Dynamics of clonal interference in an M. tuberculosis infection. 
Many clonal lineages harbouring different drug resistance mutations (DRM, 
identified by asterisks) appear along time and compete amongst themselves. 
Some of these lineages eventually fix in the population (green), whilst others 
never reach fixation status (blue). Brown background indicates lineages with 
mutations not known to confer DRM (identified by circles), and mutations for 
which inferred trajectories differ from clonal dynamics are in red. Based on the 
data from (Eldholm et al. 2014), figure retrieved from (Wilson et al. 2016). 
for stronger resistance mutations. Additionally, they also imply that practices of 
isolating a single resistant clone from infections might be misleading, since there 
the level of diversity is high. Recognizing the segregation of cohorts of mutations 
that hitchhike with the fitter resistant alleles is also fundamental to understand the 
chains of transmission of infections between patients (Eldholm et al. 2014). 
 
Compensation to costly resistance mutations 
Mutations that confer resistance to antibiotics allow bacteria to survive in 
the presence of the drugs, but most of them are actually costly to the cell (Schrag 
& Perrot 1996; B R Levin et al. 1997; Andersson & Hughes 2010) (but see also 
(Rodríguez-Verdugo et al. 2013) for a study where rifampicin resistance has 
emerged in the absence of the antibiotic). Because many antibiotic resistance 
mutations occur in genes that encode essential cellular mechanisms (Spratt 1994; 




terms of growth rate, virulence and competitive performance (Björkman et al. 
1998). For instance, resistance to fluoroquinolones can cause impaired motility 
(Stickland et al. 2010), while resistance to aminoglycosides can interfere with the 
structure of the ribosome, reducing the translation rate and impairing growth in rich 
media (Schrag et al. 1997; Paulander et al. 2007). These deleterious effects of 
antibiotic resistance mutations are mostly prevalent when the drug is withdrawn, 
and the resistant cells have a competitive disadvantage to sensitive cells 
(Andersson & Hughes 2010). Therefore, without the selective pressure of 
antibiotics, resistant cells should decrease in frequency, ultimately driven to 
extinction by sensitive cells. Indeed, the fitness cost of resistant cells is the main 
responsible for the decrease in frequency of resistant variants in bacterial 
communities, as postulated theoretically (B R Levin et al. 1997; 2000), and 
assuming no further adaptation would occur. 
There are two main strategies for resistant bacteria to avoid extinction: the 
first is through a mutation that reverts the resistance allele, returning the bacteria 
into a sensitive state (Gifford & MacLean 2013); the second is by acquiring 
additional chromosomal modifications, in other sites of the genome, that buffer the 
deleterious effects of the resistance mutation, conferring a compensatory effect 
(Schrag et al. 1997; Reynolds 2000; Björkman et al. 2000; Maisnier-Patin et al. 
2002; Brandis & Hughes 2013). The latter is arguably the worse outcome for the 
host, because it allows bacteria to maintain their resistance ability, but at a much 
lower competitive cost. As a consequence, a resistance allele might be stabilized 
in the population (Schrag & Perrot 1996; Andersson & B R Levin 1999), because 
its fitness cost is either reduced or non-existent, and a reversion of the mutation 
now lies across an adaptive valley (B R Levin et al. 2000). Compensatory 
adaptation is not limited to antibiotic resistance mutations, potentially occurring 
whenever there is a deleterious modification in the genome (Szamecz et al. 2014; 
Bouma & Lenski 1988). A deleterious mutation was estimated to have, on 
average, 12 possible compensatory mutations (Poon & Chao 2005) and therefore, 
because the number of sites in a genome that can compensate a costly mutation 
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is higher than the single allelic location that can lead to a back mutation, 
compensation is more likely to occur than true reversions (B R Levin et al. 2000). 
Even if a reversion has a strong beneficial effect, since it restores the original state 
of an individual, its low rate of appearance explains why compensatory mutations 
of lower beneficial effects can dominate a population. Once a reversion appears, 
different compensatory alleles are already segregating, and its relative lower effect 
increases the likelihood of being lost by drift (Gifford & MacLean 2013). 
Discovering the evolutionary dynamics of acquisition and segregation of 
these compensatory mutations is the subject of intense investigation, because it is 
paramount to predict stabilization and avoid the long-term maintenance of the 
resistance mutations and the spread of drug resistance (Andersson & Hughes 
2011; Hughes & Andersson 2015). Compensatory adaptation has been observed 
and studied both in laboratory and clinical settings, and has been shown to be 
strongly dependent on the demographic conditions of the populations (Maisnier-
Patin et al. 2002). When E. coli resistant to streptomycin, through mutations in 
rpsL, was serially passaged in streptomycin-free media, the populations 
maintained the resistance to the drug whilst acquiring compensatory mutations in 
other loci, restoring the efficacy of translation (Schrag & Perrot 1996). Mutations 
compensatory for a resistance mutation in the rpsL gene were estimated to occur 
at a rate of at least 10-7 per cell per generation (Maisnier-Patin et al. 2002). In 
another study by Björkman and colleagues, S. typhimurium populations resistant 
to streptomycin, rifampicin or nalidixic acid were serially passed in laboratory mice 
without antibiotic treatment. The virulence of these strains was initially impaired, 
but after evolution this ability was restored, and in the majority of cases these was 
due to mutations in other loci (Björkman et al. 1998). In clinical settings, a study by 
Comas et al has shown that the genomes of rifampicin resistant isolates of M. 
tuberculosis harboured mutations in other loci, such as rpoA or rpoC, that 
compensated the fitness cost without the loss of resistance (Comas et al. 2012).  
Importantly, studying compensatory adaptation has also shed light on 




proteins (Maisnier-Patin et al. 2007). This is due to the fact that many 
compensatory mutations occur either in the same protein where the original 
resistance mutation emerged, or on functionally connected proteins (Brandis et al. 
2012). These secondary mutations that interact epistatically with drug resistance 
mutations are important factors that need to be incorporated when making 
predictions about the epidemiological consequences of drug resistance mutations 
(Wilson et al. 2016).  
Multiple antibiotic resistances 
Because organisms adapt to the cost of resistance mainly through 
mutations in other alleles, if an infection is maintained, or re-occurs, the same 
antibiotic is ineffective and cannot be used again. Occasionally, some resistance 
mutations acquired in the presence of an antibiotic are known to, by themselves, 
confer resistance to other drugs. This effect is called collateral resistance, or 
cross-resistance, and it renders certain alternative treatments less efficient (Lázár 
et al. 2014). However, the most common scenario is that resistance is specific to a 
certain drug and, in such cases, alternative antibiotics can be used to curb 
infections (Kim et al. 2014). This new pressure can, however, lead to the 
acquisition of yet another resistance, thus increasing the repertoire of antibiotics to 
which a microorganism can survive, and increasingly constrain the options for the 
treatment of infections. The emergence and spread of these multiple drug 
resistances (MDR) are increasing at an alarming rate (World Health Organization 
2014). In some case, bacteria seem to acquire resistance faster than new 
antibiotics are developed and, for antibiotic treatments, technology might be losing 
the arms race with evolution (Hede 2014). In some extreme cases, namely for 
tuberculosis, extensively drug resistance (XDR) strains have been clinically 
detected, meaning that they are resistant to the majority of known therapeutics, 
rendering clinical treatment highly ineffective (Velayati et al. 2009). A broad 
research effort is dedicated on how to deal with these MDR pathogens, including 
how to effectively use antibiotic therapeutics to minimize the emergence of these 
strains or even revert their multiple resistant state (Kim et al. 2014). 
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An interesting aspect of MDR is that different resistance mutations are 
known to interact epistatically (Borrell et al. 2013; Trindade et al. 2009). This is not 
surprising, since, as discussed, antibiotic resistance mutations often modify 
proteins that are responsible for essential machinery of the cells, which commonly 
interact and are part of the same cellular processes. So, for instance, it is likely 
that a mutation affecting translation interacts epistatically with another that affects 
transcriptional processes (Hall et al. 2011). The actual mechanistic processes 
involved in these interactions are, for the most part, unknown. However, research 
suggests that different allelic mutations in the same genes display a variety of 
epistatic effects (Durão et al. 2015; Trindade et al. 2009). Of particular concern is 
the fact that some secondary resistant mutations are themselves compensatory for 
the fitness deficits imposed by one of the resistance alleles (Hall & MacLean 
2011). For instance, a study by Borrell and colleagues indicates that 35% of 
combinations of Mycobacterium smegmatis resistant to both rifampicin and 
oflaxocin have a higher fitness than at least one of the corresponding single 
resistant mutant (Borrell et al. 2013). These observations indicate that not only the 
acquisition of multiple antibiotic resistances has a non-linear effect on the cellular 
processes, but also that the interactions can be intricate and concealed by other 
effects. A possible implication from this observation is that the compensatory 
adaptation of multi-resistant bacteria might differ from what is known regarding 
single resistant alleles. So far, this question remains unexplored (MacLean & 
Vogwill 2015). 
 
The immune system as an adaptive pressure 
The thin line between pathogenicity and commensalism 
Many laboratory studies that follow real-time adaptation in microorganisms 
are performed in simple abiotic environments, with either single or multiple sugars, 
and constant, daily bottlenecks (Kawecki et al. 2012). There is a vast array of 




real world of organisms. Therefore, parameters inferred from such in vitro 
experiments, like mutation rates and selective effects, might differ from the ones 
where microorganisms normally exist. For instance, the effects of antibiotic 
resistance mutations are very different when assessed in vitro or in vivo (Martinez 
& F Baquero 2000; Luangtongkum et al. 2012). Although recently experimental 
evolution studies following adaptation in more realistic and complex environments 
have begun to be explored (Gordo et al. 2014; Hindré et al. 2012), most of the 
knowledge about evolutionary parameters originates from adaptation to abiotic 
conditions.  
One of the complex environments where microorganisms live is within a 
mammalian host, where they can play both the role of commensals and pathogens 
(Leimbach et al. 2013). Often this definition is ambiguous, because it depends 
strongly on the conditions experienced by a microorganism. Disease or illness 
symptoms within a host are commonly the result of the wrong cell multiplying in a 
wrong place at the wrong time. For instance, Klebsiella Pneumoniae, an 
opportunistic pathogen that causes pneumonia and urinary tract infections, is a 
normal commensal member of the mammalian gut flora (Lau et al. 2008). Another 
example is found when bacterial cells take advantage of a disrupted 
gastrointestinal barrier to invade the blood stream and cause septicemia 
(Rowlands et al. 1999; Macpherson et al. 2005). Therefore, uncontrolled growth of 
bacteria that would, otherwise, be harmless can spell disaster to its host. This is 
why the control of bacterial populations by the immune system is crucial.  
The antagonism of the innate immune system 
Whilst the immune response to the presence of a pathogen is part of a 
complex cascade, the first responders to an invasion are usually components of 
the innate immune system (Akira et al. 2006). Macrophages are one of the key 
elements of this system, providing defense against invading bacteria by the direct 
and immediate bactericidal response through phagocytosis (Underhill & Ozinsky 
2002). This process is complex, and involves several steps, through which a 
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bacterial cell is recognized, engulfed and destroyed within the macrophages. First, 
recognition is mediated by pattern-recognition receptors (PRR), which identify 
molecular structures in the surface of the bacterial cell (Medzhitov 2007). The 
main structures targeted by PRRs are microbe-associated molecular patterns 
(MAMPs), which can include lipopolysaccharides, peptidoglycans, carbohydrates 
and endotoxins (Medzhitov 2007). Different pathways can be activated upon a 
successful recognition, and depending on the type of activation, macrophages are 
modified physically and chemically in order to engulf the microbes (Mauel 1982). 
When this happens, bacteria are confined to phagosomes, which are endocytic 
vessels that undergo a continuous fusing process (first with early and then with 
late endosomes, and finally with lysosomes) (Vieira et al. 2002). At the end of this 
process, bacteria are destroyed through mechanisms such as dramatic increases 
in pH and the deployment of high concentrations of reactive oxygen species and 
antimicrobial peptides (Slauch 2011). 
Pathoadaptative mutations 
With such strong antagonistic interactions with macrophages, bacteria face 
a tremendous selective pressure. Many bacterial pathogens have evolved 
mechanisms to escape, resist or even kill phagocytic cells (Rosenberger & Finlay 
2003; Baxt et al. 2013). These mechanisms include avoidance of detection by the 
innate immune system (by modifying the molecules that trigger TLR signaling, for 
instance (Le Negrate 2012)), inhibition of engulfing by macrophages (through the 
secretion of proteins that interfere with the phagocytic process (Celli & Finlay 
2002)), or survival in the intracellular environment within phagocytes (by 
increasing its resistance mechanisms against the microbicidal attacks of the cell 
(Ernst et al. 1999)). This latter strategy is particularly interesting, because it marks 
the beginning of an adaptive path that may lead to pathogens that were once 
extracellular to be able to survive (and even replicate (Helaine et al. 2010)) within 
host cells. Inhabiting a host cell can serve both the purpose of avoiding other 
elements of the immune system (Li & Yang 2008), or to acquire nutrients from 




intracellular pathogens, as in the case of Chlamydia (Fields et al. 2011), many 
pathogens are facultative intracellular, being able to survive both inside and 
outside eukaryotic cells (Silva & Pestana 2013). This is the case for Shigella, 
Salmonella or M. tuberculosis, the last of which inhabits macrophages by arresting 
phagosome maturation and avoiding delivery to the lysosome (Kelley & Schorey 
2003). The exit of the intracellular niche usually implies that the host cells are 
destroyed in the process, through microbial induction of cell death, for instance 
(Hybiske & Stephens 2008).  
Adaptation to endure encounters with the immune system can occur 
through the acquisition of pathoadaptive mutations, which are changes in 
particular traits that increase pathogenicity behaviours in bacteria (Sokurenko et 
al. 1999). It is then important to understand what are the types of genomic 
adaptations that can lead to pathoadaptive mutations, and what are the dynamics 
of clonal interference that give rise to strong pathoadaptations. It is likely that 
studying these dynamics in complex environments differ from the ones observed 
in abiotic environments, due to different ecological and demographic processes, 
such as intracellular replication rates (Helaine et al. 2010) or the existence of 
spatial structure in the gut (Lu et al. 2014). The mere presence of an additional 
species in a medium can influence the dynamics of adaptation of bacteria, as 
suggested by the increased rates of adaptation and diversification of E. coli 
evolving in the presence of phages (Buckling & Rainey 2002). Therefore, it is 
crucial to understand how biotic environments and antagonistic interactions with 
the immune system shape the adaptation of bacteria and drive the important 
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Abstract 
Determining the distribution of adaptive mutations available to natural 
selection is a difficult task. These are rare events and most of them are lost by 
chance. Some theoretical works propose that the distribution of newly arising 
beneficial mutations should be close to exponential. Empirical data are scarce and do 
not always support an exponential distribution. Analysis of the dynamics of adaptation 
in asexual populations of microorganisms has revealed that these can be 
summarized by two effective parameters, the effective mutation rate Ue and the 
effective selection coefficient of a beneficial mutation Se. Here we show that these 
effective parameters will not always reflect the rate and mean effect of beneficial 
mutations, especially when the distribution of arising mutations has high variance, 
and the mutation rate is high. We propose a method to estimate the distribution of 




The method, which we call One Bi-allelic Marker ABC, makes use of experimental 
data consisting of periodic measures of neutral marker frequencies and mean 
population fitness. Using simulations, we find that this method allows the 
discrimination of the shape of the distribution of arising mutations and that it provides 
reasonable estimates of their rates and mean effects in ranges of the parameter 
space that may be of biological relevance.   
Keywords 




At what rate do beneficial mutations arise and what are their fitness effects? 
These are two of the most important questions regarding adaptation of organisms to 
novel environments (Kimura and Ohta 1974; Lang, Botstein, et al. 2011). Reflecting 
its importance, estimating genomic mutation rates of new beneficial alleles (U) and 
uncovering the mean effects of those beneficial mutations (E(S)) have been the 
subject of many studies (Bataillon, Zhang, et al. 2011; Estes, Phillips, et al. 2011; 
MacLean and Buckling 2009; Perfeito, Fernandes, et al. 2007; Rozen, de Visser, et 
al. 2002; Sawyer, Parsch, et al. 2007; Sousa, Magalhães, et al. 2012). Experimental 
evolution in clonal populations presents some advantages in determining these 
parameters, but some difficulties still arise, even in these controlled and relatively 
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simple environments. One of these difficulties is being able to assay all the beneficial 
mutations. Different distributions of fitness effects are important to the adaptive 
process: the distribution of newly arising mutations, the distribution of contending 
mutations, which escape initial stochastic loss, and the distribution of mutations that 
survive competition with other mutations (clonal interference) and are able to actually 
fix, contributing to long term adaptation (see (Gordo, Perfeito, et al. 2011) for a 
review). The greatest difficulty is to uncover the distribution of arising mutations, 
because they may easily be lost before reaching detectable frequencies. Despite this 
difficulty, determining the distribution that characterizes arising mutations, f(S),  is 
important, because it is this distribution that determines the nature of adaptation (Orr 
2010; Perfeito, Fernandes, et al. 2007; Rozen, de Visser, et al. 2002; Sousa, 
Magalhães, et al. 2012). For this reason, some studies have tried to determine this 
distribution in viruses (Rokyta, Beisel, et al. 2008; Sanjuán, Moya, et al. 2004), in 
bacteria (Kassen and Bataillon 2006; Stevens and Sebert 2011) and in other 
organisms (Burke, Dunham, et al. 2010; Desai, Fisher, et al. 2007; Orozco-terWengel, 
Kapun, et al. 2012; Schoustra, Bataillon, et al. 2009). Experimental support for an 
exponential distribution of arising beneficial mutations has been obtained (Kassen 
and Bataillon 2006; MacLean and Buckling 2009), but this has not always been the 
case in all organisms and environments (Barrett, MacLean, et al. 2006; Bataillon, 
Zhang, et al. 2011; Gordo, Perfeito, et al. 2011; Mcdonald, Cooper, et al. 2011; 
Rokyta, Beisel, et al. 2008). From the mutations that arise, those that end up 
outcompeting other beneficial mutations will drive long-term adaptation (Gerrish and 




arising, contending and fixed mutations is expected to depend on the effective 
population size (Crow and Kimura 1970), the mutation rate (Charlesworth, Morgan, et 
al. 1993) and on the level of mal-adaptation, with increasingly adapted organisms 
having access to increasingly lower amount of beneficial mutations (Fisher 1930), 
The biggest challenge in determining f(S) lies in the rarity of beneficial 
mutations. In principle, this distribution can be determined directly by measuring 
fitness effects of extremely large samples of mutants (Hietpas, Jensen, et al. 2011; 
Lind, Berg, et al. 2010). It can also be inferred from sequence data collected from 
natural populations (Eyre-Walker and Keightley 2007; Jensen, Thornton, et al. 2008a; 
Jensen, Thornton, et al. 2008b; Nielsen 2005; Schneider, Charlesworth, et al. 2011). 
Indeed, scans for signatures of positive selection across the genome of different 
species, including our own, have been performed (Biswas and Akey 2006; Cutter and 
Choi 2010; Enard, Depaulis, et al. 2010; Grossman, Andersen, et al. 2013; Hancock 
and Di Rienzo 2008). Disentangling the signature of selection from that caused by a 
complex demography is difficult (Grossman, Shlyakhter, et al. 2010; Sinha, Dincer, et 
al. 2011), and checking the performance of different methods under departures from 
model assumptions is therefore an important task (Keightley and Eyre-Walker 2010). 
Recent advances have been made in developing methods for estimating selection 
coefficients from time series data of allele frequencies (Bollback, York, et al. 2008; 
Malaspinas, Malaspinas, et al. 2012; Mathieson and McVean 2013) and also in 
disentangling alleles under positive selection from passenger mutations (Illingworth 
and Mustonen 2011). In the context of experimentally evolved populations, where 
typically the experimenter imposes a particular demographic regime, one method that 
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has been used proposes to study beneficial mutations through assaying the 
evolutionary dynamics of neutral markers in asexual populations (Hegreness, 
Shoresh, et al. 2006; Imhof and Schlotterer 2001). The basic principle underlying this 
method relies on the “hitchhiking effect” of a neutral allele with mutations that give an 
advantage to the organism (Maynard-Smith and Haigh 1974). This same principle is 
at the heart of methods to detect positive selection across the genome of sexually 
reproducing organisms (Thornton, Jensen, et al. 2007). In experimentally evolved 
populations, the frequency of a neutral allele can be easily measured (e.g. by using 
neutral fluorescent markers), and inferring evolutionary parameters from neutral 
marker dynamics can thus be performed under certain theoretical assumptions 
(Barrick, Kauth, et al. 2010; Dykhuizen and Hartl 1983; Hegreness, Shoresh, et al. 
2006; Illingworth and Mustonen 2012).  A simple and quite elegant method was 
proposed by Hegreness et al. (Hegreness, Shoresh, et al. 2006): using simulations, 
they showed that a simple population genetics model, where all beneficial mutations 
have the same effect, is able to reproduce the dynamics of a commonly used marker 
system involving one locus with two neutral markers. The dynamics can therefore be 
summarized by 2 parameters that theoretically represent the evolutionary process: 
the effective mutation rate (Ue) and the effective selection coefficient (Se). Barrick et 
al. extended this method and determined the values of Ue and Se in different strains of 
Escherichia coli (Barrick, Kauth, et al. 2010; Woods, Barrick, et al. 2011). While it may 
be useful to be able to summarize the process under a single mutational effect, far 
more realistic distributions of fitness effects can also explain the data. Recently, 




estimate the distribution of haplotype fitnesses in experimentally evolving populations. 
When tested against simulated data under the assumption of an exponential 
distribution of arising beneficial mutations, the method is able to retrieve the correct 
distribution of haplotype fitnesses for values U below 10-6. It is however not known 
how the method performs for other distributions of arising beneficial mutations and for 
larger values of U. Moreover, this method estimates the distribution of haplotype 
fitnesses segregating in populations and not the distribution of beneficial arising 
mutations. Here we ask two questions: how do the effective parameters compare with 
the more biologically meaningful parameters U and E(S)?; and, since frequency 
dynamics appear insufficient to distinguish between different distributions (Hegreness, 
Shoresh, et al. 2006), is there a reasonable set of data that can be obtained, which 
allows the determination of the distribution of arising beneficial mutations?  
We address both these questions from a theoretical perspective, taking a 
commonly used experimental setup to study the adaptation of asexual populations in 
controlled environments as a motivation. This setup simply involves tracking a marker 
locus with two neutral alleles. We show that the effective evolutionary parameters can 
provide good estimates of U and of the mean effect of beneficial mutations only when 
the distribution of effects of arising mutations has limited variance. However, when the 
variance is increased (for example, if arising mutations follow an exponential 
distribution), we find that Ue can underestimate the true value U, while Se can 
overestimate the true value of E(S). We propose a new method based upon 
measurements of both the frequency of neutral markers and mean population fitness, 
at periodic time intervals. This method, which was motivated by typical experimental 
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setups easily applied to experimental evolution, is theoretically expected to estimate 
the mutation rate reasonably well, and allows distributions of arising beneficial 
mutations with different shapes to be distinguished. 
 
Methods 
Model of adaptation to simulate evolutionary dynamics 
We assume a clonal population reproducing according to the Wright-Fisher 
model, where periodic bottlenecks occur (with a period of Tbot). The population is 
initially isogenic, with the exception of a neutral marker, which is biallelic and has a 
frequency f0=0.5 for one of the alleles. The initial population size is N0. Generations 
are discrete and the population doubles each generation for t < Tbot. With period Tbot, 
the population size is reduced by random sampling to N0. This assumed demography, 
involving periodic bottlenecks where the number of individuals is fixed, is typical of 
most experimental setups, where daily passages of a sample of the population are 
performed, and population numbers are experimentally controlled. At each 
generation, mutations occur at a rate U per genome, following a Poisson distribution. 
All mutations are beneficial and the effects of each mutation (S) are drawn from a 
continuous distribution f(S). We allow for variation of the selective effects of arising 
mutations, assuming a Gamma distribution, with shape and scale parameters, α and 
β, respectively, implying a mean E(S) = αβ. Like other studies that previously 
proposed to estimate the distribution of arising deleterious mutations (Eyre-Walker 




because it can have a wide range of shapes.  Multiplicative fitness is assumed, so 
that the effects of mutations do not depend on the genetic background where they 
arise. This is obviously an oversimplification, since the distribution can change along 
the adaptive walk (Martin and Lenormand 2006; Sousa, Magalhães, et al. 2012), but 
we consider a short-term evolution scenario where U and f(S) may be assumed 
constant. Genetic drift is modeled by sampling, from a multinomial distribution, 
classes of individuals with the same fitness. The frequency dynamics of the neutral 
marker (f(t)), as well as the mean population fitness (w(t)), are followed. This model of 
adaptation is used to produce a set of simulated evolutionary dynamics, from which 
evolutionary parameters are estimated using different methods: a method developed 
by Hegreness et al. (and extended by Barrick et al), and a new method that we 
propose here that simultaneously tries to estimate U and f(S) (see below).  
The range of parameters chosen to produce simulated data with the described 
model was made in accordance with current estimates in different systems, but 
mostly in microorganisms. U is currently estimated to achieve values between 10-4 
and 10-9, depending on the environment and genetic background (Denver, Wilhelm, et 
al. 2012; Drake, Charlesworth, et al. 1998; Lang, Botstein, et al. 2011; Perfeito, 
Fernandes, et al. 2007). An effective population size Ne=105 was assumed 
(corresponding to bottlenecks with a period tbot=5 generations) for all simulations 
except when indicated differently. 
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Generating pseudo-observed data  
Pseudo-observed data sets were generated under the model of adaptation 
described above, with a specific value of the mutation rate U and a specific Gamma 
distribution (with parameters α and β) with mean E(S). These data sets represent 
biological data that can be acquired in an experiment. The new method proposed 
here with the goal of estimating f(S) and U, requires the periodic measure of the 
frequency of the neutral markers and the mean population fitness (every 50 
generations for a 300 generation experiment). These appear reasonable to obtain 
experimentally and require experimental work that is typical in evolution experiments 
performed in controlled environments: in addition to assaying the frequency of the 
markers (as already is typically done (Woods, Barrick, et al. 2011)), fitness has to be 
measured by performing either a direct competitive fitness assay against the 
ancestral strain or a measurement of the population growth rate at different times 
along the experiment (Gordo, Perfeito, et al. 2011). Furthermore, the choice of 
studying 100 replicate populations reflects the 100 or 96 well plate experimental setup 
that is commonly used (Kvitek and Sherlock 2011; Lemonnier, Levin, et al. 2008). 
These plates are affordable by most labs, and, with a multichannel pipet, several 
passages can be performed in little time, space, and at low cost, particularly when 
studying microbial populations. Regarding the markers, many strains expressing 
different fluorescent alleles are available, which makes the acquisition of frequency 
data a relatively easy task. This can be performed using flow cytometry or another 
fluorescence reader. Competitive fitness measurements (Elena and Lenski 2003) can 




 The pseudo-observed data therefore consist of the marker frequencies and 
the fitnesses at periodic time points of the experiments (ti) for n independently 
evolved populations. Different pseudo-observed data sets assuming different 
distributions of S were generated to test the two different methods: Barrick et al. 
method (which requires the marker frequencies only), to compare Ue with U and Se 
with E(S), and the One Bi-allelic Marker ABC (which requires both the marker 
frequencies and the fitnesses) to assess its ability to estimate U, α and β (see later). 
Estimation of U and E(S) by Ue and Se based upon the dynamics of the first significant 
deviation of f(t)  
For a given set of pseudo-observed data we obtained the effective parameters 
Ue and Se and compared them with the biologically meaningful values of U and E(S). 
To obtain Ue and Se we followed Barrick at al. A large set of simulated evolutionary 
dynamics under the assumption that all beneficial mutations have the same value of 
S was generated. This simulated data consists of sets of 100 replicate populations 
evolved under different parameter combinations of U and S. The range of log10(U) 
was [-8; -3.95], with increments of 0.15, and the range of S was [0.01; 0.18], with 
increments of 0.01. This simulated data is the input of Barrick et al. method (Barrick, 
Kauth, et al. 2010) to obtain Ue and Se. For each simulation it consists of the logarithm 
of the ratio of the two subpopulation frequencies (Rf=f(ti)/(1-f(ti)) at several time 
points, ti, (ln(Rf(ti))), where ti=5*i. We then use this input in the program 
marker_divergence_fit.pl, whose output is fed into the program marker_divergence_significance.pl, both 
available at http://barricklab.org/twiki/bin/view/Lab/ToolsMarkerDivergence, to obtain Ue 
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and Se. The first program summarizes the evolutionary dynamics (both in the 
simulated data sets and in the pseudo-observed data) in two statistics: τe and αe. The 
first is the time, τe, where a significant deviation of Ln(Rf(τe)) from Ln(Rf(t=0)) occurs. 
The second is the rate of change of Ln(Rf(t)) with time, i.e. τe sets the time of 
divergence of marker frequency and αe the rate of divergence. Each replicate 
population is summarized by a single value of τe and αe., and the n replicate 
populations (characterized by a given combination (U , S)) result in a distribution of 
T(τe) and A(αe). These distributions are then compared, using the second program, to 
the distributions of τe and αe that summarize the pseudo-observed data To(τe) and 
Ao(αe) using a two-dimensional Kolmogorov-Smirnov to test the fit between the 
simulated data and the pseudo-observed data. The combination (U, S) that gives rise 
to the highest P-value is taken as Ue and Se, even when the hypothesis that the 
distributions are different cannot be rejected.  
This procedure was done to obtain the results in Figures 1, S1 and S4, where 
twenty independent replicates of each pseudo-observed data set (under the same U, 
α and β) were performed and the average of Ue and Se obtained for each pseudo-
observed data set is presented.  
 
New estimation method based upon the dynamics of frequency and fitness  
We propose a new method, the One Bi-allelic Marker ABC (Figure 2), which 
aims to infer the distribution of arising mutations. The pseudo-observed data used to 




explained before, but the method now analyses the distributions, along time intervals 
(ti), of both marker frequency (f(ti)) and fitness (w(ti)), where ti=i*50 generations (i=0 
to 6) are measured for 100 replicate populations evolving under a given U, α and β. A 
large data set with 1 million simulated evolutionary dynamics is produced, each with a 
set of 100 replicate populations evolving under a specific combination of parameters 
U, a and b. For each of the simulations, each parameter is randomly chosen from the 
following distributions: log10(U) ~ Uniform [-9;-4]; a ~ Uniform  [0.5; 15]; and log10(b) ~ 
Uniform [-4;-0.08]. Both the pseudo-observed data and the simulated data are 
summarized as the distribution of the values of |0.5-f(ti)| represented as a histogram, 
with 5 binned classes, for the marker frequency at different time points (ti), and of the 
distribution of fitness effects at the same time points, w(ti), represented as a 
histogram with  6 binned classes. This results in 11 summary statistic values for each 
of the 6 time points used in the analysis (table in Figure 2). 
Summary statistics from pseudo-observed and simulated data are compared 
using an Approximate Bayesian Computation (ABC) method (Beaumont, Zhang, et al. 
2002) implemented in R (Csilléry, François, et al. 2012) (package downloaded from 
and available at http://cran.r-project.org/web/packages/abc/index.html). ABC 
approaches have previously been used, for example, to determine rates of selective 
sweeps using sequence data from populations of Drosophila melanogaster (Jensen, 
Thornton, et al. 2008a). The input of the ABC method are the summary statistics of 
the 100 replicate populations that compose the pseudo-observed data (S(y0)) and the 
previously described 1 million simulations (S(yi)). The ABC method computes the 
posterior probability distribution of a multivariate parameter, θ (composed of a 
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combination of U, α and β). A value for this parameter, θi, is sampled from the prior 
distributions, and the summary statistics computed from simulated data S(yi) are 
compared to those of the pseudo-observed data S(y0) using the Euclidian distance d. 
If d is below a given threshold, the parameter value θi is accepted. The threshold 
(tolerance) chosen was 0.5%, which corresponds to the proportion of accepted 
simulations. The estimation of the posterior probability distribution for θ can be 
improved by different regression-based methods available in the ABC R package 
(Csilléry, François, et al. 2012): local linear regression and neural networks. We used 
the neural network method, which performs a dimensionality reduction in the 
summary statistics, and is suggested to be appropriate for use with high 
dimensionality (Csilléry, François, et al. 2012). Through this procedure, we obtain 
estimates for U, α and β, outputted as posterior distributions for each parameter. For 
each combination of parameters (U, α and β), twenty independent pseudo-observed 
data sets were considered to produce the statistics presented in the results. A 
scheme with the different steps described here is represented in Figure 2. 
Effect of variation in initial frequency of marker and presence of deleterious mutations 
We tested the effect of small variations in the initial frequency of each of the 
initial subpopulations (Figure S3) as they may occur in any experimental setup. We 
also tested how the estimates would be affected by the occurrence of deleterious 
mutations (Figure S2). For the first scenario, we generated pseudo-observed data 
sets under the same assumptions of the adaptation model described above except 




Uniform distribution, e ~ Uniform [-0.03, 0.03] (Figure S3). For testing the effect of 
deleterious mutations we generated pseudo-observed data sets assuming that, in 
addition to beneficial mutations, deleterious mutations can also occur at a rate of 10-3 
and each having a selection coefficient Sdel = 2%. Multiplicative fitness was also 
assumed (Figure S2). All other assumptions were kept the same. Pseudo-observed 
data sets for both cases were generated with a Gamma distribution of fitness effects 
with α = 1. 
 
Results 
Comparison of effective parameters Ue and Se with U and the average effect of 
beneficial mutations 
To determine if the effective parameters Ue and Se are good estimates of U 
and S, we generated pseudo-observed data for a given value of U and with fitness 
effects drawn from a Gamma distribution with different shape and scale parameters 
(Figure 3). For populations with Ne=105, the estimated values of the effective 
parameters are shown in Figure 1, where we also have included results for the case 
where pseudo-observed data was generated under a model where all beneficial 
mutations have the same effect, since this is the case where the estimates are 
expected to perform best. Figure 1A shows that Ue provides a good estimate of U 
for Gamma distributions with shape parameter bigger than 1. This is observed in the 
cases where U is low (<10-6), but when U=10-5 and E(S)=0.02, Ue underestimates U 
by a quarter of its real value. Larger biases can be seen for the Exponential 
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distribution (α=1), particularly under high mutation rates (>10-7), where clonal 
interference may be more pronounced. We find that when the distribution of S is 
Exponential with mean 2% and the mutation rate is 10-5 (parameters that have been 
estimated in some bacteria evolution experiments (Perfeito, Fernandes, et al. 
2007)), Ue considerably underestimates the real value of U by an order of 
magnitude. This also happens when the mean effect of beneficial mutations is 6%. 
The underestimation becomes smaller when either the mutation rate or the variance 
in S decreases. As expected, Ue provides an accurate estimate of U when S is 
constant (except for the case where a high value of the mutation rate is considered). 
Figure 1B shows that Se overestimates E(S) 2 to 4 times for a mutation rate higher 
10-6, with a=1. For α=10 this overestimation is small (less than 1.5-fold). Importantly, 
however, most of these values for Se seem to provide an estimate of the order of 
magnitude of the mean effect of beneficial mutations. To test if the bias in Ue and Se 
increases with clonal interference, we also studied populations with increased 
effective population size (Ne=106). Indeed, we find that both Ue (Figure S1A) and Se 
(albeit to a lesser extent) (Figure S1B), show larger deviations from U and E(S), 
that can be up to a 50 fold underestimates of U and a 6 fold overestimates of E(S). 
In sum, higher levels of clonal interference (more pronounced in larger populations 
and with higher values of the mutation rate) lead to larger biases in Ue and Se. 





Figure 1: Performance of the single S model, according to the highest 
scoring estimates for pseudo-observed data with f(S) as Gamma 
distributions of different variances. A) Ratios of estimates of U over real 
parameter U; B) Ratios of estimates of S over the mean effect of S. The box plots 
of 20 independent estimation processes are shown, with the median indicated as 
a bar. Asterisks indicate cases where none of the 20 independent replicates was 
fitted significantly. 
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1 million simulations generated with parameters uniform and randomly chosen from:
Priors for U Priors for α Priors for β 
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Priors for ABC Inference
Transform simulations into the summary statistics created with experimental data
Posterior for U (log10) Posterior for α Posterior for β (log10)
0.65 0.1 0 0.1 0.15
0.15 0.1 0 0 0.75
0.1 0 0 0.05 0.85
0.05 0.05 0 0.05 0.85
0.05 0.05 0 0 0.9







0.65 0.1 0.1 0.05 0.05 0.05
0.35 0.2 0.2 0.1 0.05 0.1
0.35 0.3 0.1 0.1 0.1 0.05
0.2 0.2 0.15 0.15 0.15 0.15
0.2 0.25 0.15 0.15 0.15 0.1
0.15 0.25 0.2 0.25 0.05 0.1
Summary Statistics
Experimental Data




































Figure 2: Schematic description of the One Bi-allelic Marker ABC.  
Data is obtained from an evolution experiment (here called pseudo-
observed data), at specific time points, involving replicate adaptations to a 
common environment (an example of 20 replicate populations is shown). 
For each time point the data is condensed to summary statistics, for 
marker frequency and mean population fitness, which are histograms with 
the frequency of populations that fall in different bins (5 for frequency data, 
6 for fitness data) at every 50 generations (Gen.). The choice of the bin for 
the frequency statistics is dictated by the module of the difference 
between the initial and current frequency of the subpopulations, so that 
this value is, at most, 0.5 (for marker frequencies of 1 or 0). A large 
simulated data set is built against which the experimental data is 
compared. The priors chosen to produce the simulated data set, which 
consist in 1 million simulations, are shown. Each simulated data (obtained 
with a given value of U, α and β) is then classified according to the same 
summary statistics as calculated for the observed data – called Summary 
stats (Priors) and Summary stats (Experimental), respectively. Using ABC 
inference these summary statistics are compared and the ones closest to 
the experimental data chosen. The 5000 top ranked values (0.5%) of each 
of the parameters are shown as the posterior distribution where the 
median value is highlighted in red. 
Figure 3: Theoretical distributions of beneficial selective coefficients 
assumed to produce pseudo-observed data.  A) Gamma distribution with 
shape parameter α=1 (Exponential distribution), for different scale (β) 
parameters; B) Gamma distribution with shape parameter α=10, for different 
scale (β) parameters. 
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Estimation of the distribution of arising beneficial effects  
To go beyond the mean effect of beneficial mutations and to try to estimate the 
distribution of arising beneficial mutations, we developed a new method, which we call 
One Bi-allelic Marker ABC (Figure 2). To test its performance in retrieving the 
evolutionary parameters U, α and β, we explored different sets of pseudo-observed 
data with combinations of parameter values that seem reasonable given the current 
literature (Denver, Wilhelm, et al. 2012; Lang, Botstein, et al. 2011; Perfeito, 
Fernandes, et al. 2007).  
In Figure 4 we show the ability of the One Bi-allelic Marker ABC method to 
estimate U, α and β, when the distribution of arising mutations is Exponential. This is 
the most commonly assumed distribution in theoretical studies of the adaptive 
process (Betancourt & Bollback, 2006; Orr, 2010). Figure 4A shows that the One Bi-
allelic Marker ABC method provides estimates of U within an order of magnitude, for 
all cases tested. The worst performance lies in retrieving U for both high values of 
E(S) (5% and 10%) and high U (3x10-5), but even in these cases the estimated value 
allows for a correct estimate of the order of magnitude of U. For the intermediate 
value of the mutation rate studied (U=3x10-6) the method provides an accurate 
estimate of U. Figures 4B and 4C provide the results for the estimates of the shape 
and scale parameters of f(S). As shown in Figure 4B, the estimate of the shape 
parameter a is close to 1 or 2, for the majority of the cases considered. Exceptions 





Figure 4: Performance of the One Bi-allelic Marker ABC method, for 
pseudo-observed data generated with f(S) as a Gamma distribution with 
α=1 and different scales (β). Labels above the bars show the mean selection 
coefficient for each case, and x-axis shows the value assumed for the mutation 
rate. A) Ratios of estimates of U over real parameter U; B) Estimates of the 
shape (α) parameter; C) Ratios of estimates of the scale (β) parameter over the 
real scale parameter. The box plots of 20 independent estimation processes are 
shown, with the median indicated as a bar. 
variance. Estimation of β, shown in Figure 4C, is remarkably good, across the 
parameter range studied, being always below 2-fold the real value of β.  
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We also studied the case where the distribution of arising beneficial mutations 
has a different shape, specifically α=10 (see Figure 3). As shown in Figure 5A, the 
estimated values of U are very close to the real ones in this case, rarely exceeding 2 
times the real U values, although it can be either over or underestimated, depending 
upon the average selective effect. The two parameters characterizing the 
distribution of arising mutations are also remarkably close to the real values. Figure 
5B shows that α is always estimated to be close to its true value (between 7 and 
12), irrespectively of the value of U. Importantly, this estimate of α allows us to 
detect that the distribution of arising mutations is not Exponential. The method, 
therefore, has power to reliably distinguish between distributions of effects with 
distinct shapes. In Figure 5C the performance of the estimates regarding the β 
parameter of the distribution of effects is shown. β is well estimated, never 





Figure 5: Performance of the One Bi-allelic Marker ABC method, for pseudo-
observed data generated with f(S) as a Gamma distribution with α=10 and 
different scales (β). Labels and symbols are as in Figure 4.	  
 
To further assess the power of the method in distinguishing distributions with 
different shapes, we studied intermediate values of α, between 0.75 and 10. In 
Figure 6, we show that the One Bi-allelic Marker ABC method is able to discriminate 
not only between the two limiting cases in our simulations, but also between 
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Figure 6: Estimates for the shape (α) parameter, for pseudo-observed data 
generated with f(S) as a Gamma distribution with varying α and scales (β), 
in order for E(S) to be constant within a mutation rate. Labels show the α 
parameters used as pseudo-observed data for each case. The box plots of 20 
independent estimation processes are shown, with the median indicated as a 
bar. 
intermediate α values. The method fails to distinguish the shape of the distribution of 
arising mutations when 0.75 < a < 2, especially when U is large. In these cases, α is 
overestimated (by about 2 fold). When a > 2, estimates of a consistent with the true 
value are obtained. When a=4, rejection of an exponential distribution is obtained. 
Overall, the method provides a reliable distinction between different shapes of the 
distribution of arising mutations, although distinguishing between α values lower 





In order to estimate the parameters that describe the dynamics of adaptation, 
we need powerful methods. Beneficial mutations are essential in driving adaptation 
and their statistical properties remain an open question (Orr 2010). Although 
methods developed to tackle this subject may never perfectly capture the complete 
nature of the evolutionary process, they can provide reasonable estimates regarding 
the strength of the forces involved in the process (Keightley and Eyre-Walker 2010; 
Thornton, Jensen, et al. 2007). 
A simple theoretical approach assumes that all mutations have the same 
fitness effect and has been shown to have predictive power in explaining certain 
patterns of data obtained in experimentally evolved populations (Hegreness, 
Shoresh, et al. 2006). Notwithstanding, several direct measurements of mutation 
effects point to the existence of considerable variation (Kassen and Bataillon 2006) 
which motivates the development of new methods that try to infer the underlying 
distribution of arising beneficial effects.  
Regarding the estimated effective evolutionary parameters studied here, it 
seems clear that the relation with the real parameters is dependent on the actual 
distribution of effects of arising mutations: exponential-like distributions of beneficial 
effects result in values of Ue below the true mutation rate and values of Se above the 
true mean effect of mutations, with the difference being reduced when the 
distribution of effects decrease in variance. Nevertheless, assuming a fixed value for 
S has been a commonly used method to infer the evolutionary parameters from 
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experimental data, for example in studies that address how evolvability is dependent 
upon the genetic background. In one such study, Barrick et al. (Barrick, Kauth, et al. 
2010) isolated 8 clones of Escherichia coli with different mutations in the rpoB gene, 
encoding the β subunit of RNA polymerase. As these mutations are generally 
deleterious in environments without antibiotics, and they can cause a wide range of 
fitness defects (Trindade, Perfeito, et al. 2010), the authors estimated Ue and Se to 
determine the evolvability of different (but related) genotypes. The two neutral 
markers dynamics were used to estimate the evolutionary parameters and, from 
these dynamics, it was inferred that mutants with a higher fitness defect had a 
higher evolvability caused by a stronger selective effect of beneficial mutations. 
Interestingly, the inferred mutation rate (through Ue) appears to be independent of 
the genetic background. Since we show here that Ue may be below U and Se above 
E(S), some caution is to be taken when drawing conclusions regarding the relation 
between evolvability and fitness effects of such mutations. Similar caveats apply in 
the study of Woods et al. (Woods, Barrick, et al. 2011). That study involved a long-
term evolution experiment, running for more than 50,000 generations, where clones 
sampled at generation 500 were found to carry mutations in topA and rbs. These 
were shown to be beneficial and fixed after generation 1500, and their carriers were 
called “eventual winners”. Other contemporaneous genotypes (with other mutations) 
were deemed “eventual losers”. Even though both sets of clones had increased 
fitness related to the ancestral, the “eventual losers” also had, counter intuitively, 
increased fitness relative to the “eventual winners”. To understand why the “eventual 




E(S) were inferred (through Ue and Se ) by assaying neutral marker dynamics. The 
authors found that “eventual winners” had, indeed, the ability to generate beneficial 
mutations with stronger effects, compared to the “eventual losers”.  
The approach used in both studies to determine evolvability may provide an 
overestimate of the mean selective coefficient in the order of two to three times the 
real values if the mutation rates are in the order estimated by the authors, or even 
more, if the mutation rates are underestimated (see Figure 1B). As a consequence, 
this could imply that the actual mean selective coefficients are lower than the one 
estimated, and small differences in evolvability may be difficult to detect.  
In general, inferring evolutionary parameters and, more specifically, the 
distribution of arising mutations, from data of evolving populations is a difficult task. 
Experimentally, one way to gain further insight into the distribution of effects is to use 
more than two neutral markers, which can bring more power (Perfeito, Fernandes, et 
al. 2007). Theoretically, we can expect that new and improved methods are likely to 
emerge. Recently, Zhang et al. (Zhang, Sehgal, et al. 2012) extended the previous 
model by Hegreness et al. to incorporate a continuous initial growth phase, dividing it 
in 50 time intervals, and developing an analytical model to find the distributions of 
estimators for U and S. Like the previous work, however, only the initial dynamics are 
considered (the first significant deviation), and the method does not consider the 
occurrence of clonal interference. Illingworth and Mustonen (Illingworth and Mustonen 
2012), on the other hand, developed a maximum likelihood method where the marker 
dynamics over the total amount of time followed is used. The method determines the 
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minimum number of mutations that best describe the dynamics and allows inferring 
the distribution of haplotype fitnesses that are segregating. Although the performance 
of the method is quite good under certain conditions, it is not clear how it will perform 
under a wide range of mutation rates.  
Here we propose a new theoretical approach that is expected to contribute to 
improved insight regarding the distribution of arising beneficial mutation effects. Using 
Approximate Bayesian Computation, we propose a set of summary statistics to be 
used under a simple experimental setup, where distributions of marker frequencies 
and the mean fitness of the population are recorded at periodic time intervals. These 
statistics allow a reasonable estimation of the distribution of arising mutations and of 
the mutation rate, provided that we accept that such a distribution may be well 
approximated by a Gamma. Combining the parameters of the Gamma distribution (α 
and β), it is also possible to estimate the mean effect of arising beneficial mutations 
(E(S)). Figure 7 shows the estimates of E(S) given by the method when α=1 or α=10. 
Under an Exponential distribution of fitness effects (Figure 7A), which is commonly 
assumed, the mean effect can be overestimated up to 5 or 6 fold, for large values of 
the mutation rate. For α=10, the estimate E(s) is very accurate, reflecting its real value 








Figure 7: Ratios of estimated average beneficial selective coefficient over 
the real average beneficial selective coefficient (both calculated as αβ). 
Labels above the bars show the mean selection coefficient for each case, and x-
axis shows the value assumed for the mutation rate. Pseudo-observed data was 
generated with f(S) as a Gamma distribution with α=1 (Exponential distribution of 
f(S)) (A) or α=10 (B). The box plots of 20 independent estimation processes are 
shown, with the median indicated as a bar. 
 
The One Bi-allelic ABC method seems to allow distinguishing between 
distributions with different shapes and scales. The underlying model used makes 
several assumptions, which could be violated in a real experiment. In particular, it 
assumes that the initial population is composed of two equally sized subpopulations, 
each with a different marker, and it also assumes that no deleterious mutations occur. 
To test the robustness of the approach in the face of these assumptions, we 
performed new simulations where pseudo-observed data was generated. In one 
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case, the initial marker frequency was allowed to deviate from its expectation of 0.5 
(Figure S3). In the other case, deleterious mutations were allowed to occur with rates 
and effects typical of those inferred from mutation accumulation experiments with 
bacteria (Kibota and Lynch 1996; Trindade, Perfeito, et al. 2010) (Figure S2). In both 
these cases, the inference of the values of U, α and β were similar to those obtained 
before.  
We performed the analysis of a method, which assumes a common 
experimental setup with only one neutral locus with 2 alleles and fitness 
measurements at periodic time intervals. In principle this setup can be extended to 
follow variation of one locus with more alleles or neutral variation at more loci. The 
method could then be extended and a thorough study of the best summary statistics 
would be needed to ask what would be the minimal set of data required to reasonably 
estimate the rate and distribution of arising beneficial mutations. 
 We have also tested the effect of considering a smaller number of populations 
in order to determine if the approaches can provide reasonable estimates when 
applied to data that have been obtained in studies involving experimental evolution 
with fewer replicates. Figure S4 shows the comparison of Ue with U and Se with E(S) 
when the number of replicate populations is 10, which corresponds to the 
approximate size of previously published experiments (Barrick, Kauth, et al. 2010; 
Hegreness, Shoresh, et al. 2006; Woods, Barrick, et al. 2011). We observed similar 
biases to those found when considering 100 replicate evolved populations. Regarding 




reduced number of populations, reasonable estimates of U can be obtained; the 
estimated values of a tend to produce an overestimation which can be up to 15 fold, 
while the estimates of β are close to the real ones (Figure S5). 
The One Bi-allelic Marker ABC method, as the alternatives discussed above, 
displays certain limitations in its performance, which are particularly apparent when 
dealing with very intense clonal interference, for which a system with more markers 
would be desirable. It is a method that tries to estimate the distribution without limiting 
the number of mutations in a given genetic background, and taking into account the 
dynamics of the entire process of adaptation. For a wide spectrum of mutation rates, 
we are able to estimate the parameters of the underlying distribution of beneficial 
mutations. The One Bi-allelic Marker ABC method was tested over a range of 
distributions of beneficial selective coefficients and beneficial mutation rates, including 
high mutation rates, which are typically not studied in the analysis of other methods. 
This gives us a fairly good degree of confidence that, in applying the method to real 
biological data from adaptation experiments of clonal populations using the two-
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Figure S1: Performance of the single S model, according to the highest scoring 
estimates for experimental data with f(S) as Gamma distributions of different 
variance and Ne=106. A) Ratios of estimates of U over the real parameter U; B) Ratios 
of estimates of S over the mean effect of S. The box plots of 20 independent 
estimation processes are shown, with the median indicated as a bar. Asterisks indicate 
cases where none of the 20 independent replicates was fitted significantly. 
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Figure S2: Effect of the presence of deleterious mutations in the estimation of U, 
a, b and E(S) with the One Bi-allelic Marker ABC method. Pseudo-observed data 
sets were generated with a model where deleterious mutations occurred at rates 
Ud=0.001, each having an effect 0.02. Beneficial mutations were sampled from a 
gamma distribution with α=1. A) Estimation of U; B) Estimation of α;  C) Estimation of 
β;  D) Estimation of the mean beneficial effect αβ . Asterisks indicate the cases where 
the inferences for pseudo-observed data sets with both beneficial and deleterious 
mutations is significantly different (Mann-Whitney test P < 0.05) from the inference 
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Figure S3: Effect of uncertainty in the value of the initial marker frequency when 
estimating U, a, b and E(S) under the One Bi-allelic Marker ABC method. Pseudo-
observed data sets were generated assuming random variation around the initial 
marker frequency (0.5) by adding a random error uniformly distributed [-0.03; 0.03]. A) 
Estimation of U; B) Estimation of α ;  C) Estimation of β;  D) Estimation of the mean 
beneficial effect αβ. Asterisks indicate the cases where the inferences for pseudo-
observed data sets including error in initial frequencies is significantly different (Mann-




















































































Figure S4 Estimation of U and S through the effective evolutionary parameters 
(Ue and Se) with pseudo-observed data from 10 replicate populations with f(S) as 
Gamma distributions of different variances and Ne=105. A) Ratios of estimates of U 
over real parameter U; B) Ratios of estimates of S over the mean effect of S. The box 
plots of 20 independent estimation processes are shown, with the median indicated as 
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Figure S5 Estimation of U, a, b and E(S) with the One Bi-allelic Marker ABC 
method with pseudo-observed data from 10 replicate populations. A) Estimation 
of U; B) Estimation of α;  C) Estimation of β;  D) Estimation of the mean beneficial 
effect αβ. Asterisks indicate the cases where the inferences are significantly different 
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Abstract 
One of the simplest models of adaptation to a new environment is Fisher’s 
Geometric Model (FGM), in which populations move on a multidimensional 
landscape defined by the traits under selection. The predictions of this model have 
been found to be consistent with current observations of patterns of fitness 
increase in experimentally evolved populations. Recent studies investigated the 
dynamics of allele frequency change along adaptation of microbes to simple 
laboratory conditions and unveiled a dramatic pattern of competition between 
cohorts of mutations, i.e. multiple mutations simultaneously segregating and 
ultimately reaching fixation. Here, using simulations, we study the dynamics of 
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phenotypic and genetic change as asexual populations under clonal interference 
climb a Fisherian landscape, and ask about the conditions under which FGM can 
display the simultaneous fixation of mutations along the adaptive walk. We find 
that FGM under clonal interference, and with varying levels of pleiotropy, can 
reproduce the experimentally observed competition between different cohorts of 
mutations (“cohort interference”), some of which have a high probability of fixation 
along the adaptive walk. Overall, our results show that a simple version of FGM is 
able to capture the dynamics of cohorts of mutations that are observed in 
experiments involving the adaptation of microbial populations. 




Understanding the mechanisms and dynamics underneath the adaptive 
process is still a great challenge in evolutionary biology. Even in relatively simple 
environments, evolution experiments demonstrate that this process often involves 
complex dynamics such as: (1) competition between clones carrying different 
adaptive alleles (Maharjan & Ferenci 2015; Desai & D S Fisher 2007; Perfeito et 
al. 2007) , (2) hitchhiking, along with beneficial alleles, of neutral and even 
deleterious mutations (Maharjan & Ferenci 2015; Gerrish & Lenski 1998; Desai & 
D S Fisher 2007; Lang et al. 2013; Perfeito et al. 2007), (3) second-order selection 
of mutations which lead to increased mutation rates and mutator phenotypes 
(Maharjan & Ferenci 2015; Sniegowski et al. 1997; Desai et al. 2007; Tenaillon et 
al. 2001; Perfeito et al. 2007; Barrick et al. 2009; Wielgoss et al. 2013), or (4) the 
emergence of negative frequency-dependent interactions between genotypes 
(Desai & D S Fisher 2007; Maharjan & Ferenci 2015; Lang et al. 2013; Maharjan 
2006; Gerrish & Lenski 1998; Desai et al. 2007; Herron & Doebeli 2013; Perfeito et 
al. 2007). It is increasingly evident that not only these dynamics influence the 
adaptive process but also that they emerge as a result of the adaptive process. 
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For instance, the fixation of mutator phenotypes has been typically observed in 
adapting populations, as their higher mutation rate provides them with a higher 
probability of acquiring and hitchhiking with rare beneficial mutations (Desai & D S 
Fisher 2007; Chao & Cox 1983; Lang et al. 2013; Taddei et al. 1997; Tanaka et al. 
2003; Gentile et al. 2011; Torres-Barceló et al. 2013). More recently, experimental 
findings from microbial evolution experiments coupled with sequencing analysis 
unveiled that a dramatic level of polymorphism in populations can occur during 
adaptation. Interestingly, a pattern of aggregation and hitchhiking of multiple 
mutations is observed – cohorts – in populations adapting to the same 
environmental laboratory conditions. Synchronous increase or decrease in 
frequency of these mutations, competition between distinct cohorts and the 
simultaneous fixation of the mutations that form the cohorts is pervasive during 
this laboratory microbial adaptations (Sniegowski et al. 1997; Lang et al. 2013; 
Tenaillon et al. 2001; Ming-Chun Lee & Marx 2013; Barrick et al. 2009; 
Maddamsetti et al. 2015; Wielgoss et al. 2013).   
A classical model of adaptation to a novel environment is Fisher’s 
Geometrical Model (FGM), where a population adapts towards a fixed optimum 
(Ronald Aylmer Fisher 1930). FGM considers the process of adaptation assuming 
that individuals are defined by their traits under selection, which are geometrically 
represented in a defined multidimensional landscape. In this model, directionality 
in selection emerges by assuming that fitness is related to the distance of each 
phenotype to the optimum. Thus, a population moves towards the fitness peak 
through the gradual accumulation of beneficial mutations. FGM has been 
extensively studied beyond its original scope to make predictions under different 
scenarios about the distribution of beneficial mutations during adaptation (Orr 
1998; Martin & Lenormand 2008; Bataillon et al. 2011), the level of epistasis 
between mutations (Martin et al. 2007; Blanquart et al. 2014), the effects of 
deleterious mutations accumulated under relaxed selection (Martin & Lenormand 
2006; Perfeito et al. 2014), the effect of drift load in the fitness at equilibrium  (Otto 
& Orive 1995; Lourenço et al. 2011), sympatric speciation in an environment with 
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multiple fitness peaks (Barton 2001; Sellis et al. 2011) and the effect of mutation 
pleiotropy (the number of traits affected by a single mutation) in adaptation (Welch 
& Waxman 2003; Chevin, Martin, et al. 2010b; Lourenço et al. 2011). Martin 
(Martin 2014) recently proposed that FGM basic assumptions can emerge from 
models which consider the nature of complex metabolic networks within a cell. 
FGM predictions are largely compatible with observations coming from 
experimental evolution studies, mostly in microorganisms (MacLean et al. 2010; 
Chou et al. 2011; Khan et al. 2011; Gordo & Campos 2013; Sousa et al. 2012; 
Weinreich & Knies 2013; Tenaillon 2014).  
Here we ask whether the patterns of competition and fixation of 
simultaneous segregating mutations (cohorts) along an adaptive walk observed 
experimentally can be reproduced under FGM. Since the simplest version of FGM 
assumes full mutational pleiotropy, which is a restrictive assumption and thought 
to bear poor biological realism (Welch & Waxman 2003; Orr 2005; Wang et al. 
2010; Chevin, Lande, et al. 2010a; Wagner & Zhang 2011; Lourenço et al. 2011), 
we also studied a model assuming partial pleiotropy. The degree of mutational 
pleiotropy is expected to influence the dynamics of adaptation (Wagner & Zhang 
2011). In our model of partial pleiotropy, similar to that of (Lourenço et al. 2011), a 
single mutation can only change a subset of traits (m), taken at random from the 
full set of traits (n) that contribute to fitness. When populations have small sizes or 
mutation rates are low, the analytical expressions for predicting the rate of 
adaptation under this model suggest that mutational pleiotropy can affect the 
dynamics of adaptation of populations approaching a fitness peak (Lourenço et al. 
2011). However, such analytical results rely on a strong simplifying assumption: 
the populations are monomorphic most of the time. This assumption is quite 
restrictive given the increasing experimental evidence for high rates of beneficial 
mutations both in natural (Eyre-Walker & Keightley 2007; Jensen et al. 2008) and 
in experimental populations (Perfeito et al. 2007; Good et al. 2012), which 
promptly produce competition between segregating mutations arising in distinct 
lineages and drive the dynamics of cohorts described above. To address these 
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more relevant scenarios, we use stochastic simulations of FGM for populations 
undergoing strong clonal interference. We consider large populations and values 
of mutation rate and mean effect of mutations that are in reasonable agreement 
with current estimates for microbial populations (Gordo et al. 2011; Perfeito et al. 
2014).  
Most of theoretical analysis done so far focused on predicting the 
equilibrium mean fitness, and did not address the time scale at which such 
equilibrium is in fact reached. As experiments where evolution is followed for 
longer and longer periods are emerging (Barrick & Lenski 2013; Lang et al. 2013), 
it is also important to have theoretical expectations on the full dynamics of the 
approach to equilibrium under classical models of adaptation, both at the 
phenotypic and genotypic level, as we do here. By tracking each individual 
mutation during the adaptive walk as the populations approach the optimum, we 
find that the simplest version of FGM can generate the complex cohort dynamics 
observed in microbial adaptation experiments, under specific evolutionary 
parameters within a biological realistic range.  
 
Methods 
Simulation Methods of Fisher Geometrical Model 
FGM considers each individual as a point in a n-dimensional space, where 
n is the number of traits under selection. Each individual is characterized by a 
vector of coordinates (z1, z2,…, zn) that gives the position of the individual in the 
fitness landscape. This vector represents the phenotypic values for each trait. 
Without loss of generality, we define the optimum as the origin of the n-
dimensional space. As commonly done, we assume that fitness is given by a 
Gaussian function of the distance to the optimum, .  We assume 
that mutations follow a Poisson distribution with a genomic mutation rate U, per 
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individual, per generation. Each mutation changes m traits chosen at random from 
the total n traits, and the effect it causes in each affected trait follows a normal 
distribution with mean 0 and variance s2.  We consider a Wright-Fisher model and 
assume multinomial sampling with fixed population size N. The contribution of 
each individual to the next generation is proportional to its fitness. We assume 
large population sizes and consider values of genomic mutation rates (U ~0.001) 
that are reasonable estimates for the genome-wide mutation rate in DNA microbes 




Dynamics of approach to equilibrium mean fitness  
 We start by studying the dynamics of fitness increase along tens of 
thousands of generations for different levels of phenotypic complexity, pleiotropy 
and mean effect mutations. Figure 1A shows that the initial rate of fitness increase 
is lower under low pleiotropy across all values of the mean fitness effect of 
mutations (E(S)) studied. The effect is particularly strong for large values of E(S) 
(E(S)>0.01). However, in the long run populations with lower pleiotropy reach 
higher levels of mean fitness (see also Supplementary Figure S1). Increasing 
genetic complexity (n), while maintaining a similar level of pleiotropy, shows a 
similar pattern for the fitness plateau, where populations with fewer traits reach 
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Figure 1: Dynamics of mean fitness increase under FGM with partial 
pleiotropy 
A) Dynamics of mean fitness of asexual populations with varying degrees of 
pleiotropy. All populations have high complexity (n=96) and distributions of 
fitness effects (DFEs) with different means are studied. Other parameters are 
N=104, U=0.001 and the initial fitness w0=0.5. B) The effect of increasing 
phenotypic complexity (n) on the dynamics of fitness increase. Other population 
parameters are: N=104, U=0.001, s2=0.004, m=3 and the initial fitness w0=0.5. 
Short term dynamics are highlighted as an inset. 
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Cohort of mutations fixed in the initial steps of adaptation 
Next, we studied the dynamics of mutation fixation along the adaptive walk. 
We first studied populations with maximum pleiotropy and various degrees of 
complexity across different E(S) and mutation rates, and ask how many mutations 
fix simultaneously in the first step. Figure 2 shows that fixations of cohorts of 
mutations can be very common, reflecting the degree of clonal interference 
occurring in these large populations. Across all parameters, the major determinant 
of the number of mutations fixing in cohorts is the mean effect of mutations (E(S)), 
with lower effect mutations promoting fixation of cohorts of larger size. The other 
relevant parameter to the size of the fixed cohorts, as expected, is the mutation 
rate, with an increased mutation rate showing the largest cohorts of mutations 
fixed. Therefore, the combination of small effect mutations generated at a high rate 
leads to the fixation of larger cohorts. We performed the same analysis on 
simulations where we relax the assumption of full pleiotropy. Populations with 
partial pleiotropy (m=3, 10 or 20) for the highest level of complexity previously 
tested (n=30) show patterns that are qualitatively similar (Supplementary Figure 
S2). The main difference detected occurs in simulations with a high mutation rate, 
where the likelihood of observing large cohorts of stronger effect mutations 
increases relative to the case of full pleiotropy. Additionally, both in the cases of 
full or partial pleiotropy, the complexity of evolving populations shows a minimal 
effect on the size of the fixed cohorts of mutations. Therefore, the number of 
mutations observed fixing simultaneously in the first step of adaptation is mainly 
determined by the mutation rate and the mean selective effect of mutations. 
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Figure 2: FGM can lead to simultaneous fixation of cohorts of mutations. The 
probability distribution of the number of mutations fixed during the first fixation event 
in the adaptive walk. Parameter values are N=104, the initial fitness w0=0.5 and 
other parameters as indicated in each panel. Data is shown for 100 simulations per 
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Cohort of mutations fixed along the adaptive walk 
In order to understand how the probability of observing the fixation of 
cohorts changes along the adaptive walk, we next study the distribution of 
mutations fixed beyond the first step of adaptation.  Figure 3 shows the pattern of 
cohorts fixed along an adaptive walk lasting 30000 generations. Each point in the 
panels of Figure 3 corresponds to a fixation event occurring during this time 
period, with the number of mutations (i.e., the size of the cohorts) that compose 
each of these fixations represented in the y-axis. The probability of observing 
cohorts consisting of a large number of mutations later in the adaptive walk is 
strongly dependent on the average selective effect of these mutations. Lower 
effect mutations lead to the fixation of cohorts of larger sizes not only in the first 
steps, but also as populations approach the equilibrium fitness. Interestingly, we 
observe that, for the lower values of E(S), the likelihood of fixing cohorts of larger 
sizes (from 4 to 8 mutations) increases for populations with a higher complexity, 
throughout the adaptive walk. For high values of E(S) and populations with a lower 
number of traits, fixation of large cohorts becomes an increasingly rare event once 
they approach the fitness equilibrium. Overall, along the adaptive walk, the size of 
fixed cohorts tends to shrink, at a faster pace for large E(S). Therefore, for long-
term adaptation in populations approaching a fixed optimum, fixation of single 
mutations is expected to become the dominant pattern. However, when E(S) is 
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Figure 3: Number of mutations fixed (cohort size) along the adaptive walk. 
Parameter values are N=104, the initial fitness w0=0.5 and other parameters as 
indicated in each panel. In all panels full pleiotropy is assumed (m=n). Data is 
shown for 100 simulations per combination of parameters. 
 
Dynamics of cohorts of mutations 
Finally, we study the dynamics of polymorphism expected in populations 
climbing the Fisherian landscape. We focus our simulations on short-term 
evolution, a time scale for which polymorphism data has been obtained recently 
(Lang et al. 2013). Figure 4 shows the dynamics of frequency change of each 
individual mutation segregating in populations evolving for 1000 generations. 
Aggregation of cohorts of mutations can be clearly observed across the different 
replicate populations, all with the same evolutionary parameters. The parameter 
set shown was chosen to be one where we could find a pattern similar to that 
observed in the evolution experiments done in yeast (Lang et al. 2013). In the 
replicate simulated populations, cohorts of different sizes emerge and compete 
against each other, with some achieving fixation and others being outcompeted. 
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Figure 4: Dynamics of frequency change of individual mutations along time 
across independently evolving populations. Aggregation of multiple mutations 
in cohorts can be easily detected by the simultaneous increase in frequency of 
different mutations (in different colors). Competition between cohorts can be 
commonly observed during the first 1000 generations of adaptation. Parameter 
values used are N=105, the initial fitness w0=0.5, n=10, m=3 and E(S)=0.012. 
Gaussian noise (mean 0, variance 0.02), mimicking experimental error, was 
added to the dynamics for increasing visibility and comparison with experimental 
data. 
Although this phenomenon of “cohort interference” is more likely for cohorts 
competing at lower frequencies (where many mutations are segregating), it can 
also be observed when mutations reach high frequencies (e.g., first and third 
panels in the first row). Even under the same parameter values different patterns 
can be observed among the replicates:  sequential fixation of cohorts of low size in 
some populations (e.g., fourth and seventh panels) and fixation of cohorts of large 
size in other populations (e.g., fifth, sixth and ninth panels). The same qualitative 
behavior is observed when simulating a higher number of replicate populations 
adapting under FGM (see Supplementary Figure S3).  
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Discussion 
With the advances of next generation sequencing, increased power to 
observe the dynamics of adaptation at the resolution of individual mutations has 
emerged. The data recently gathered indicates that adaptation of microbial 
populations adapting in laboratory environments exhibit patterns very distinct from 
the classic single selective sweep model of periodic selection. Instead the 
dynamics of molecular evolution in these microbes evolving in real time shows that 
aggregates of beneficial mutations segregate and fix simultaneously (Lang et al. 
2013; Maddamsetti et al. 2015; Zanini et al. 2016). Given the easiness of FGM to 
produce dynamics of fitness change similar to those observed in such 
experiments, we asked if such dynamics of molecular change could be expected 
under this model. The simulations performed, show that Fisher’s Geometric Model, 
in its simplest version, can reproduce dynamics of cohort interference such as the 
ones observed in experimental settings. Cohort interference can be common 
during the initial steps of adaptation, but it is more likely if the mean effect of 
mutations is small and mutation rates are not too small. In these scenarios many 
small effect mutations simultaneously segregate, each taking a long time to reach 
fixation, which likely results in the acquisition of additional mutations (either 
beneficial, neutral or slightly deleterious) in the same genetic background. In 
contrast, when E(S) is large, beneficial mutations sweep to fixation faster, and the 
likelihood of acquiring additional mutations in their background diminishes. As 
expected the size of the interfering cohorts increases as the mutation rate 
increases, since an increased amount of mutations segregating in these high U 
populations prevents the fast fixation of a single mutation. Remarkably when 
simulating the dynamics of individual mutations produced under FGM, we could 
find patterns very similar to the ones that are increasingly being assayed through 
whole genome sequencing of evolving microbial populations (e.g. compare Figure 
4 with Figure 1 in (Lang et al. 2013)). Although such pattern is dependent on the 
parameters used, it could be observed in simulated populations assuming a set of 
parameters within a biological plausible range: a mean effect of mutations around 
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1% (Eyre-Walker & Keightley 2007; Gordo et al. 2011) and a genomic mutation 
rate of 10-3 (H Lee et al. 2012).   
The relationship between the size of cohorts and both the mean effect of 
mutations and the mutation rate is also detected when we study adaptation over 
longer periods (Figure 3). The size of fixed cohorts tends to shrink along the 
adaptive walk, and does so at a faster pace for large values of E(S). Therefore, for 
populations approaching a fixed optimum the pattern of long-term adaptation is 
expected to become dominated by fixation of single mutations. However if E(S) is 
small such pattern may take many thousands of generations to be detected (right 
panels in Figure 3), a time scale that is out of reach for most laboratory 
experiments so far studied. The famous LTEE in Escherichia coli constitutes an 
important exception, where patterns of adaptation can be studied over periods as 
long as 60000 generations (Lenski et al. 1991; Maddamsetti et al. 2015). The 
access to samples frozen every 500 generations allows the tracking of individual 
mutations and the reconstruction of the evolutionary genetic history of an 
individual population. Maddamsetti et al tracked the emergence of 42 mutations in 
one of the evolving populations and showed competition and interference between 
lineages carrying several mutations, including the simultaneous fixation of these 
sets (Maddamsetti et al. 2015). In this population however, not only clonal 
interference was observed but also frequency-dependent selection was important 
in driving the dynamics of mutation cohorts. On a shorter-term experiment, also 
with E. coli but now evolving in a chemostat, Maharjan and colleagues detected 
synchronous sweep of multiple mutations but the levels of polymorphism were 
also driven by frequency dependent interactions between clones (Maharjan et al. 
2015). As we show here clonal interference alone can lead to dynamics of cohort 
interference, but given the emergence of frequency dependent selection even in 
the simplest environments it will be important in future work to model other fitness 
landscapes which can allow for the simultaneous occurrence of both processes. 
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Conclusions 
In the current work, we study a simple version of the Fisher’s Geometrical 
Model that assumes partial or full pleiotropy. Despite its simplicity, FGM has been 
successfully used to reproduce patterns of the dynamics of the adaptive process 
(Chevin, Martin, et al. 2010b; Martin 2014). A common pattern emerging from the 
short-term dynamics of populations of microorganisms evolving in laboratory 
conditions is the finding that mutants carrying multiple segregating mutations can 
go to fixation (Lang et al. 2013; Maddamsetti et al. 2015). Before resorting to more 
complex models of fitness landscapes, we inquired whether a simple and less 
parameterized model, such as FGM, could capture the essence of this sort of 
observation under reasonable parameters.  Assuming large population sizes close 
to those in the experiments, and mutation rates typical of microbes, thus naturally 
driving population to a clonal interference regime, we show that FGM, both under 
full and partial pleiotropy, generates patterns of segregation and competition of 
cohorts of mutations that are consistent with experimental observations. 
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Supplementary Figure S1: Long term dynamics of mean fitness of 
populations as a function of the mean effect of mutations (E(S)). Dynamics 
are shown for high and low levels of pleiotropy (m=96 and m=3). Other parameters 
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Supplementary Figure S2: Effect of pleiotropy in the simultaneous fixation of 
cohorts of mutations during the first step of adaptation. The complexity, n, is 
fixed at 30 while the pleiotropy, m, varies between 3, 10 and 30 (full pleiotropy). 
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Supplementary Figure S3: Additional simulations showing the dynamics of frequency 
change of individual mutations along time. The diverse patterns of cohorts observed 
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Epistatic interactions shape compensatory adaptation of multiple antibiotic 
resistances 
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Abstract 
The rate and effects of compensatory mutations are key determinants for the 
maintenance of costly antibiotic resistance mutations. While compensation of 
single resistance mutations has been well studied, this process may differ in multi-
resistant strains, due to epistasis between resistance alleles. Using experimental 
evolution and whole genome sequencing, we compared the pace and genetic 
basis of compensation of a streptomycin and rifampicin double resistant 
Escherichia coli with those of each of the respective single mutants. We found 
minimal overlap between the compensatory mutations acquired by double 
resistant bacteria and those found in single resistance strains, and provide direct 
evidence for mutations that compensate specifically for the interaction between the 
resistant alleles. Furthermore, the pace of compensatory evolution is higher in the 
double resistant strain due to rapid accumulation of adaptive mutations with 
stronger fitness benefits. This is the first study describing the compensatory 
landscape of double resistant bacteria and demonstrating that the process of 








 Antibiotics are one of the most important medical advancements in history, 
preventing millions of deaths from bacterial infections. Nevertheless, bacteria 
engage in a constant arms race, through the acquisition of genes or chromosomal 
mutations that confer resistance to the drugs (J Davies & D Davies 2010; Hughes 
& Andersson 2015; van Hoek et al. 2011). Resistance mutations are widely spread 
in bacterial populations, both in clinical (Gullberg et al. 2011; MacLean & Vogwill 
2015; Hughes & Andersson 2015) and environmental settings (Forsberg et al. 
2012; Bhullar et al. 2012), providing a reservoir of genetically encoded antibiotic 
resistance that can be transmitted by horizontal gene transfer (van Hoek et al. 
2011; Kriegeskorte & Peters 2012). Moreover, as microbes become resistant to a 
specific drug, the subsequent use of alternative antibiotics might create further 
resistance, thus leading to the increasing threat of multi-drug resistant strains 
(Hughes & Andersson 2015; Mwangi et al. 2007; Velayati et al. 2009; Zhang et al. 
2013). This is a prevalent case in Staphylococcus aureus, Escherichia coli or 
Mycobacterium tuberculosis, for instance, where multiple resistances pose a 
serious threat to human health (Hede 2014; Petty et al. 2014; Mwangi et al. 2007; 
Warner et al. 2014). Determining the evolutionary dynamics governing the 
emergence of these mutations and the mechanisms behind resistance is 
paramount to design more effective treatments. Although the effects vary across 
environments, mutations conferring resistance are typically deleterious in the 
absence of antibiotics (Schrag et al. 1997; Sousa et al. 2012), where resistant 
strains should be outcompeted by sensitive bacteria. Yet, the widespread 
prevalence of resistance mutations in bacteria indicates that populations can curb 
this deleterious effect. In order to understand how antibiotic resistant bacteria 
survive, spread in populations and acquire further resistances, it is crucial to 
realize how this fitness cost is overcome.  
 Mutations conferring antibiotic resistance typically alter bacterial targets 
involved in key processes, such as the ribosome, for the case of resistance to 
stremptomycin (Luzzatto & Apirion 1968; Couturier et al. 1964) or the RNA 
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polymerase, for resistance to rifampicin (Wehrli 1983; Goldstein 2014). The 
changes in essential machinery caused by resistance mutations usually lead to 
deleterious effects and, in the absence of antibiotics, resistant strains face different 
possible outcomes: extinction, reversion of the resistance mutation, or acquisition 
of further mutations that compensate for the fitness cost (Schrag et al. 1997; 
Reynolds 2000; Andersson & Hughes 2010; Brandis et al. 2012). The latter is, 
arguably, the worse outcome for the host, since antibiotic resistance alleles might 
become stabilized in the population while paying little or even no cost (Levin et al. 
2000). Acquiring additional mutations to overcome the fitness cost of resistance is 
also more likely to occur than the reversion of the resistance mutation, since the 
genomic target range for compensation is much broader (Levin et al. 2000; Poon 
2005). Therefore, understanding the key evolutionary dynamics of compensatory 
adaptation is necessary to predict and counteract the survival and spread of 
antibiotic resistant strains.  
 Compensation for the cost of resistance by further genetic changes has 
been widely described both in clinical (Comas et al. 2012; Zhang et al. 2013) and 
laboratory (Reynolds 2000; Maisnier-Patin et al. 2002; Qi et al. 2016) settings. The 
rate of compensation depends on the resistance alleles, whose compensatory 
targets might differ in nature and size, and might have different distributions of 
effects (Moura de Sousa et al. 2015). The dynamics of compensatory adaptation 
depend also on populational parameters, such as bottleneck size (Maisnier-Patin 
et al. 2002) and mutation rate (Levin et al. 2000). Over the last decades, 
numerous targets of compensation for single resistance alleles have been 
described (e.g. (Maisnier-Patin et al. 2002; Brandis & Hughes 2013; Qi et al. 
2016)). However, compensation in bacteria harbouring more than one resistance 
mutation is likely to be different, because these alleles are often known to interact 
(Borrell & Gagneux 2011). This epistasis might originate from the fact that 
resistance mutations affect functionally interconnected cell machinery (Chakrabarti 
& Gorini 1977; Chao 1978). Thus, different, co-occuring, genetic modifications (for 
instance, in proteins involved in transcription and translation) might lead to 
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functional conflicts that diverge their cumulative effects from linearity (Trindade et 
al. 2009; Hall & MacLean 2011; Borrell et al. 2013). We hypothesize that, for 
cases of strong negative epistasis, genetic reversions in one of the original 
resistance alleles are amongst the strongest beneficial mutations, since it 
compensates both the individual effect of the reverted allele and the synergistic 
cost. Thus, reversions could be more frequently observed in these cases, 
compared to single resistance backgrounds, where their effect is limited to the cost 
of the resistance itself. Moreover, certain targets of compensation can be specific 
to these epistatic interactions, and thus the effects of compensatory mutations 
may be different in single or double resistance strains. In this scenario, the rate, 
targets and effects of compensatory mutations in multi-resistant bacteria could 
deviate considerably from the ones observed during compensation of single 
resistances. 
 In order to investigate this question, we performed experimental evolution, 
in antibiotic-free media, of three different Escherichia coli resistant genotypes: 
RpoBH526Y (conferring resistance to rifampicin), RpsLK43T (conferring resistance to 
streptomycin), and a double resistant mutant (RpoBH526YRpsLK43T) that shows 
negative epistasis for fitness costs of double resistance. Neutral marker dynamics 
indicated a faster pace of adaptation in double resistant bacteria, while whole 
genome sequencing of clones of evolved populations revealed minor overlap 
between the genetic targets of compensation in double resistant strains and those 
in each of the single resistant alleles. Unexpectedly, genetic reversions of the 
RpoBH526Y allele were detected both in the single RifR and the double resistant 
background at non-significant different frequencies (2 out of 12 and 1 out of 24, 
respectively). While no reversion for StrR was detected, overlap at the level of 
single nucleotide polymorphisms occurred in three of the putative compensatory 
targets for the StrR mutation. By testing the effects of a specific allele in the original 
resistance backgrounds, we showed it could compensate specifically for the 
epistatic interaction between the resistances, being deleterious in the single 
resistant background where it was expected to provide a benefit. Together, these 
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results indicate that the pattern of compensation can be specific to the interactions 
between different resistance alleles in multi-drug resistant bacterial strains. 
Faster pace of adaptation in double resistant populations 
 E. coli independent populations were founded from one of three different 
antibiotic resistant genetic backgrounds: 12 populations which are RifR 
(RpoBH526Y), 12 populations which are StrR (RpsLK43T) and 24 double mutant 
populations RifRStrR (RpoBH526YRpsLK43T). These genetic backgrounds have 
different fitness costs (see Extended Data Fig. 1), and the double mutant shows 
negative epistasis (i.e. its fitness cost is bigger than the sum of the costs of the 
single resistances). The resistant backgrounds were tagged with a fluorescent 
marker (either CFP or YFP) and the replicate populations were serially passed for 
22 days in rich media without antibiotics (see Methods). The fluorescent markers 
hitchhike with beneficial mutations and allow tracking adaptive events in evolving 
populations (Hegreness 2006). Therefore, the frequencies of the markers were 
followed during the adaptive process (Fig. 1). We observed that, for double 
resistant RifRStrR E. coli (Fig. 1c), markers deviate from their initial frequency 
faster and with steeper slopes, compared to the populations in either one of the 
corresponding single resistant bacteria, RifR (Fig. 1a) or StrR (Fig. 1b). In double 
resistant populations, the markers either sweep to near fixation within the first 6 
days or show strong signs of clonal interference, which is indicative of multiple 
adaptive clones competing against each other. In single resistant bacterial 
populations, near fixation (>0.95) of a marker is only observed in a minority (3 out 
of 12 RifR and 1 out of 12 StrR populations) of the independently evolving 
populations, and only after 14 days of evolution. Moreover, the dynamics of all RifR 
alone show no obvious sign of clonal interference, whereas in StrR some 
populations are likely adapting by acquiring compensatory mutations in both CFP 
and YFP backgrounds (e.g., populations 3 and 11). As expected, given its much 
lower fitness, the double resistant populations show more signs of interference. 
This suggests that the pace of adaptation is faster for the bacteria harbouring two 
resistance alleles. 




Figure 1: Faster compensatory evolution in double antibiotic resistant 
bacteria. Dynamics of a fluorescent neutral marker during adaptation to rich 
media without antibiotics in (A) 12 independent Escherichia coli populations 
resistant to rifampicin (RpoBH526Y); in (B) 12 populations resistant to 
streptomycin (RpsLK43T) and in (C) 24 populations resistant to both rifampicin 
and streptomycin (RpoBH526YRpsLK43T). 
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Faster adaptation of RifRStrR is driven by beneficial mutations with stronger 
effect 
 To understand why double resistant populations adapt faster than single 
resistant ones, we measured the average competitive fitness of the evolving 
populations (see Methods) at days 5, 9, 15 and 22 along the adaptive process 
(Fig. 2a). Despite variation between the populations, the general pattern of fitness 
increase differs between the resistances. While the RifR populations on average 
increase in fitness linearly over time (Fig. 2a, leftmost panel), both the StrR 
populations and the RifRStrR populations show a substantial increase in fitness at 
day 5 and subsequently reach a plateau (Fig. 2a, middle and rightmost panel, 
respectively). Moreover, the fitness increase in RifRStrR bacteria is both 
remarkably strong and fast, with the high initial cost of the double resistance (red 
dashed line in rightmost panel of Fig. 2a) being on average completely mitigated 
at day 5. Interestingly, while all populations show increased competitive fitness 
compared to the ancestral resistances, we see stabilization at different fitness 
peaks (Fig. 2a and Extended Data Figure 2), which suggests multiple pathways 
for compensation.  
Rate and effects of compensatory mutations 
 The higher fitness increase in double resistant bacteria can be due to 
either a higher rate of acquisition of beneficial mutations (due to a large target 
size, for instance) or to the acquisition of mutations with stronger beneficial effects. 
Using a modified version of the TwoMarkerABC algorithm (Moura de Sousa et al. 
2013) that considers both the marker dynamics and the fitness along the adaptive 
walk (see Methods), we inferred the rate of acquisition of beneficial mutations and 
the distribution of effects of arising beneficial mutations for each of the 
backgrounds. We found that the inferred rate of acquisition of beneficial mutations 
is not significantly different between the double resistance and the RifR populations 
(around 3x10-6), although both are significantly lower compared to the StrR genetic 
background, which is in the order of 10-5 per cell per generation (Fig. 2b). 
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However, the mean selective effect of beneficial arising mutations is significantly 
higher for the RifRStrR background, compared to either of the individual single 
resistances (around 0.18, versus 0.1 for the RifR and 0.05 for the StrR) (Fig. 2c). 
This suggests that beneficial mutations with higher mean selective effect are 
available to the double resistant bacteria. These observations point to the 
existence of different compensatory paths, which might entail the acquisition of 
different mutations in each background.  
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Figure 2: Compensatory mutations have stronger effects in double 
resistant mutants. A) Competitive fitness of each evolving population at 
different days during adaptation. Each circle corresponds to a population with 
similar color shown in figure 1. Red dashed lines correspond to the fitness of 
the ancestral resistance mutant strain. B) Estimation of the rate of acquisition of 
beneficial mutations and (C) mean selective effects of arising beneficial 
mutations are shown in the violin plots, and correspond to the distribution of the 
top 20 simulations that best explain the experimental data. In panel B Red line 
indicates the median of the distributions. 
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The genetic basis of compensation 
 Selective effects between double and single resistances suggests that the 
mutations underlying compensation could either be diverse and specific for each 
background or, alternatively, that similar targets have distinct effects depending on 
the resistant background. In order to analyse the genetic basis of compensatory 
adaptation, we performed whole genome sequencing of one clone, from the 
fluorescence at the highest frequency, from each evolved population at the end of 
the experiment. For each resistance background, the clones from all populations 
were pooled and sequenced together (see Methods), in order to capture a broad 
spectrum of the compensatory landscape (Fig. 3 and Extended Data Table 1). 
We found that mutations are, indeed, diverse and strikingly more so for the double 
resistance background (37 different gene targets) (Fig. 3c) compared to either of 
the single resistances (9 and 16 genes targeted in RifR and StrR evolved 
populations, respectively) (Fig. 3a and b). Several mutations in RifR (10 out of 16 
allelic changes) and RifRStrR (16 out of 52) were detected in known compensatory 
targets for the single resistance mutations in either rpoB (rpoB itself, rpoA and 
rpoC) or rpsL (rpsE, rpsD and tufA) (see expanded arrows in Fig. 3). Other novel 
putative compensatory targets were identified, which point to an overlap in 
functional targets of compensation, namely in genes encoding membrane proteins 
(i.e., ybjO and nanC in RifR; ydhK in RifR and StrR; yeaI and yojI in StrR; ompF and 
ydiY in RifRStrR) and ribosomal proteins (rplL in RifRStrR and rplI in StrR). On the 
other hand, mutations affecting other genes involved in DNA replication, 
transcription and translation (i.e., dnaG, multL, rpiR, secE (nusG) and rpsJ (nusE)) 
seem to occur preferentially in the double resistant evolved populations. At the 
allelic level, we found that a genetic reversion in rpoB and three StrR mutations 
overlap between the double resistance and either of the two single resistances. 
This minimal parallelism indicates that either numerous targets of compensation 
exist or that there is an abundance of targets specific to the double resistant 
background. 
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Figure 3: Distinct allelic targets of compensation in double resistant 
bacteria. Genetic targets associated with compensatory adaptation for each 
antibiotic resistant background were identified through metapopulation 
sequencing. Mutations detected at least in one population map 
(approximately) at the position indicated  (see Extended Table 1). Zoomed 
genes indicate known targets of compensatory mutations for the 
corresponding resistant background. A) In blue, mutations found in the 12 
independently evolved RifR populations. B) In green, mutations found in the 12 
independently evolved StrepR populations. C) In black, mutations found in the 
24 independently evolved RifRStrepR, with mutations found also in single 
resistant populations indicated in the correspondent color. In A) and C) a red 
box indicates a reversion of the original resistance mutation (RpoBY526H). In all 
panels, stars indicate mutations that were likely in more than one population 
(i.e., frequency of reads was above the one expected for one clone in the 
population pool).  
 
Genetic reversion of RifR mutation 
 The only allelic mutation that was found to be shared between the RifR and 
the RifRStrR evolved populations is a back mutation in rpoB (red squares in Fig. 3a 
and c). Reversions are rare in single resistance backgrounds (Levin et al. 2000; 
Poon 2005), but clinically relevant, since bacteria regain sensitivity to the 
antibiotic. In either the single or double resistant background, reversion here was 
also rare, being detected in 2 out of 12 RifR populations and 1 out 24 RifRStrR 
populations (see Extended Data Table 1), all of which were confirmed to be 
sensitive to rifampicin (Extended Data Table 2). The difference in the number of 
reversions is non-significant between the single and double resistant mutations 
(P=0.243, Fisher exact test). Given the epistatic interaction in the double 
resistance, this mutation should have a very strong beneficial effect (~23%), 
accounting for a substantial portion of the fitness increase (see Fig. 2a). However, 
its low frequency across double resistant evolved populations is indicative that 
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there are many other strong effect beneficial mutations that compensate the 
fitness cost of a double resistant background without the loss of resistance. 
Notably, a reversion of the RpsLK43T allele, which would also confer a 20% fitness 
benefit, was not detected through sequencing, although there are one StrR and two 
RifRStrR evolved lines that have subpopulations of clones with increased sensitivity 
to Streptomycin (Extended Data Table 2). The fact that, contrary to expectations, 
reversions are seldom seen in compensated double resistant populations is in 
agreement with our inference of a distribution with high mean selective effects for 
this background.  
 
RpoCQ1126K shows sign epistasis between RifR and RifRStrR 
 The limited parallelism for compensatory mutations between the RifRStrR 
background and the corresponding single resistances can be expected under two, 
non mutually exclusive, hypothesis: i) the number of targets for compensation can 
be so large that our assay was insufficient to capture its full spectrum; and ii) many 
mutations are only beneficial when both resistances are present. Because rpoC is 
a common compensatory target for rifampicin resistance mutations in the rpoB 
gene (De Vos et al. 2013; Brandis et al. 2012; Comas et al. 2012), we selected 
two mutations appearing in this gene, RpoCH450P and RpoCQ1126K. The first one 
was detected in the evolved single RifR populations and the second was observed 
in the evolved double RifRStrR background. We reconstructed new strains (see 
Methods) harbouring one of the original resistance allele(s) (RpoBH526Y or 
RpoBH526YRpsLK43T) and either one of these putative compensatory mutations. We 
then competed these reconstructed strains against their corresponding ancestral 
(i.e., only the resistance allele(s)) in order to assert its fitness advantage, if any 
(Fig. 4). As expected, the reconstructed double mutant RpoBH526YRpoCH450P has a 
competitive fitness advantage (0.05±0.01) over the ancestral strain (RpoBH526Y) but 
the beneficial effect of this mutation is higher (0.10±0.013) in the double resistance 
background (RpoBH526YRpsLK43TRpoCH450P) (Fig. 4a). Given the strong advantage 
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conferred by this allele, the fact that it was not observed in any of the 24 evolved 
RifRStrR populations is indicative of the existence of many strong compensatory 
mutations competing, supporting the first hypothesis (the compensatory targets 
were not exhausted) and in concordance with our inference (Fig. 3c). To test for 
the second hypothesis, similar competitive assays were performed with the 
second mutation in rpoC (RpoCQ1126K), which arose in the RifRStrR populations. As 
expected, the triple mutant RpoBH526YRpsLK43TRpoCQ1126K shows a high fitness 
advantage over its ancestral (RpoBH526YRpsLK43T) but, strikingly, this mutation 
shows decreased fitness in the single resistant strain (RpoBH526YRpoCQ1126K) with 
respect to its ancestral (RpoBH526Y) (Fig. 4b). Therefore, the beneficial effect of the 
RpoCQ1126K mutation is conditional to the presence of the second resistance allele 
RpsLK43T, being deleterious in the context of the RpoBH526Y mutation alone. This 
provides evidence for the second hypothesis, suggesting that this mutation might 
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Figure 4: A compensatory mutation buffers the epistasis between RifR and 
StrepR. Strains reconstructed to incorporate compensatory mutations are 
competed against their corresponding ancestral (i.e., the resistant strain without 
the compensatory mutation). A) A compensatory mutation of RifR populations, 
mapping in the rpoC gene (RpoCH450P), is beneficial also in the RifRStrepR 
background, with an even stronger compensatory effect in the latter, 
demonstrating a remarkably broad range for compensatory targets. B) The allele 
RpoCQ1126K, found in adapted RifRStrepR populations, is beneficial in that 
background but deleterious in the single RifR mutant, indicating that it 
compensates specifically for the epistasis between RifR and StrepR alleles. Mean 
values and standard error bars correspond to 3 replicate competitions for each of 
the 4 independently constructed clones for each allelic replacement. 
 
 




 As concerns increase regarding the generation and spread of multi-drug 
resistant bacteria, it is of crucial importance to understand how these resistant 
alleles are maintained in populations (Hughes & Andersson 2015). Investigating 
the process of acquisition of compensatory mutations is essential and, although 
compensation for single resistance mutations has been well described, our 
findings suggest that these observations are not entirely transferrable into the 
compensatory process of multi-drug resistant strains. The results presented here 
demonstrate that RifRStrR bacteria, when compensating for their fitness cost, can 
follow an evolutionary path that is distinct from either one of its corresponding 
single resistances. Not only the pace of adaptation is faster, but the double 
resistant background also has access to stronger effect mutations. The results 
from our theoretical inference provide support for this observation, with estimates 
of the rate of acquisition of mutations that range from 10-6 in RifR and RifRStrR 
populations to 10-5 in StrR (per cell, per generation). These are slightly above the 
ones estimated in compensation of the K43N allele in Salmonella Thypimurium, 
which is in the order of 10-7 (Maisnier-Patin et al. 2002). Since this rate was 
estimated from the rate of fixation of mutants, in scenarios of intense clonal 
interference this value could be an underestimation of the true compensatory rate. 
It is important to notice here that the underlying model of adaptation used for the 
estimation of these parameters in our work does not take into account epistasis 
(Moura de Sousa et al. 2013), which is very likely affecting mutations acquired 
during adaptation. Therefore, both the rate of acquisition of beneficial mutations 
and the average mean effects of beneficial mutations are probably 
underestimated, particularly for the StrR and RifRStrR, where fitness increases 
shows more prevalent diminishing returns. However, our inference of higher 
selective effects in the double resistant populations is in agreement with their 
measured competitive fitness, which also show a higher increase. In principle, this 
could be due to the fact that the RifRStrR is inherently more costly, and thus similar 
mutations could have a stronger effect in this less adapted background. However, 
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the genetics of evolved populations indicate a different story. The minimal overlap 
between the putative compensatory mutations identified in the evolved populations 
is indeed suggestive of alternative evolutionary paths that are shaped by the 
epistatic interaction between the two resistant alleles. We had a priori indications 
that the we would not be able to completely exhaust the targets of compensation, 
first because the known targets of compensation for streptomycin, for instance, 
can be very diverse, of at least 35 allelic changes in the genes coding for 
ribosomal proteins alone (Maisnier-Patin et al. 2002). Moreover, we sequenced 
only one clone per population, and our sequencing protocol does not have a 
resolution that would enable the detection of every single compensatory mutation. 
Nevertheless, and even with this limited sampling procedure, we found that 3 
mutations co-occur between StrR and double resistant evolved populations, 
suggesting that some of compensatory mutations can be strongly selected in both 
the single and double resistant backgrounds. The fixation of a reversion in the 
RpoBH526Y allele in two out of 12 RifR evolved populations indicates that the rate of 
reversion for this particular allele might be higher than previously thought. 
However, the fact that the reversion was observed at a comparable frequency in 
both the single RifR and double resistant populations was surprising, since this 
mutation should have a very strong beneficial effect on the latter background. We 
reasoned this might indicate competition with several other compensatory 
mutations that have high selective effects. Moreover, the fact that we do not detect 
genetic reversions for the StrR evolved populations is indicative that the 
compensatory spectrums differ between the resistance mechanisms, possibly both 
in size and effects. Of notice, however, is the fact that some evolved StrR (and 
some RifRStrR) populations show increased sensitivity to streptomycin. No 
reversion of the original RpsLK43T was found in our sequences, meaning that an 
eventual reversion, if it emerged, has not swept to fixation as in the RifR 
populations. It is also possible that this is a phenotypic reversion caused by 
mutations in other genes, which we are currently investigating. For instance, some 
of the alleles where we detected mutations in rpsD and rpsE are known to confer a 
ribosomal ambiguity phenotype (Maisnier-Patin & Andersson 2004; Ogle & 
Chapter IV   
	  
	  148	  
Ramakrishnan 2005), which might functionally revert the effect of the original StrR 
RpsLK43T mutation, rendering the cells sensitive to the antibiotic.  
 Several mutations observed in the ribosomal genes in the evolved StrR 
(RpsEA110V) in RifRStrR (RpsDT86A, RpsDD50Y, RpsET103P and RpsEG109R) 
backgrounds affected residues previously described as compensatory for the 
RpsLK43N resistance allele in S. Typhimurium, at least at the level of the residue 
(Maisnier-Patin et al. 2002). Some of the SNPs in rpoA (RpoAT196I) and in rpoC 
(RpoCH450P) where also previously identified as compensatory for the RpoBH526Y 
allele (Moura de Sousa et al. 2015). Nevertheless, many of the remaining putative 
compensatory targets identified here are, to the best of our knowledge, previously 
unidentified in the literature. The minimal allelic overlap between the mutations 
acquired in the three different backgrounds suggests that these mutations confer 
specific compensatory effects instead of general adaptation to the selected growth 
conditions. Additionally, the fact that some of the targets are directly related to the 
cellular mechanisms of replication, transcription and translation, provides further 
indication of their compensatory role. The double resistant background in 
particular accumulates a staggering amount and diversity of mutations, which span 
multiple cellular characteristics and mechanisms. Importantly, functional 
mechanisms specifically targeted by compensatory mutations in the RifRStrR 
background include DNA transcription and translation, and might modulate the 
interaction between the resistances themselves. A particular mutation, RpoCQ1126K, 
even though it maps in a gene known to harbour compensatory mutations for RifR, 
becomes deleterious when associated with the original RpoBH526Y alone, while 
being beneficial in the double resistance background (RpoBH526YRpsLK43T). Thus, 
this mutation could specifically compensate for the epistatic interaction between 
the resistance alleles. If this is true, it would be extremely interesting to disclose 
the molecular mechanisms underlying this compensatory effect. Moreover, other 
identified mutations provide an interesting indication of compensation for the 
interaction between resistances. For instance, mutations affecting the regulatory 
regions of rpsJ (nusE) or the secE-nusG operon target proteins that constitute the 
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physical link between transcription and translation machineries (Burmann et al. 
2010), suggesting that they could compensate for the epistasis by affecting the 
coordination between these two processes. Furthermore, to the best of our 
knowledge, these targets have not been identified in studies of compensation in 
single resistance alleles. We expect that our current analyses of the specific 
effects of these mutations will provide new insights on the molecular mechanisms 
involved. Since many resistance mutations affect essential mechanisms that 
commonly interact (Borrell et al. 2013; Durão et al. 2015), there are plenty of 
opportunities for a spectrum of mutations that supress or correct these epistatic 
interactions, which will be missed by studying the individual resistance alleles 
alone (MacLean & Vogwill 2015). The ability to identify them and determine how 
they affect the interactions between the resistant alleles is determinant for 
understanding how multi-resistances emerge and persist in bacterial populations. 
This may provide a theoretical framework for the development of new antimicrobial 
strategies that exploit potential weaknesses of multi-drug resistant bacteria. 
 
Material and Methods 
Strains and growth conditions  
 E. coli K12 MG1655 marked with constitutive expression of yellow (YFP) or 
cyan (CFP) fluorescent proteins (∆lacIZYA galK::CmR YFP/CFP) and with 
chromosomal resistance to either streptomycin (RpsLK43T allele), rifampicin 
(RpoBH526Y allele) or both, was used in the long term propagation experiment in to 
Luria-Bertani broth (LB) without the presence of antibiotics. Cultures were grown in 
a 96-well plate incubator at 37º C with shaking (700rpm). Non-fluorescent wild-
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Experimental evolution for compensation  
In order to acclimatize bacteria to the environment, strains were grown 
separately from frozen stocks in LB media (150ul per well) in 96-well plates at 37º 
C with shaking (12 replicates per strain were inoculated in a checkered format to 
avoid cross-contaminations). After 24h, 10ul of bacteria culture diluted by a factor 
of 10-2 was transferred into 140ul fresh LB media and let grow for additional 24h. 
Isogenic strains differing only in the marker were diluted again by a factor of 10-2 
and then mixed based on their cell numbers given by the Flow Cytometer (LSR 
Fortessa) in order to obtain an initial ratio of 1:1. A total of 48 competitions were 
initiated by inoculating 140ul of LB media with 10ul of each mixed population 
which were allowed to grow for 24h, reaching a concentration of, approximately, 
109 CFU/ml. After every 24h of growth, and for 22 days, these cultures were 
propagated by serial passage with a constant dilution factor of 10-2 (10 ul of 
diluted culture was transferred into 140 ul of fresh medium). In parallel, cell 
numbers were counted using the Flow Cytometer in order to measure the 
frequency of each strain in the mixed population during the experiment, by 
collecting a sample (10ul) from the spent culture each day. Samples were frozen 
at days 5, 9, 12, 15, 18 and 22. 
 
Competitive fitness assays  
 The relative fitness of each evolved population at the end of the 
propagation experiment, at day 22, was measured by competitive growth against 
the reference strain E. coli K12 MG1655. The competitor (each evolved 
populations, potentially composed of both YFP and CFP) and the reference 
(unmarked) strains were first unfrozen and acclimatized separately for 48h (with 
two growth periods of 24h) and then mixed in a proportion of 1:1 using a method 
similar to the one preveiously described. To assess the cost of the resistances 
themselves before any compensation, control competitions were performed 
between the ancestral of each resistant mutant and the reference strain by mixing 
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25% of YFP + 25% of CFP with 50% of the unmarked strain. Thus, a total of 52 
competitions were initiated by inoculating 140ul of LB media with 10ul of each 
mixed population and allowed to compete for 48h. The initial and final frequency of 
the strains was obtained by counting their cell numbers in the Flow Cytometer. 
Generation time was estimated from the doubling time of the reference strain 
(approx. 8 generations) and the fitness was determined as the average of three 
independent replicates for each competition.  
 
Sensitivity assay of evolved populations 
 Evolved cultures were grown in 96 well plates with LB for 24h and 
subsequently plated in antibiotic-free solid media. From each evolved population 
clones were picked with a pipette tip, which then was used to inoculate 
sequentially both a spot in antibiotic (plates containing media with 100ug/ml of 
rifampicin, streptomycin or both drugs) and antibiotic-free plates (LB agar only). 
Clones were classified as sensitive if they grew on an antibiotic-free media but not 
on media with antibiotic(s). 50 clones were initially tested for each population. 
Populations where sensitive clones were found were subsequently tested for 
another 150 clones. 
 
Estimation of evolutionary parameters 
 The method used to estimate the rate of acquisition of beneficial mutations 
and the distribution of selective effects was modified from the one published in 
(Moura de Sousa et al. 2013). Briefly, the method simulates 1 million marker 
dynamics with parameters (mutation rate, shape and mean of a gamma 
distribution for the selective effects of new mutations) chosen from a uniform 
distribution. Afterwards, marker frequency and average population fitness is used 
to summarize both the experimental data and the simulated dynamics. This data is 
used as summary statistics to be compared by Approximate Bayesian 
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Computation (ABC). The difference in the method used here is that instead of 
using the neural network function in ABC, a simple ranking and rejection method 
was used, where simulations are ranked by the Euclidean distance between 
summary statistics form the simulated and experimental data, and the top 20 
simulations were chosen for the distributions of parameters. 
 
DNA extractions  
 The evolved populations were plated onto LB agar plates and grown for 
24h at 37º C. One colony, with the most frequent marker, was picked from each 
population was grown overnight into 10 mL of liquid LB, at 37º C with shaking. The 
bacterial DNA was then extracted and its concentration and purity were quantified 
using Qubit and NanoDrop, respectively. Following quantification, equal 
concentration of each DNA sample was taken and pooled together with the clones 
from the populations of similar resistant background, resulting in 3 pools of DNA 
(RifR pool with 12 clones, StrR pool with 12 clones and RifRStrR pool with 24 
clones). 
 
Whole Genome Sequencing Analysis 
 The DNA extracted was sequenced using the Miseq Illumina platform. 
Coverage of the different pools was as following: 521x for 12 clones in the RifR 
pool; 640x for 12 clones in the StrR pool; 631x for 24 clones in the RifRStrR pool. 
The resulting sequences were analysed in Breseq version 2.3, using E. coli K12 
genome NC_000913.2 as a reference, and with the polymorphism option selected 
and following parameters: a) rejection of polymorphisms in homopolymers of 
length greater than 3; b) rejection of polymorphisms that are not present in at least 
3 reads in each strand; c) rejection of polymorphisms that don not have a p-value 
for quality bigger than 0.05. All other Breseq parameters were used as default. 
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Allelic reconstructions and competitions 
 The putative compensatory mutations located in rpoC were co-transduced 
together with rpoB H526Y to wild-type (∆lacIZYA galK::CmR YFP/CFP) and rpsL 
K43T backgrounds by P1vir transduction, using the propagated line harbouring 
each rpoC mutation as donor and either wild-type (∆lacIZYA galK::CmR YFP/CFP) 
or the rpsL K43T ancestral as recipient strains, and selecting for rifampicin 
resistance. The presence of the desired mutations in the transductant isolates was 
assessed by amplification of the rpoC gene and sequencing. The resulting strains, 
which were stored at -80ºC, harbour either the rpoC mutation linked to the rpoB 
H526Y allele (reconstruction of the rpoC mutation in the single resistant 
background) or these two mutations and the rpsL K43T allele (reconstruction of 
the rpoC mutation in the double resistant background). Both reconstructed strains 
and ancestral resistant strains were unfrozen and acclimatized during 24h, to 
avoid compensatory mutations to appear in the more costly backgrounds. 
Reconstructed mutants were competed against the respective ancestral strain to 
assess their competitive advantage per generation, assuming the competition lasts 
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Supplementary Figures and Tables 
 
 
Extended Data Figure 1: Competitive fitness at 48h of the resistant strains used 
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Extended Data Figure 2: Dynamics of competitive fitness increase for the 
RifRStrepR populations show stabilization at different levels of fitness. Error bars 
indicate the standard error across 3 independent replicates. In A are the dynamics 
of all the 24 populations, and in B are shown 6 indicative populations, for clarity. 
 








































































































































Mutations in H526Y Evolved Populations (12)
Genome Position Gene(s) Mutation Region Frequency
897,450 ybjO T→C I80T (ATC→ACC) 6.10%
1,720,637 ydhK Δ3 bp coding 1%
1,876,095 yeaP A→G G119G (GGA→GGG) 8.10%
2,438,935 fabB Δ135 bp coding 1%
3,056,065 serA Δ3 bp coding 7%
3,438,465 rpoA G→A T196I (ACC→ATC) 16.40%
4,179,832 G→A D189N (GAT→AAT) 10.50%
4,180,843 T→C Y526H (TAC→CAC) 19.30%
4,180,886 G→A R540H (CGT→CAT) 6.00%
4,182,538 G→A G1091S (GGT→AGT) 6.40%
4,182,629 C→T A1121V (GCG→GTG) 7.70%
4,184,672 A→C I434L (ATC→CTC) 8.40%
4,184,721 A→C H450P (CAC→CCC) 6.70%
4,186,458 C→T T1029I (ACC→ATC) 8.00%
4,187,043 G→A R1224H (CGT→CAT) 6.10%
4,537,292 nanC A→G V78A (GTT→GCT) 9.50%
Mutations in K43T Evolved Populations (12)
Genome Position Gene(s) Mutation Region Frequency
751,564 ybgD G→A S152L (TCA→TTA) 6.80%
880,317 dacC A→T D123V (GAC→GTC) 0.70%
1,721,544 ydhK A→T Q467L (CAA→CTA) 0.90%
1,868,555 yeaI T→C G49G (GGT→GGC) 7.70%
1,894,732 nudL T→G I180R (ATA→AGA) 6.30%
1,994,442 sdiA Δ88 bp coding (328‑415/723 nt) 0.80%
1,977,514 insA/uspC IS1 (+) +9 bp intergenic (‑275/‑255) 49.80%
2,305,001 yojI G→C T546R (ACG→AGG) 8.50%
3,281,366 kbaY G→A A68T (GCC→ACC) 9.10%
3,350,771 arcB Δ42 bp coding (236‑277/2337 nt) 6.3%/8.7%
3,442,923 rpsE G→A A110V (GCA→GTA) 7.50%
3,468,261 tufA A→T I364N (ATC→AAC) 18.50%
4,122,178 A→C L101R (CTG→CGG) 6.70%
4,122,338 C→G A48P (GCC→CCC) 6.30%
4,122,434 C→T A16T (GCC→ACC) 8.80%
4,178,694 rplL Δ6 bp coding (112‑117/366 nt) 17%/14.8%
4,424,464 rplI A→C K112Q (AAG→CAG) 8.10%
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Mutations in H526Y-K43T Evolved Populations (24)
Genome Position Gene(s) Mutation Region Frequency
22,409 ileS A→C T7P (ACC→CCC) 8.40%
134,997 speD Δ150 bp coding (437‑586/795 nt) 3.10%
231,469 yafD A→G A116A (GCA→GCG) 3.60%
501,096 ybaL A→C L456R (CTG→CGG) 2.30%
965,210 ycaI C→T S556S (AGC→AGT) 5.70%
985,489 ompF A→G G239G (GGT→GGC) 4.70%
1,319,447 trpE G→A R508R (CGC→CGT) 5.10%
1,364,027 puuE G→A A152T (GCG→ACG) 4.40%
1,457,453 paaH A→G T126A (ACC→GCC) 6.30%
1,555,702 ddpF A→G L121L (TTG→CTG) 6.90%
1,803,390 ydiY T→C T240A (ACC→GCC) 6.60%
1,977,418 insA/uspC IS1 (+) +8 bp intergenic (‑179/‑352) 14.10%
2,149,881 yegK T→C T206A (ACC→GCC) 7.80%
2,173,375 gatZ C→T P323P (CCG→CCA) 6.40%
2,236,388 IS1 (+) +9 bp coding (916‑924/1521 nt) 6.10%
2,236,609 IS1 (+) +9 bp coding (695‑703/1521 nt) 3.00%
2,237,521 G→A Q284* (CAG→TAG) 3.00%
2,238,169 G→A Q68* (CAG→TAG) 5.00%
2,238,178 G→A Q65* (CAG→TAG) 3.50%
2,346,145 nrdB A→G Q247R (CAG→CGG) 4.40%
2,445,777 prmB A→C L229R (CTG→CGG) 4.40%
2,759,683 yfjK A→G V627A (GTG→GCG) 3.90%
3,209,504 dnaG T→C F126L (TTT→CTT) 4.00%
3,273,728 garD T→C V142A (GTC→GCC) 4.60%
3,438,854 rpoA A→C H66Q (CAT→CAG) 4.70%
3,439,442 T→C T86A (ACC→GCC) 5.80%
3,439,550 C→A D50Y (GAC→TAC) 3.10%
3,442,927 C→G G109R (GGT→CGT) 5.20%
3,442,945 T→G T103P (ACC→CCC) 2.90%
3,451,341 rpsJ / gspB A→G intergenic (‑49/+189) 3.90%
3,468,261 tufA A→T I364N (ATC→AAC) 10.40%
3,961,252 gpp G→T A334E (GCG→GAG) 4.80%
3,977,997 wecG G→A A7T (GCA→ACA) 4.00%
4,032,002 trkH G→T G279C (GGC→TGC) 4.40%
4,175,194 tufB / secE T→C intergenic (+43/‑187) 4.40%
4,178,694 rplL Δ6 bp coding (112‑117/366 nt) 4.90%
4,180,843 rpoB T→C Y526H (TAC→CAC) 6.30%
4,181,500 G→A E745K (GAA→AAA) 10.90%
4,182,295 Δ9 bp coding (3028‑3036/4029 nt) 3%
4,185,654 C→A A761E (GCG→GAG) 3.50%
4,185,723 C→T A784V (GCG→GTG) 4.00%
4,186,209 C→T A946V (GCT→GTT) 2.30%
4,186,461 A→C E1030A (GAA→GCA) 26.10%
4,186,748 C→A Q1126K (CAG→AAG) 26.70%
4,186,991 G→T G1207C (GGT→TGT) 2.30%
4,187,115 T→C I1248T (ATT→ACT) 3.80%
4,305,980 alsE A→G G174G (GGT→GGC) 6.40%
4,310,594 rpiR C→G A141P (GCC→CCC) 3.70%
4,397,222 mutL Δ1 bp coding (1788/1848 nt) 4.20%











Extended Data Table 1: Mutations acquired during the 22 days adaptation to 
antibiotic free media. Mutations are shown for the 3 different resistant 
backgrounds, along with the frequency at which they were detected. Mutations in 
known compensatory targets are marked in bold. 
 
 
Extended Data Table 2: Sensitivity assays in the evolved populations. Shown are the populations 
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ABSTRACT Aim: To investigate the cost of antibiotic resistance versus the 
potential for resistant clones to adapt in maintaining polymorphism for resistance. 
Materials & methods: Experimental evolution of Escherichia coli carrying different 
resistance alleles was performed under an environment devoid of antibiotics and 
evolutionary parameters estimated from their frequencies along time. Results & 
conclusion: Costly resistance mutations were found to coexist with lower cost 
resistances for hundreds of generations, contrary to the hypothesis that the cost of 
a resistance dictates its extinction. Estimated evolutionary parameters for the 
different resistance backgrounds suggest a higher adaptive potential of clones with 
costly antibiotic resistance mutations, overriding their initial cost of resistance and 
allowing their maintenance in the absence of drugs. 
KEYWORDS: Evolvability; Antibiotic Resistance; Experimental Evolution; 
Epistasis; Clonal Interference; 
 
INTRODUCTION 
Bacterial populations can acquire antibiotic resistance (AR) as a result of 
transfer and acquisition of new genetic material between individuals of the same or 
different species but also by chromosomal DNA mutations, which alter existing 
bacterial proteins. One landmark example of this second process is provided by 
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Mycobacterium tuberculosis (the etiologic agent of tuberculosis in humans), which 
albeit incapable of horizontal gene transfer can display “total drug resistance” 
(Velayati et al. 2009). This kind of resistance is typically acquired by the sequential 
accumulation of mutations that alter the cellular target for the drug action. During 
this process extensive clonal competition has also been observed (Solomon H 
Mariam et al. 2011). Understanding how these AR determinants disseminate and 
are maintained in bacterial populations is therefore of paramount importance.  
Mutations that confer spontaneous AR can occur at relatively high rates 
(Mwangi et al. 2013). For instance, rifampicin (Rif) resistance occurs 
spontaneously at frequencies that can be higher than 10-8 in wild isolates of E. coli 
(Baquero et al. 2004). In fact, the levels of resistance in pathogenic populations 
continue to rise at an alarming rate (Walsh 2000; Laxminarayan et al. 2013) 
having reached the same significance as any other virulence factor (J Davies & D 
Davies 2010). However, in the absence of the drug, AR mutations typically bear a 
cost (Andersson & Levin 1999; Lenski 1998; Andersson & Hughes 2010). This 
cost depends on the specific resistance allele (Deneke H Mariam et al. 2004), on 
the environment (Björkman et al. 2000; Chait et al. 2007) and on the genomic 
background where the mutation happens to arise (Trindade et al. 2009; Angst & 
Hall 2013). Nevertheless, suppressive mutations that mitigate this cost can occur 
either in the presence or absence of antibiotics. In the absence of drugs, one can 
expect that sensitive bacteria, will sweep through the population, driving the AR 
mutant to extinction. However, more often than not, resistant strains have been 
observed to acquire additional beneficial mutations that reduce the costs of 
resistance without loss of resistance, thus preventing the elimination of resistance 
alleles (Maisnier-Patin & Andersson 2004). These compensatory mutations are 
common in clinical isolates (Comas et al. 2012; De Vos et al. 2013) and hinder the 
possibility of reverting the resistance mutation, due to their epistatic nature (Davis 
et al. 2009). Since the probability of a compensatory mutation tends to be much 
higher than that of reversion for several resistance mutations (Andersson & 
Hughes 2010; Levin et al. 2000; Poon 2005; Sousa et al. 2012; Gifford & MacLean 
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2013), it is likely that resistance alleles may take long periods of time to be 
eliminated from populations.  
Many mutations that confer AR occur in essential genes and are likely to 
result in pleiotropic effects altering several bacterial traits. Important examples 
include resistance to Rif and streptomycin (Str) (Couturier et al. 1964; Romero et 
al. 1973). Rif is one of the frontline anti-tuberculosis drugs (Koch et al. 2014). The 
co-occurrence of resistance to this antibiotic and isoniazid typically classifies M. 
tuberculosis as multi-drug-resistant. These are the two most commonly used and 
effective drugs for the treatment of tuberculosis. The main genetic target for Rif 
resistance is rpoB, which codes for the β subunit of the RNA polymerase. Besides 
typically decreasing the rate of transcription and consequently the growth rate, 
rpoB resistance mutations are probably some of the most pleiotropic among AR 
mutations. Their effects can range from regulation of competence, sporulation and 
germination in Bacillus subtilis (Maughan et al. 2004), temperature and phage 
sensitivity in E. coli (Jin et al. 1988), growth advantage in stationary phase in E. 
coli and Salmonella enterica (Wrande et al. 2008), increased antibiotic resistance 
in Staphylococcus aureus (Cui et al. 2010; Watanabe et al. 2011), amongst others 
(see (Koch et al. 2014) for a review). rpoA and rpoC, as well as additional 
mutations in rpoB, have been pointed as targets for compensatory mutation 
relieving the deleterious effects of rpoB Rif resistance mutations in M. tuberculosis, 
S. enterica and E. coli (Comas et al. 2012; Brandis et al. 2012; Brandis & Hughes 
2013; Reynolds 2000). Another frequent resistance is Str, occurring through 
mutations in the rpsL gene, which codes for the S12 subunit of the ribosome 
compromising translational speed and accuracy. Compensatory mutations for Str 
resistance have been observed in Salmonella thyphimurium, and some of the 
target genes include rpsL, rpsD, rpsE and rplS (Schrag et al. 1997; Björkman et al. 
2000; Maisnier-Patin et al. 2002), which encode the ribosomal subunits S12, S4, 
S5 and L19. Recent analysis of 161 genomes of M. tuberculosis with a broad 
range of resistance profiles, revealed seven possible additional targets for 
compensatory mutations to Str resistance (Hongtai Zhang et al. 2013).  
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Given such broad targets for increasing the fitness of AR mutants we may 
expect that these resistances change the evolvability of bacteria, through altering 
the range of beneficial mutations that can be accessed by a given resistance 
genotype. Here we use the term evolvability as “the genome’s ability to produce 
adaptive variants” (Wagner & Altenberg 1996). In this sense, a costly AR mutant 
may be able to effectively compete with a less costly resistance allele (i.e., with a 
higher selective coefficient when in direct competition) if the evolvability of the 
former is higher. The conditions for this to happen will depend on the distribution of 
effects of beneficial mutations (DEBM), as well as on the rate of beneficial 
mutations available to each genotype (Handel et al. 2006; Sousa et al. 2012; 
Barrick et al. 2010).  
Most studies addressing the competitive fitness effects associated with AR, 
consider resistant strains competing with the ancestral sensitive strain. However, 
in many natural environments the frequency of resistance can be very high and 
competition between different resistant alleles may be a common event (Farhat et 
al. 2013; Hongtai Zhang et al. 2013; Forsberg et al. 2012; Nolan et al. 1995; 
Mwangi et al. 2007; Solomon H Mariam et al. 2011; Sun et al. 2012). For instance 
in (Solomon H Mariam et al. 2011), a monoclonal Mycobacterium tuberculosis 
infection was followed and both clonal sweeps and the coexistence of different 
resistant mutants were observed in the dynamics of the population. Competition 
between different resistant strains is also likely to occur whenever there is spatial 
heterogeneity, with different areas posing different selective pressures (Hermsen 
et al. 2012; Q Zhang et al. 2011; Solomon H Mariam et al. 2011). Furthermore, 
bacteria with multiple resistance alleles are also commonly segregating in natural 
populations (Wright 2010; Borrell et al. 2013; Merker et al. 2013). This competitive 
context might therefore play a crucial role in the maintenance of antibiotic 
resistance. 
Here we study the process of fitness recovery mimicking an environment 
with different resistance backgrounds competing at high frequency. We use an 
experimental evolution approach (Jansen et al. 2014) to test the ability of clones 
                               Potential for adaptation overrides cost of resistance 
	  
	   169	  
with costly AR alleles to coexist or even outcompete clones with less costly 
resistances. In a drug free environment, the differences in the fitness costs of 
resistance alleles should determine their probability of extinction. Contrary to this 
simple expectation, we observe the maintenance of costly resistance alleles over 
hundreds of generations even when their fitness impairment should predict fast 
extinction. We infer that differences in adaptive potential for each AR mutant exist 
and suggest that these can explain the observed outcomes in the evolution of 
resistance. 
 
MATERIALS AND METHODS 
Bacterial strains and growth conditions 
All bacterial strains used in this study were derived from Escherichia coli 
K12 MG1655 and have in common the following genotype: galK::yfp/cfp cmR 
(pKD3), ΔlacIZYA.  The yellow (yfp) and cyan (cfp) alleles were integrated at the 
galK locus under the control of the lac promoter and were constructed by P1 
transduction(Silhavy et al. 1984) of yfp/cfp inserts from previously constructed 
strains (Hegreness 2006).  In these strains the fluorescence marker is 
constitutively expressed. In this common backbone different antibiotic resistance 
mutations were introduced by P1 transduction. The donor strains were 
spontaneous antibiotic resistant mutants previously obtained by plating the 
sensitive bacteria in Luria-Bertani (LB) supplemented with agar and 100 mg/mL of 
either streptomycin or rifampicin (Trindade et al. 2009). A total of eight strains were 
constructed: K43TStr-YFP, S531FRif-YFP, H526YRif-YFP, H526DRif-YFP and 
K43TStr-CFP, S531FRif-CFP, H526YRif-CFP, H526DRif-CFP, such that the same 
resistance allele was introduced in the two fluorescence backgrounds. K43TStr 
confers resistance to streptomycin and all the other aminoacid changes confer 
resistance to rifampicin. In order to confirm the identity of the mutations transferred 
by P1 transduction, the antibiotic resistance target gene (rpoB for rifampicin or 
rpsL for streptomycin) was amplified and sequenced using the following primers: 
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for the relevant fragment of the rpoB gene, 5’-CGTCGTATCCGTTCCGTTGG-3’ 
and 5’-TTCACCCGGATAACATCTCGTC-3’ and for the rpsL gene, 5’-
ATGATGGCGGGATCGTTG-3’ and 5’-CTTCCAGTTCAGATTTACC-3’. Each 
resistant clone was grown from a single colony in LB medium supplemented with 
the respective antibiotic at 37ºC with aeration and stored in 15% glycerol at - 80°C.  
Fitness assays and test for frequency dependent selection  
The fitness costs of antibiotic resistance mutations were first measured in 
competition against a sensitive reference strain (Table S1). The reference strain 
carried a yfp allele if the resistant strain carried the cfp allele (and vice versa). 
Competitions were done after acclimatization, where each bacterial strain was 
grown in the same environment of the competition: in a 96 well plate with 150µL of 
LB per well at 37°C with aeration.  Acclimatization consisted of two consecutive 
passages where 5µL from the first 24 hour grown culture were used to inoculate a 
new plate for another 24h. Competitions were performed by inoculating ~105 cells 
of both competitor and reference strain in LB medium and allowed to grow for 24 
hours (~9 generations). The initial and final ratios of both strains were determined 
by Flow Cytometry. Fitness effects of the resistance mutations were estimated as 
the slope between 0 and 24h of the ln(f(NR)/(1-f(NR))), where f(NR) is the frequency 
of resistant bacteria in the population or one of the reference resistance 
backgrounds, in the case of the competitions of the evolved clones.  
H526YRif and H526DRif strains were tested for negative frequency 
dependent selection in the same conditions as described above, and the number 
of cells was measured using the Flow Cytometer BD LSR Fortessa (BD 
Biosciences), at different initial ratios of the two strains: 100:1, 10:1, 1:1, 1:10 and 
1:100 (H526YRif:H526DRif). 
Long-term propagation of resistant populations  
Prior to the start of the long-term competitions, acclimatization of the 
bacterial strains was performed in plates with a checkered arrangement (one plate 
for YFP strains, another for CFP strains). Each well was inoculated with an 
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independent starting sample, from a frozen culture, into 150ml of LB medium, to 
maximize the probability of sampling a large pool of beneficial mutations. We note 
that it is possible that beneficial mutations occur during the acclimatization period, 
since the rate of mutations which compensate for the cost of resistance can be 
very high. After 24 hours, 5ml of the grown cultures where inoculated into fresh LB 
media and after 48h the numbers of bacteria were measured. Appropriate dilutions 
were done to achieve the required initial ratio (1:1) of YFP and CFP strains for the 
long-term evolution of competing clones. This evolution was performed in the 
same conditions as the fitness assays, with daily passages of about ~105 bacteria 
for ~280 generations (30 days). Samples of the evolving populations were frozen 
every day, from which the relative abundance of each resistance was followed by 
measuring the frequencies of their linked fluorescent alleles by Flow Cytometry. 
The following three pairs of mutants were studied: K43TStr vs S531FRif, H526YRif vs 
H526DRif and H526YRif vs S531FRif. For each pairwise competition of mutants, 16 
replicas were performed: half where one of the resistances, say R1, was linked to 
the yfp background and the other half where it was linked with the cfp background. 
Pairwise combinations of mutants (R1-YPF vs R2-CFP and R1-CFP vs R2-YFP) 
were settled in a checkerboard arrangement (Figure 1), where half of the wells 
were filled solely with LB to control for external contamination.  
 
Estimation of relative parameters of beneficial mutations  
The dynamics of a given costly resistance allele (R1) when competing with 
another resistant clone (R2), with a different fitness cost, were analyzed under a 
simple model of positive selection, that assumes the occurrence of new beneficial 
alleles which are sweeping towards fixation. We first fitted the simplest possible 
model (Model 1), which can allow for a costly resistance allele to be maintained for 
hundreds of generations despite its initial cost. In this model we assume an initial 
population composed of two distinct genotypes, with different resistances and 
initial fitnesses, wR1 and wR2. The initial frequency of the more costly genotype, 
R20, is taken from a uniform distribution within the interval R2Experimental0 ± 0.1, while 
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that of the other genotype is R10=1-R20. At generation TN a new genotype, with 
fitness wN, is assumed to have arisen and reached a frequency N0=0.001. From 
that time onwards it is assumed to change in frequency deterministically towards 
fixation. Therefore, we modeled selection deterministically in discrete time with two 
genotypes for t<TN, and three for t>TN. We estimated, by maximum likelihood, the 
parameters R20, TN and wN that best fit the observed values of ln(M/(1-M)), where 
M is the measured frequency of a fluorescent marker, at several time points, 
assuming a normal distribution for  measurement error (with average 0 and 
standard deviation 0.2). The search for the set of parameters that maximize the 
likelihood of the data in the space of the possible parameters was performed using 
the Nelder-Mead Method, as implemented in Mathematica 8.0 
(http://mathworld.wolfram.com/Nelder-MeadMethod.html), with 100 iterations and 
repeated for 100 realizations with different initial starting combinations of 
parameter values. While Model 1 could provide a reasonable fit for some of the 
replicate experimental lines, for others it did not. We therefore fitted the next 
simplest model (Model 2) which assumes that two beneficial mutants (N1 and N2), 
one for each background and fluorescent marker (with fitnesses WN1 and WN2), 
emerged at times (TN1 and TN2). We selected the model with the lower AIC (Akaike 
Information Criteria) to test if the different resistances would have distinct 
evolvabilities. Specifically, for each pair of competing resistances and each 
experimental evolved population, we asked if the times of appearance of beneficial 
mutations or the effects of accumulated beneficial mutations were significantly 
different. If the genetic target for acquiring beneficial mutations is larger for 
resistance background R2 than for R1, but the effects of the compensatory 
mutations are similar, then we expect the time of appearance of mutations to be 
smaller in R2 than in R1. If the target is similar but the effects depend on the 
background we expect to observe a significant difference between the effects 
accumulated in one resistance background versus the other. The method used 
here is a discrete adaptation of existing methodologies to infer evolutionary 
parameters (Illingworth & Mustonen 2012), with the added difference of allowing 
for different initial fitness values in competing genetic backgrounds. Code for these 
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simulations is available upon request. The inference process and summary relative 
effects are shown for a single line, as an example, in Figure S1. 
Whole genome sequencing of H526YRif and S531FRif evolved clones 
A single clone of each resistance (H526YRif and S531FRif) from each 
evolved population was isolated in LB agar plates with rifampicin at the end of the 
evolution experiment. In six populations the frequency of clones from the S531FRif 
background was very low and no resistant clone was sampled. DNA was extracted 
from each sampled clone, and then pooled according to resistance background. 
Paired-end sequencing using Illumina MiSeq Benchtop Sequencer, with mean 
coverage of 207x was performed. The resulting reads were trimmed at a Phred 
quality score of 99.9%, and were then aligned using Escherichia coli K12 MG1655 
(NC_000913.2) as the reference genome. Mutation prediction was done using 
version 0.23 of the BRESEQ analysis pipeline available for download at 
http://barricklab.org/twiki/bin/view/Lab/ToolsBacterialGenomeResequencing, with 
polymorphism detection on. Other settings were used as default except for: a) 
requirement of a minimum coverage of 3 reads on each strand per polymorphism; 
b) polymorphism predictions occurring in homopolymers of length greater than 3 
were discarded; c) polymorphism predictions with significant (p-value<0.05) strand 
or base quality score bias were discarded. 
 
RESULTS 
Pairwise competitions between different AR alleles were performed in an 
antibiotic free environment for around 280 generations. Each strain carries a 
neutral fluorescence marker. Three pairs of resistance mutations were studied: 2 
pairs involving 3 different Rif resistance alleles, and one pair involving a Str and a 
Rif resistance allele (Figure 1). The costs of each resistance allele measured 
against a sensitive reference strain of E. coli are shown in Table S1. The cost of 
resistance in relation to the sensitive is higher for the S531FRif mutation (0.1 ± 
0.01) and the K43TRif mutation (0.09 ± 0.03), followed by H526YRif (0.07 ± 0.01) 
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and H526DRif (0.06 ± 0.02) mutations. We then inferred the fitness cost of the 
same resistance mutations but this time in the presence of another resistance. 
Whether a resistance allele was more or less costly was estimated from the 
change in frequency of the fluorescent markers, linked to the resistances, during 
the first three days of evolution where the pairs of AR mutants were competing 
(Figure 2, 3 and 4, and also Figure S2 for each of the replicates identified by its 
neutral marker). We assume that during this short period new beneficial mutations 
have not yet arisen, or are at a frequency too low to interfere with the relative 
fitness differences that both clones may have.  
For each pairwise evolution experiment we query whether different AR 
mutants show distinct adaptive potential. For that, we inferred the fitness effects of 
new beneficial mutations that could explain the observed long-term frequency 
dynamics of the AR alleles. We allowed for one or two beneficial mutations of 
different effects to emerge at different times, in either of the backgrounds (see 
Methods). We sought to infer the combination of parameters (time of emergence, 
effect of the beneficial mutation, and the initial frequency of one of the resistance 
alleles) that provided the best fit to the observed evolutionary dynamics. We 
started by fitting a model where a single new beneficial mutation (with effect SN, at 
time TN) escapes stochastic loss in the background with lower initial fitness (Model 
1). We estimated the value of SN and TN that best fits the dynamics of each 
resistance, under this model. We then used a model assuming that two beneficial 
mutations had increased in frequency, one in each background, and fitted the 
parameters of this second model (TN1, SN1, and TN2, SN2) to the dynamics 
observed. The lines shown in Figure S3 represent the model that best fits the 
data, and the inferred parameters are presented in Table 1, 2 and 3.  
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Figure 1. Testing the evolvability of different antibiotic resistances. First, 
polymorphic populations are created by mixing, in a 1:1 ratio, clones with two 
different antibiotic resistance mutations. All clones are isogenic, except for this 
different resistance mutation and a neutral fluorescent marker. 16 replicate 
populations are followed for each competition, where half of these replicates 
have one of the resistances linked with one of the neutral markers, while the 
other to the other marker. 3 different competitive scenarios were studied, 
between Rifampicin mutations (circles) and between Rifampicin and 
Streptomycin (squares). Next, populations are passaged in rich media in 96 
well plates, organized in a checkered layout and separated by control wells 
(with media but without bacteria). Every 24 hours, all populations are 
passaged serially into a new 96 well plate with fresh media, during 30 days. 
The frequencies of the neutral markers (and hence the resistance alleles) are 
analyzed to unravel possible differences in the evolutionary parameters 
according to the resistance background. 
 
 
Potential for adaptation causes the maintenance of high cost resistance 
We first studied the fate of two AR mutations, conferring resistance to the same 
antibiotic – Rif – and altering the same aminoacid in the β subunit of RNA 
polymerase: H526YRif and H526DRif. While the costs of these resistances are not 
statistically different when measured against a sensitive strain, their relative fitness 
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cost differs when they compete. From the initial generations of competition 
between these two strains, a fitness difference of 0.074 was inferred, with strain 
H526YRif being highly detrimental in this competitive environment (Figure 2A, 
black solid line). The cost carried by strain H562YRif leads to the rapid decline in its 
frequency, detected in the first tens of generations. With such a relative fitness 
cost, it should go extinct in 100 generations (as indicated by the black line). 
Strikingly though, H526YRif is clearly able to resist extinction in the majority of the 
replicate lines that were evolved. Four of the lines show a frequency too low to be 
reliably detected by Flow Cytometry. However, plating these populations at 
generation 280 allows observing the presence of fluorescent colonies of the 
H526YRif background at extremely low frequencies. This lack of extinction can be 
expected under two different scenarios: negative frequency-dependent selection 
and/or an ability to access higher effect beneficial mutations. We therefore tested 
for a possible signature of negative frequency-dependent selection, i.e., advantage 
from rarity of the H526YRif mutation when competing against H526DRif. In 
competitions between these two backgrounds, starting with different frequencies of 
the H526YRif allele, no advantage from rarity can be detected (Figure S4), so 
frequency-dependent selection is unlikely to be responsible for the observed lack 
of extinction of this mutation. On the other hand, analysis of the long-term 
frequency dynamics revealed a significant difference between the fitness effects of 
the mutations inferred to have emerged, with its median difference (sH526YRif – 
sH526DRif) deviating from 0 (P<0.001, Wilcoxon Signed Rank Test, Figure 2B). 
The mean difference in fitness effects between these two genetic backgrounds 
was 0.07 (Table 1, Figure 2B), with H526YRif background accumulating stronger 
effect mutations. Regarding the times of appearance of new beneficial mutations, 
no significant difference was detected between the backgrounds (P=0.41, 
Wilcoxon Signed Rank Test, Figure 2C). When considering these results together, 
there is a strong indication that the mean effect of beneficial or compensatory 
mutations for H526YRif is higher, thus qualifying the strain with the H526YRif 
mutation as more evolvable than the strain with the H526DRif mutation. Such 
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Figure 2. High evolvability of costly H526Y allows its long-term 
maintenance A) Long-term dynamics, for 30 days (280 generations) of 
evolution in 15 replicates of a population composed of resistance strain 
H562Y and resistance strain H526D. Shown are the dynamics for the H526Y 
background. The slope of the black line represents the initial difference in 
fitness between the resistances. B) Whisker-box shows the relative fitness 
differences inferred for new beneficial mutations between the two resistant 
backgrounds, with H526Y background as a reference. C) Whisker-box shows 
the relative differences in time of appearance inferred for new beneficial 
mutations between the two resistance backgrounds. 
higher evolvability can explain the avoidance of extinction of background H526YRif, 
contrary to the a priori expectation based on its lower initial fitness.  
 




Table 1. Evolutionary Parameters estimated for the competition between 
strains H526Y and H526D. W stands for the fitness of the emerging haplotype 
and T its time of appearance. Initial Freq stands for the inferred initial frequency 
of the H526Y background. In the cases where only one of the backgrounds has 
acquired a mutation, the inferred parameters are in bold for the background 
where no mutation was inferred. 
 
Higher evolvability of H526YRif upheld in competition with an alternative resistance 
We then studied the ability of the H562YRif background to outcompete a 
mutant bearing a resistance mutation in a different aminoacid, S531FRif. 
Resistance to the antibiotic rifampicin is now provided by mutations causing 
different aminoacid substitutions in the β subunit of RNA polymerase. . Relative to 
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the sensitive strain, H526YRif is estimated to impose a smaller mean fitness cost 
than S531FRif (see Table S1), although the difference is not significant. The 
relative fitness difference between strains H562YRif and S531FRif inferred from their 
direct competition is 0.015 (Figure 3A, black solid line). All lines initially decrease 
in frequency, in accordance with a cost of H526YRif, but in all replicates this 
tendency is inverted. After generation 30, the frequency of each of the resistance 
background stabilizes at 50% in all populations. After generation 125, additional 
changes in frequency can be detected. This is expected if other arising beneficial 
mutations increase in frequency in one or both backgrounds. In some replicate 
lines one of the resistance alleles starts to increase in frequency but later 
decreases. This is likely the result of clonal interference (Sniegowski & Gerrish 
2010), with multiple beneficial mutations competing amongst them. There were 
more replicates in which H526YRif increased in frequency than expected, even 
under the assumption that the initial fitness difference between the backgrounds 
would be negligible. At generation 280, 14 out of 16 lines have a frequency of this 
allele above that expected by chance (p=0.004, Binomial two-sided test), which is 
even more striking considering that its initial frequency is below 50% in most of the 
lines. This deviation suggests again differences in the adaptive potential between 
the resistance backgrounds.  
We tested for possible differences in the adaptive potential of each strain 
by inferring the time of appearance and fitness effects of new beneficial mutations 
that could explain the changes in frequency of the neutral markers (Figures 3B 
and 3C). The mean value for differences in fitness between the two genetic 
backgrounds was 0.034 (see Figure 3B and Table 2). The median of the 
distribution of relative effects deviates significantly from 0 (P<0.001, Wilcoxon 
Signed Rank test, Figure 3B). The times of appearance of the new inferred 
beneficial mutations, however, did not appear to be significantly different between 
the genetic backgrounds (P=0.3, Wilcoxon Signed Rank test, Figure 3C). The 
overrepresentation of the H526YRif resistance background in the evolving 
populations, together with this analysis, indicates that H526YRif has a higher 




Figure 3. Different evolvabilities between Rifampicin resistance alleles A) 
Long-term dynamics, for 30 days (280 generations) of evolution in 16 replicates of 
a population composed of resistance strain H562Y and resistance strain S531F. 
Shown are the dynamics for the H526Y background. The slope of the black line 
represents the initial difference in fitness between the resistances. B) Whisker-
box shows the relative fitness differences inferred for new beneficial mutations 
between the two resistant backgrounds, with H526Y background as a reference. 
C) Whisker-box shows the relative differences in time of appearance inferred for 
new beneficial mutations between the two resistance backgrounds. 
evolvability across different competitive contexts and therefore can be easily 
maintained.  
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Table 2. Evolutionary Parameters estimated for the competition between 
strains H526Y and S531F. The meaning of the parameters is as in Table 1. 
 
Potential for adaptation drives the fate of resistances to different antibiotics 
Differences in evolvability are expected to be larger amongst resistances 
affecting different genes than between alleles from the same gene. This is so 
because the target for beneficial mutations is expected to be more similar between 
mutations affecting the same function than between mutations impairing different 
traits. To query if the costs or the evolvabilities are determinant to the competition 
of resistances to distinct drugs, we studied the fate of the Str resistance allele 
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(K43TStr) when in competition with the Rif resistance allele (S531FRif). K43TStr is 
estimated to impose a cost to the sensitive strain of ~0.09, which is not statistically 
different from the cost imposed by S531FRif. However, upon competition between 
these two strains, K43TStr shows a disadvantage of around 0.03 relative to 
S531FRif (Figure 4A, black solid line). This is observed in the initial 25 generations, 
where K43TStr decreases in frequency in most replicate competitions. The long-
term evolutionary dynamics, however, depart from those observed in the previous 
studied cases. In Figure 4A, a higher variation in the outcome of which resistance 
wins the competition emerges in this pair of competing resistances. In the vast 
majority of the replicate lines the K43TStr mutation survived extinction for the 
duration of the experiment, contrary to what would have been expected from its 
initial relative fitness cost. In most of the lines, K43TStr is kept at a stable frequency 
of around 30% and in three lines it rises in frequency, sweeping to majority status 
(above 99% frequency) by generation 280. Contrary to expectations, extinction 
(frequency below 1%) of the more costly allele was only observed in two of the 
populations. Most of the lines where the K43TStr resistance was kept at a stable 
but low frequency at the middle time points had different outcomes, with some 
rising and others decreasing in frequency. Overall, at the end of the 280 
generations, the background with the K43TStr allele reached a frequency higher 
than 50% in 6 out of 15 evolved replicate lines. The inference of evolutionary 
parameters performed for the long-term dynamics indicates that there is a 
significant difference in the strength of mutations acquired by each background 
(P=0.014, Wilcoxon Signed Rank Test, Figure 4B). K43TStr acquires beneficial 
mutations of a stronger effect than does the background S531FRif (mean difference 
0.03, Table 3). No significant difference was detected for the times of appearance 
of beneficial mutations between both backgrounds (P=0.6, Wilcoxon Signed Rank 
Test, Figure 4C). The differences inferred from the dynamics in Figure 4A 
therefore depart from the expectation of a non-epistatic model of beneficial 
mutations, where both backgrounds would access mutations of similar effect. 
Extinction might have been avoided for this Str resistance mutation by its ability to 
accumulate stronger effect mutations when competing with the Rif resistant strain. 
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Figure 4. Differences in evolvability between Rifampicin and 
Streptomycin resistance alleles A) Long-term dynamics, for 30 days (280 
generations) of evolution in 14 replicates of a population composed of 
resistance strain K43T and resistance strain S531F. Shown are the dynamics 
for the K43T background. The slope of the black line represents the initial 
difference in fitness between the resistances. B) Whisker-box shows the 
relative fitness differences inferred for new beneficial mutations between the 
two resistant backgrounds, with K43T background as a reference. C) Whisker-
box shows the relative differences in time of appearance inferred for new 
beneficial mutations between the two resistance backgrounds. 
 
 




Table 3. Evolutionary Parameters estimated for the competition between 
strains K43T and S531F. The meaning of the parameters is as in Table 1. 
 
Genetic characterization and fitness determination of evolved clones isolated from 
the long-term competition between  H526YRif and  S531FRif 
In the three cases of long-term competitions studied, the differences in 
evolvability inferred resulted from differences in the effects of the beneficial 
mutations acquired. We inferred that H526YRif could acquire higher effect 
mutations, relative to those emerging in S531FRif clones, even though these two 
different alleles cause very similar fitness costs. To gain further insight into the 
                               Potential for adaptation overrides cost of resistance 
	  
	   185	  
mutations acquired by the H526YRif background in this competitive context, we 
performed whole genome sequencing (see Methods for a description of the 
procedure) of a sample of H526YRif and of S531FRif clones, after these two 
lineages had evolved in competition (Figure 3). Table 4 shows the mutations 
identified in each of the evolved backgrounds. We could identify 12 (in 10 distinct 
genes or intergenic regions) for possible beneficial (and compensatory) mutations 
in H526YRif (all single point mutations), and 10 (all in different genes/intergenic 
regions) in S531FRif (seven of them were single point mutations , the other three 
involved transpositions of insertion sequence elements). Mutations in the H526YRif 
background were observed at a higher frequency compared to the ones observed 
in S531FRif. This suggests that the mutations appearing in the H526YRif 
background have stronger effects, since they are acquired by different replicate 
evolving populations, pointing to a rapid fixation due to their beneficial effect. To 
enquire if this is indeed the case we performed competition assays between each 
individual clone and the ancestral strains. Since the whole genome sequencing 
was performed with a mixture of clones (see Methods) we targeted sequencing 
each individual clone to gain access to the haplotypic composition of each clone. 
For the clones carrying the H526YRif mutation, we targeted the most prevalent 
mutations detected (see Table 4). Fifteen out of the 16 H526YRif clones carried at 
least one mutation in the target genes (Supplementary Table 2) and one clone 
was found to have two mutations, one single point mutation in rpoA and another in 
waaZ. The aminoacid change T196I in rpoA was present in 8 independently 
evolved clones. Since all of them have the same genetic background (H526YRif 
YFP), this suggests that this mutation could already have been present prior to the 
long-term evolution experiment. All S531FRif clones, except one, carried one of the 
previously identified mutations (Supplementary Table 2) and rpoC was also a 
target for beneficial mutations in this RifR background. We then measured the 
competitive fitness of each of these evolved clones to directly assay their fitness 
advantage. In order to increase in frequency during the long-term propagation, 
these mutants had to outcompete their ancestral and also the competitor with a 
different resistance background. Figure 5 shows that when competing either 
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Table 4. Potential compensatory mutations identified in the genomes of the clones 
evolved in the competition between resistances H526Y and S531F 
Mutations were identified in the genomes of the evolved clones in comparison with a 
reference genome. Shown are the Single Nucleotide Polymorphisms (SNPs) or Insertion 
Sequence (IS) events identified in either of the backgrounds, and the frequencies at which 
they were detected. Mutations that occurred between genes (intergenic) are identified as 
such; otherwise all remaining mutations occurred within the gene indicated. The mutations 
previously identified to be compensatory are identified with a grey shaded cell. 
against their respective ancestral or the other resistance clone, the selective 
effects of the evolved H526YRif clones are stronger than the selective effects of the 
mutations acquired by the S531FRif background. For the latter background, the 
mutations are advantageous against their ancestral, supporting their increase to 
detectable frequencies, but most are neutral or even deleterious versus the 
opposite H526YRif background. Remarkably, mutations in rpoA and rpoC provided 
the strongest competitive fitness advantages. Overall, these results therefore 
provide further support for the previously identified higher evolvability of the 
H526YRif background and strongly suggest that the H526YRif resistance may be 
easily maintained in populations. 
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Figure 5. Differences in selective effects of evolved clones from the 
competition between H526YRif and S531FRif. A) Fitness effects of 
selected clones evolved from the H526YRif background, when in 
competition with their ancestor (light bars) or against their other resistant 
competitor (S531FRif, dark bars). B) Fitness effects of selected clones 
evolved from the S531FRif background, when in competition with their 



























In order to understand the relative role of cost versus evolvability in the 
maintenance of AR mutations we studied how subpopulations carrying different 
resistant alleles compete. This system mimics the composition of a population 
after drug exposure, where the different AR mutants co-exist at relatively high 
frequencies. This scenario has rarely been studied, though it possibly occurs in 
natural contexts, as has been observed in strains sampled from the same patient 
(Solomon H Mariam et al. 2011; Sun et al. 2012). Here we address this situation 
by following the fate of pairwise combinations of different alleles conferring 
resistance to the same or different drugs. We observe that the cost of resistance 
measured in competition against the sensitive bacterium is not always a good 
predictor of the difference in costs between two resistance mutations, and 
transitivity between these two fitness measures is not always observed. Therefore, 
to understand why some resistant alleles are rarely segregating while others are 
pervasive, it is important to also measure their selective coefficients when in 
coexistence in addition to measure their costs against the sensitive strain.  
In this work we studied two sets of mutations whose fitness costs were 
barely distinguishable when compared with the sensitive strain. The first set 
comprised 3 alleles of the same gene (H526YRif, H526DRif and S531FRif), thus 
conferring resistance to the same drug; the second group comprised alleles of 
different genes, (S531FRif and K43TStr), thus conferring resistance to different 
antibiotics. In the first set we found that H526YRif has a very significant cost (0.074) 
when competing with mutation H526DRif and it is less costly when competing with 
S531F (0.015), implying that, all else being equal, H526YRif should rapidly go 
extinct when competing with H526DRif, but do so at a slower pace when in 
competition with S531FRif. The long-term outcome of these competitions indicated 
that this does not always occur and the H526YRif allele can be maintained in both 
cases. The evolvability analysis undertaken suggests that the difference between 
H526YRif and H526DRif could be attributed to a higher mean effect of beneficial 
mutations accessible to H526YRif. This result was unexpected, because this pair of 
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mutations involves the same aminoacid replacement and the different single point 
mutations cause a fitness defect of similar magnitude. Given this, one could expect 
similar evolvabilities between the resistance backgrounds (Fisher 1930). The 
outcome of the competition between H526YRif and S531FRif (mutations in different 
aminoacids but again in the same gene) shows a tendency for the former to 
increase in frequency, and this could also be due to access of the former 
background to higher effect mutations, when in comparison with the latter. This 
observation is further supported by the different competitions between H526YRif 
and S531FRif clones, where competitive fitness assays showed stronger effects of 
the mutations acquired by H526YRif, as predicted by our theoretical analysis. The 
two cases of competition between different AR mutations both show a long-term 
advantage of the H526YRif allele, through its higher mean effect of mutations. 
Interestingly, H526YRif has been reported to be the second most frequent mutation, 
in a variety of clinical settings, among the ones that confer Rif resistance in M. 
tuberculosis, even though it was also estimated that this mutation was the third 
mutation more costly in the same set (Gagneux et al. 2006; Trauner et al. 2014). 
This could be explained by the particularly high evolvability of this mutation. In the 
case of the pair of AR mutants composed of K43TStr and S531FRif, differences in 
evolvability were expected a priori since these mutations alter genes responsible 
for different cellular traits. In fact, evolution was less reproducible in this situation, 
with different replicates following different dynamics. Our results indicate that 
K43TStr acquired beneficial mutations of stronger effect than S531FRif, suggesting 
that their DEBM and hence their evolvability are different.  
The ability to access specific subsets of beneficial mutations determines 
how evolvable an organism is. If there were no constraints, then all genotypes, 
regardless of their composition or competitive context, would be able to adapt in a 
predictable sequence of mutational events. However, pleiotropy and epistasis may 
limit the access to new beneficial mutations (Trindade et al. 2009; Khan et al. 
2011; Woods et al. 2011), imposing different evolutionary outcomes in different 
genetic backgrounds, environmental conditions and/or competitive contexts. This 
is particularly relevant in the context of AR, as emergence of resistance mutants is 
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fairly common. The resistant clones would presumably be driven to extinction 
when competing against less costly strains, in the absence of the drugs. Here we 
show that it is very likely that such extinction events will not occur and, instead, 
mutations that buffer the effects of resistance alleles will accumulate (Maisnier-
Patin et al. 2002; 2007; Hall & MacLean 2011; Borrell et al. 2013), allowing their 
maintenance. Our results indicate that different adaptive abilities and the access to 
strong effect beneficial mutations depends on the genetic background and the 
competitive context, determining the long-term fate of a given resistance allele. 
Antibiotic based treatments focus on immediate clinical results, but the 
adaptive potential of resistant bacteria is subtle (Read et al. 2011; Stearns 2012) 
and we suggest it can affect their long-term fate within a host or between hosts. An 
interesting recent observation suggests that the effects of mutations conferring 
resistance to streptomycin tend to be smaller for genotypes that are well adapted 
to a given environment, relative to genotypes not adapted at all (Angst & Hall 
2013). This observation, along with the one we have made here, indicates that it is 
relevant to determine the relative roles of cost versus evolvability in other 
environments of special clinical relevance (Miskinyte et al. 2013), in order to be 
better able to predict the evolution of pathogens carrying resistance alleles.  
CONCLUSIONS 
The frequency of antibiotic resistance constitutes an alarming concern for 
public health. A key factor determining the extinction or maintenance of resistance 
alleles is the fitness costs they may entail. High cost resistance alleles are 
expected to rapidly go extinct. However, this may not be an inescapable fate. If the 
availability of beneficial mutations is dependent on the genetic background, clones 
with less fit resistance alleles may also have higher evolvability, i.e. a higher 
potential for adaptation. If so, this will lead to the maintenance of resistances with 
a higher initial cost in populations. Here we perform competitions between strains 
of Escherichia coli, which carry resistance alleles of different costs, and estimate 
the relative differences in their adaptive potential. We demonstrate that costly 
resistance alleles can coexist with resistance alleles of lower cost for hundreds of 
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generations, suggesting that their adaptive potential can override the initial relative 
cost of resistance. 
 
FUTURE PERSPECTIVE 
Antibiotic resistance poses an ever-increasing danger to public health, and 
its maintenance is the result of a multitude of processes, which require increasing 
evaluation. How the costs of resistance depend both on the specific resistant 
alleles, the environment where the bacteria grow and the ecological context to 
which they are exposed should lead to a better understanding on how resistance 
can be reduced or avoided. The ability of resistant bacteria for acquiring 
compensatory mutations and revert to sensitive state across environments should 
also be evaluated with the help of increasing powerful genomic technics. This is 
especially important for bacteria carrying multiple resistances as these are 
becoming more and more common. Assaying the ability of resistance alleles to 
emerge and thrive in ecologically relevant contexts, which are very likely to include 
several resistances competing simultaneously and multiple biotic factors will 
become crucial for our proper understanding of their long-term pathogenicity.  
 
EXECUTIVE SUMMARY 
Long-term evolution of polymorphic antibiotic resistance populations  
- In all three pairwise competitions studied, the more costly resistance 
avoided extinction with high probability. 
- In the majority of populations the costly resistance did not sweep to 
fixation.  
- The second most frequent rifampicin resistance mutation to segregate in 
natural pathogen populations (H526YRif) shows a high cost but also higher 
resistance to extinction, across multiple competitive contexts. 
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Estimation of evolutionary parameters  
- The distribution of effects for the beneficial mutations depends on the 
resistance background, with more costly resistance backgrounds acquiring 
mutations of stronger effects. 
- Differences in rate of acquisition of beneficial mutations were not detected 
between the resistance backgrounds. 
Sequencing and competitive fitness of evolved populations  
- Whole genome sequencing of the evolving replicate populations with the 
H526YRif and S531FRif competing clones revealed that the H526YRif 
background acquired more mutations at higher frequencies pointing 
towards its increased adaptive potential.  
- The number of targets identified for beneficial mutations was not 
significantly different between the resistance backgrounds, supporting the 
results from the theoretical analysis. 
- Competitive fitness assays showed that the mean effect of beneficial 
mutations is different between these two resistant backgrounds (H526YRif 
and S531FRif), as inferred from theoretical modeling. 
Conclusions  
- The initial relative difference in fitness costs between resistances is not 
predictive of their long tern evolution. 
- The long-term outcome of competitions between pairs of distinct antibiotic 
resistance alleles is polymorphism for resistance.   
- The results indicate that it is crucial to understand the ecological contexts 
and the adaptive potential of antibiotic resistance mutations in order to 
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SUPPLEMENTARY FIGURES AND TABLES 
 
Figure S1. Example of the fitting process for a simulated experimental 
population. Experimental data, shown as blue circles, was simulated with a given 
set of parameters. Normally distributed noise (with mean 0 and standard deviation 
0.2, shown also as error bars) was added to the experimental points. Red lines 
show the inferred trajectories given by simple model (one mutations) and the 
model assuming two mutations, with the fitness of the mutant (WN) and its time of 
appearance (TN) as parameters. Dotted arrows show the time at which sweeping 
beneficial mutants effectively change the dynamics of the resistance allele. Shown 
are also the calculations to obtain the relative parameters used in the distributions 
of relative effects and time. A) Model 1, with a single mutation. B) Model 2, with a 
mutation in each background, which has a lower AIC and is, therefore, chosen as 
the best model to explain the data. 
Mutation in Resistance 2 
Background (NR2)
Fitness WNR2 = 1.027 
Time TNR2 = 3
Relative Effect = s = WNR2 - WR2 = 0.027 !







































Mutation in Resistance 2 
Background (NR2)
Fitness WNR2 = 1.057 
Time TNR2 = 3
Mutation in Resistance 1 
Background (NR1)
Fitness WNR1 = 1.068 
Time TNR1= 29
Relative Effect = s = (WNR2 - WR2) - (WNR1 - 1) = 0.029!







































Figure S1. Example of the fitting process for a simulated experimental population.




Figure S2. Long-term dynamics with the identification of the fluorescent 
backgrounds. Dynamics are shown as in Figure 2, but here the color of each line 
corresponds to the fluorescent marker of the mutation whose logarithm of the ratio 
is being plotted. A) Competitions between resistances H526Y and H526D. B) 
Competitions between resistances H526Y and S531F. C) Competitions between 
resistances K43T and S531F. 







































Figure S2. Long-term dynamics with the identification of the fluorescent backgrounds
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Figure S3. Long-term dynamics from the inferred parameters for each 
replicate population. Inferred dynamics are shown as solid lines and 
experimental data is shown as full circles. A) Competitions between resistances 
H526Y and H526D. B) Competitions between resistances H526Y and S531F. C) 





























































Figure S3. Long-term dynamics from the inferred parameters for each replicate population




Figure S4. Test for negative frequency dependence selection in competitions 
between resistance strains H526Y and H526D. X-axis shows the initial 
frequency of the H526Y strain and Y-axis shows the fitness effect inferred from the 
slope of the dynamics for the first 24 hours of the competition. 
 
Table S1. Fitness costs imposed by the antibiotic resistance alleles (K43T, S531F, 




























Figure S4. Test for negative fr qu ncy dependence selectio in competitions 
between resistance strains H526Y and H526D









K43T% Streptomycin! rpsL% AAA!:!ACA!(128)! 0.092% 0.034!
S531F% Rifampicin! rpoB% TCC!:!TTC!(1592)! 0.096% 0.011!
H526Y% Rifampicin! rpoB% CAC!:!TAC!(1376)! 0.073% 0.014!
H526D% Rifampicin! rpoB% CAC!:!GAC!(1576)! 0.064% 0.017!
!
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Table S2. Genotypes of the evolved clones from the long–term competition 
between H526YRif and S531FRif
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Abstract  
The bacterium Escherichia coli exhibits remarkable genomic and phenotypic 
variation, with some pathogenic strains having evolved to survive and even 
replicate in the harsh intra-macrophage environment. The rate and effects of 
mutations that can cause pathoadaptation are key determinants of the pace at 
which E. coli can colonize such niches and become pathogenic. We used 
experimental evolution to determine the speed and evolutionary paths undertaken 
by a commensal strain of E. coli when adapting to intracellular life. We estimated 
the acquisition of pathoadaptive mutations at a rate of 10-6 per genome per 
generation, resulting in the fixation of more virulent strains in less than a hundred 
generations. Whole genome sequencing of independently evolved clones showed 
that the main targets of intracellular adaptation involved loss of function mutations 
in genes implicated in the assembly of the lipopolysaccharide core, iron 
metabolism and di- and tri-peptide transport, namely rfaI, fhuA and tppB, 
respectively. We found a substantial amount of antagonistic pleiotropy in evolved 
populations, as well as metabolic trade-offs, commonly found in intracellular 
bacteria with reduced genome sizes. Overall, the low levels of clonal interference 
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detected indicate that the first steps of the transition of a commensal E. coli into 




Bacterial populations have an enormous potential to adapt to their 
environments. This is inferred from studies of molecular evolution and variation 
that find signatures of selection in many genes (Chattopadhyay et al. 2009; 
Guttman & Dykhuizen 1994). The remarkable pace of bacterial adaptation can 
also be directly demonstrated in the laboratory by following evolution in real time, 
over many generations, in controlled environments with specific selection 
pressures (Barrick et al. 2009; Kawecki et al. 2012; Gordo & Campos 2013). Many 
studies of microbial evolution in real time involve studying adaptation to simple 
abiotic environments consisting of single or multiple sugars (Maharjan 2006; 
Herron & Doebeli 2013), characterizing compensation to the costs of deleterious 
mutations, such as antibiotic resistance genes in drug free environments (Barrick 
et al. 2010; Sousa et al. 2012), or studying adaptation in spatially structured 
environments (Perfeito et al. 2008; van Ditmarsch et al. 2013; Schoustra et al. 
2009). Complex environments, in which multiple, more natural, selective pressures 
are present, have received far less attention (Barroso-Batista et al. 2014). The 
vast majority of these experiments demonstrate the acquisition of adaptive 
mutations at high rates, with swift genetic and phenotypic changes. One way to 
quantify these evolutionary parameters is by following the dynamics of neutral 
markers in evolving clonal populations, where rapid and large allele frequency 
changes indicate the occurrence of a high rate adaptive mutations with strong 
selective effects (Moura de Sousa et al. 2013; Hegreness 2006; Koeppel et al. 
2013). 
Rapid adaptation is also detected in pathogen populations colonizing 
humans during infection (Sun et al. 2012). In these natural environments, where 
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bacteria are likely to encounter many different types of cells, key antagonistic 
interactions are imposed by the host innate immune system. Overcoming these 
interactions is often part of the transition from commensalism to pathogenesis 
(Leimbach et al. 2013; Pérez et al. 2013). Different strains of E. coli can be either 
commensals or versatile pathogens, and even switch between the two, and there 
is increasing evidence that some pathogenic strains evolved from commensal E. 
coli (Crossman et al. 2010; Tenaillon et al. 2010).  Several natural E. coli 
pathovars have been studied, some of which use common mechanisms to 
increase their virulence. Many of such virulence traits are encoded in pathogenicity 
islands (blocks of genes found in a pathogen but not in related nonpathogenic 
strains (Hacker & Kaper 2000; Schmidt & Hensel 2004)), plasmids or prophages, 
highlighting the importance of successful horizontal gene transfer in pathogen 
adaptation to new niches. In addition to gene acquisition, gene loss can also 
contribute to the emergence and diversity of existing E. coli pathovars (Maurelli 
2007), as well as other genome modifications which may lead to increased 
bacterial pathogenesis in the absence of horizontal transfer. These are usually 
called pathoadaptative mutations ( Sokurenko et al. 1999). For instance, the 
knockout of hemB, an hemin biosynthetic gene, in Staphylococcus aureus, which 
leads to increased ability to persist intracellularly, constitutes a pathoadaptive 
mutation and mutations in hemL of E. coli, encoding glutamate-1-semialdehyde 
aminotransferase, can also confer pathogenic properties [Ramiro, Costa and 
Gordo, submitted]. Another common pathoadaptive mutation is the loss of the 
gene mucA, which in Pseudomonas aeruginosa increases its ability to evade 
phagocytosis and resist to pulmonary clearance (Limoli et al. 2014). In another 
remarkable example, Koli and colleagues (Koli et al. 2011) showed that two 
genetic changes in commensal E. coli K-12 were sufficient to reprogram its cellular 
transcription and render it invasive in eukaryotic cells, both in vivo and ex vivo. 
Macrophages (MFs), one of the major cell types of the innate immune system, are 
a typical intracellular niche for certain E. coli pathovars, including Shigella, 
enteroinvasive E. coli (EIEC) and adherent-invasive E. coli (AIEC). The former, for 
instance, is commonly found in patients of Crohn’s disease, can adhere to 
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intestinal epithelial cells and invade and survive in epithelial cells and 
macrophages (Smith et al. 2013). Characterization of these pathoadaptive 
mutations is therefore important to understand the emergence of bacterial 
pathogenesis. We have previously studied the short-term adaptation of E. coli to 
recurrent encounters with macrophages and found that mucoid clones, which carry 
IS1 insertions into the regulatory region of yrfF and that overproduce colanic acid, 
repeatedly evolved (Miskinyte et al. 2013). 
Here, we use experimental evolution to study E. coli adaptation to the intra-
macrophage environment and to dissect the possible initial adaptive steps for a 
bacterium to adopt such a lifestyle. We used an established two-marker system to 
study bacterial adaptation in vitro and to determine the rate and fitness effects of 
pathoadaptive mutations. We then characterized phenotypically the bacteria that 
evolved and used whole genome sequencing to determine the most likely 
pathoadaptive evolutionary paths for the first steps in the transition into an 
intracellular environment. 
 
Materials and Methods 
Ethics statement 
All experiments involving animals were approved by the Institutional Ethics 
Committee at the Instituto Gulbenkian de Ciência (project nr. A009/2010 with 
approval date 2010/10/15), following the Portuguese legislation (PORT 1005/92) 
which complies with the European Directive 86/609/EEC of the European Council. 
Endpoints to euthanize the animals were defined prior to the experiment. The 
specific signs used to make the decision of euthanizing the animals were: weight 
drop of 20% and/or body temperature decrease below 28ºC (for two consecutive 
days). Despite the frequent monitoring of the animals’ health (at least two times a 
day), the aforementioned signals were not observed in any of the animals and, 
therefore, there was no need to perform euthanasia. 
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Strains and media 
The murine macrophage cell line RAW 264.7 (Sigma-Aldrich) was 
maintained in RPMI 1640-GlutaMAX I (Gibco) supplemented with 1 mM Sodium 
Pyruvate (Invitrogen), 10 mM HEPES (Invitrogen), 100 U/ml penicillin/streptomycin 
(Gibco), 50 µM 2-mercaptoethanol solution (Gibco), 50 µg/ml Gentamicin solution 
(Sigma) and 10% heat-inactivated FBS (standard RPMI complete medium). 
Culture conditions were at 37ºC in a 5% CO2 atmosphere. 
All bacterial cultures were grown in the same conditions as the 
macrophage line but using only 100µg/mL of streptomycin (RPMI-Strep medium) 
instead of the three antibiotics present in RPMI complete medium. The same 
medium was used for the infection assays of MΦ with bacteria. The Escherichia 
coli strains used were MC4100-YFP and MC4100-CFP (MC4100, galK::CFP/YFP, 
AmpR StrepR), which express constitutively either the yellow (yfp) or the cyan (cfp) 
alleles of GFP integrated at the galK locus in MC4100 (E. coli Genetic Stock 
Center #6152) (Bateman & Seed 2012; Hegreness 2006). Unlike certain 
pathogenic E. coli strains, our commensal strain is a derivative of K12 which is not 
able to replicate within macrophages [27]. 
Evolution Experiment 
The evolution experiment was started from two single colonies of either 
MC4100-YFP or MC4100-CFP grown in RPMI-Strep in the same conditions as the 
cell line. The two bacterial cultures were mixed in equal proportion (5x103 colony 
forming units (cfu) each) and used to infect the activated MΦ, in 20 replicates. 
Before the infection MФs were centrifuged at 201 g for 5 min and re-
suspended in RPMI-Strep. After this step ~ 105 cells per well were used to seed a 
24-well microtiter plate and incubated over-night at 37ºC with 5% CO2. 
Subsequently, activation was done by adding 2 µg/ml of CpG-ODN 1826 
(5´TCCATGACGTTCCTGACGTT 3´ - Sigma) (Utaisincharoen et al. 2002) and 
incubating at 37ºC with 5% CO2 for 24h. Following activation, cells were washed 
and infected with 104 bacteria mix (multiplicity of infection (MOI) = 1 cfu: 10 MФs). 
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After infection we centrifuged the plates at 201 g for 5min (to increase the contact 
between MФs and bacteria) and then incubated at 37ºC with 5% CO2 for 24h 
(Bateman & Seed 2012). Next we discarded the extracellular bacteria, washed the 
MФs with RPMI-Strep two times and added 100µg/mL of Gentamicin solution or 
1h at 37ºC with 5% CO2 (Mittal et al. 2010). Gentamicin penetrates poorly the 
macrophages and therefore whereas intracellular bacteria are protected from the 
bactericidal action of the antibiotic the extracellular are killed (Vaudaux & 
Waldvogel 1979). After washing out the gentamicin with PBS 1X, cells were lysed 
using a 0.1% Triton-X – PBS solution for 15 minutes (Bokil et al. 2011). 
Intracellular bacteria were collected, washed with PBS 1X and counted by flow 
cytometry using LSR Fortessa cytometer (BD Biosciences). From approximately 
106 intracellular bacteria collected, we pooled 104 and infected a new batch of 
activated MФs, in the same manner as described previously. This procedure was 
repeated for 26 days, a period after which fixation of one of the fluorescent 
markers could be observed for most of the replicate experiments, an indication of 
adaptation. This propagation protocol allows ~ 7 generations per day, calculated 
by Log2 (Nf/Ni), where Nf is the number of intracellular bacteria 24h post-infection, 
and Ni is the bacterial inoculum used to infect the macrophages (Miskinyte et al. 
2013). 
Fitness measurements 
Fitness increases of the evolved populations were estimated by 
competitive fitness assays in the presence or in the absence of MФs. A sample of 
30 clones carrying the fluorescence marker which achieved the highest frequency 
in a given population was competed against the ancestral strain labeled with a 
different marker. These samples of clones were assumed to be representative of 
the population. The competition assays for each evolved population were done in 
triplicate in the same conditions as the evolution experiment, for two passages - 
48h. The neutrality of the fluorescent marker was tested by competition of the two 
ancestral strains (9 replicates). Relative fitness, expressed as a selection 
coefficient, was estimated by calculating the slope of the natural logarithm of the 
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ratio of evolved over ancestral bacteria per generation of ancestral bacteria 
(Miskinyte & Gordo 2014). 
Whole genome re-sequencing and mutation prediction 
Ancestral genome 
The sequence reads were mapped to the reference strain Escherichia coli 
K12 MG1655 BW2952 (reference NC_012759.1). The two ancestors carry 
mutations in relation to the reference (Miskinyte et al. 2013). The sequenced 
evolved clones were then compared to the ancestral genome and the mutations 
identified are represented in Fig. 3 and listed in Table 2. 
Clone analysis 
In the last time point of the evolution experiment, we isolated a clone from 
each evolved population carrying the fluorescent marker with higher frequency. In 
the populations where both markers reached similar frequencies at the last time 
point, one clone from each marker subpopulation was isolated. Each of these 
clones was then grown in 10mL of RPMI at 37ºC. DNA isolation from these 
cultures was subsequently obtained according to (Wilson 2001).   
The DNA library construction and sequencing was carried out by the in-
house genomics facility. Each sample was paired-end sequenced using an 
Illumina MiSeq Benchtop Sequencer. Standard procedures produced data sets of 
Illumina paired-end 250bp read pairs. Genome sequencing data have been 
deposited in the NCBI Read Archive http://www.ncbi.nlm.nih.gov/sra (accession 
no. SRP066892). The mean coverage per sample was ~35x. Mutations were 
identified using the BRESEQ pipeline (Barrick et al. 2009). To detect potential 
duplication events we used ssaha2 (Ning et al. 2001) with the paired-end 
information. This is a stringent analysis that maps reads only to their unique match 
(with less than 3 mismatches) on the reference genome. Sequence coverage 
along the genome was assessed with a 250 bp window and corrected for GC% 
composition by normalizing by the mean coverage of regions with the same GC%. 
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We then looked for regions with high differences (>1.4) in coverage. Large 
deletions were identified based on the absence of coverage. For additional 
verification of mutations predicted by BRESEQ, we also used the software IGV 
(version 2.1) (Robinson et al. 2011). 
Phenotypic characterization of evolved clones 
Growth in single carbon sources 
The same samples of clones from the populations which were tested in the 
competition assays were used to estimate the growth curves in different carbon 
sources. Two media were used: M9 Minimal Media (MM) supplemented with 
maltose 0.4% or with glucose 0.4%. The growth curve assays were performed on 
a Bioscreen C microplate reader, using a volume of 150µL per sample and an 
inoculum of ~104 CFUs. Plates were incubated at 37ºC with shaking before each 
optical density measurement (OD at 600nm). All growth measurements were 
repeated at least twice. 
Fitness of effect of fhuA mutant under oxidative stress 
To test if the mutation on the fhuA gene conferred some advantage to the 
evolved bacteria in specific selective pressures characteristic of the macrophage 
intracellular environment, we grew ancestral and mutant clones under oxidative 
and iron limitation stresses. We combined different concentrations of Fe3+ (Iron (III) 
Chloride hexahydrate, Alfa Aesar #A16231) with the ferrichrome siderophore 
(Ferrichrome Iron-free, Santa Cruz Biotechnology # sc-255174) and added 
hydrogen peroxide (H2O2) (Hydrogen Peroxide solution 30% (w/w), Sigma # 
H1009). Ferrichrome captures iron III and the resulting complex is imported into 
the cell by the FhuA outer membrane transporter. Excess iron inside the cell may 
be detrimental in the presence of H2O2, due to the Fenton reaction. In the KO 
mutant of fhuA, ferrichrome-dependent uptake of iron does not occur, which could 
provide an advantage to the bacteria when exposed to oxidative stress. The 
mutant used for this experiment was the sequenced clone of population C (fhuA 
KO and selC IS), which was compared to an ancestral clone. The two clones were 
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first grown in M9 Minimal Media supplemented with 0.4% Glycerol in an orbital 
shaker at 37ºC with 230rpm, to an OD600nm of 1 (stationary phase). The cultures 
were then diluted and grown again in the same conditions until they reached an 
OD600nm of 0.4-0.6 (exponential phase). After normalization to the same O.D, 
samples were diluted 100x, divided in equal parts and centrifuged at 3220 g for 30 
minutes, before being re-suspended in the same growth media either 
supplemented, or not, with Fe3+ and Ferrichrome at two different concentrations: 
0µM Fe3+ + 100µM Ferrichrome and 100µM Fe3+ + 1000µM Ferrichrome. Samples 
were acclimatized at 37ºC with agitation for ~15 minutes before the addition of 
H2O2 to a final concentration of 2 mM. Samples were then left at 37ºC without 
agitation and collected after 1h, washed in PBS 1X and plated on LB agar. Plates 
were incubated for 16h at 37ºC, followed by CFU counting. 
Analysis of rfaI conservation in other E. coli strains 
A list of all sequenced strains of E. coli was retrieved from the European 
Bioinformatics Institute database (www.ebi.ac-uk/genomes, accessed on April 
2014). The meta-information for all the strains (i.e., laboratory origin, pathogen or 
commensal) was manually curated by accessing several different public microbial 
databases. The fasta sequences were retrieved for each of the genes comprising 
the rfa locus in Escherichia coli BW2952 (rfaBCDFGIJLPQSYZ and waaAU) and 
then BLASTed against the sequenced genomes of the genus Escherichia and 
Shigella (74 genomes in total), using Biopython. If, for a given strain, the query 
was returned as empty, we considered the gene to be absent. Otherwise, the gene 
was present but with varying degree of conservation, although not below 82% 
similarity.   
In vivo test for increased pathogenesis 
C57/BL6 mice, aged 7-10 weeks (in house supplier, Instituto Gulbenkian 
de Ciência) were given food (RM3A(P); Special Diet Services, UK) and water ad 
libitum, and maintained with a 12 hour light cycle at 21ºC. The animals were 
infected intra-peritoneally with 2x107 CFUs of either the ancestral clone or evolved 
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clone I (carrying two IS insertions, Fig. 3) diluted in 100µl of PBS. Furthermore, as 
a control, in each experimental block we injected a group of 2–3 mice with 100 ml 
of saline (these animals did not display any signs of disease). Mice were followed 
for 4 days post infection and their weights and temperatures were monitored daily. 
The infections were performed in two blocks, with n=3 mice per bacterial strain per 
block. A linear mixed effect model, with bacterial strain and day post-infection as 
factors and mouse as a random effect, was used to determine if significant 
increases in weight loss occurred in an infection with the evolved clone. 
 
Results and Discussion  
Dynamics of E. coli adaptation to intracellular life  
We followed the evolutionary dynamics and adaptation of twenty 
independent populations of E. coli during repeated exposure to the intracellular 
environment of MFs. The bacterial populations were all founded from an equal mix 
of two ancestral clones, which were isogenic except for a distinct neutral 
fluorescent marker. Under the hypothesis that periodic selection will dominate the 
pathoadaptive process, the occurrence and spread of a strong beneficial mutation 
in one of the clones with a given fluorescent marker will cause the extinction of all 
other clones and hence the loss of diversity at the marker locus (Barroso-Batista et 
al. 2014; Atwood et al. 1951). A more complex pattern may emerge if adaptive 
mutations are very common and cause clonal interference (Hegreness 2006), 
which may slow the loss of neutral variation (Barroso-Batista et al. 2014), or if 
coexisting interdependent ecotypes emerge (Maharjan et al. 2012; Koeppel et al. 
2013).  
In our experimental evolution protocol, MFs (105/ml) were infected with E. 
coli for 24 hours, after which all extracellular bacteria were killed with gentamicin. 
104 bacteria sampled from the intracellular environment of Mfs were then used to 
infect new uninfected MFs. The evolution experiment was followed for 26 days and 
the occurrence of adaptive mutations was detected through the observation of 
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Fig. 1. Evolutionary dynamics of the populations evolved within 
macrophages. Dynamics of frequency of neutral marker in the 20 replicate 
evolving lines (in (A) lines A to J; in (B) lines K to T) and variation in population 
size along the evolution experiment (in (C) lines A to J; in (D) lines K to T).  
rapid and consistent changes in the frequency of the neutral marker (Fig. 1A and 
1B). After 10 days of propagation, consistent changes in frequency started to be 
detected in some populations and by day 15 most of the populations showed 
significant deviations from the initial marker frequency (15 out of 20 populations 
showed deviations above 10%), suggesting that beneficial mutations had spread 
through the populations (Fig. 1A and 1B). During the 26 days of evolution, in only 
one of the populations (O) the deviation from the initial marker frequency was less 
than 10%. A significant increase in the total number of bacteria after infection was 
also detected after 100 generations in all the lines evolved (Fig. 1C and 1D and 
Supplementary Table S1). The increase in carrying capacity (K) of the evolving 
populations tends to be observed in synchronicity with the changes in the marker 
frequency, indicating that this fitness trait is being modified by occurring adaptive 
mutations.  
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Pathoadaptation occurs at a high rate and involves strong effect mutations  
The rapid and consistent changes in the frequency of each of the 
fluorescent alleles imply the occurrence of strong beneficial mutations. Assuming a 
simple model of positive selection we can estimate their rate and effect through 
the deviations of the neutral markers (Hegreness 2006; Illingworth & Mustonen 
2012). We have estimated these key evolutionary parameters using two different 
approaches: Marker Divergence Analysis (Hegreness 2006; Barrick et al. 2010), 
which summarizes the neutral marker dynamics using two parameters: the 
effective mutation rate (Ue) and the effective selection coefficient (Se), by fitting 
simulations to the marker dynamics. This method, which assumes all mutations 
generated within a replicate population to have a given fixed effect, has been 
shown to perform acceptably for scenarios of low clonal interference (Moura de 
Sousa et al. 2013) and summarizes the adaptive dynamics of all the populations 
by a single value of Ue and Se. The second method, Optimist (Illingworth & 
Mustonen 2012), determines the likelihood that the frequency of a neutral marker 
results from a given number of haplotypes, arising at a given time and segregating 
with a particular effect. For each particular replicate population, the number of 
haplotypes that best explains the marker frequency dynamics is chosen by the 
lowest Akaike Information Criteria (AIC), resulting in a distribution of the number of 
haplotypes, as well as their effects, for all the replicate populations. 
From the dynamics in Fig. 1A and 1B, the best estimates of Ue and Se 
were 1.6x10-6 (mutations per genome per generation) and 0.26, respectively. 
Using the method implemented in Optimist, we find a mean increase in fitness of 
mutations of 0.09 (see Table 1 for the estimated parameters and Supplementary 
Fig. S1 for the corresponding simulated dynamics that best fit the experimental 
data). These estimates of the rate and strength of fitness effects of adaptive 
mutations can be compared with those obtained in bacterial adaptation to other 
environments, and using similar methods of inference. E. coli rates of adaptation 
to compensate for the costs of antibiotic resistance were found to lay in the range 
of 10−7, and mean s in the range of 5 to 15%, dependent on the strain that evolved 
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(Barrick et al. 2010; Illingworth & Mustonen 2012). Using a different experimental 
system with more neutral markers, (Sousa et al. 2012) estimated higher rates of 
compensatory mutations to resistance U~10−5, with mean effects of 2.5 and 3.6% 
dependent on the resistance mutation. It is becoming well established that the 
distribution of effects of adaptive mutations markedly depends on the genetic 
background. For E. coli strains with the same genetic background as the ones 
used here, but adapting to a simpler environment (Luria-Bertani rich medium) 
Hegreness et al (Hegreness 2006) found Ue = 2x10-7 and Se = 0.05. These 
estimates are considerably smaller than the estimates found here, when the strain 
faces harsher conditions. Since the same strain and the same method of 
estimation were used in our experiment, the comparison of the combined 
estimates demonstrates that the evolutionary parameters strongly depend on the 
environment. They furthermore support the idea that in more stressful 
environments, where strong biotic interactions prevail, higher rates and effects of 
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Population # of W Time W Time 
A 2 0.101 28 0.073 28 
B 1 0.054 0   
C 1 0.109 63   
D 1 0.063 14   
E 1 0.056 7   
F 2 0.091 21 0.134 35 
G 2 0.123 7 0.099 14 
H 2 0.134 42 0.109 42 
I 2 0.090 7 0.094 42 
J 1 0.071 28   
K 2 0.141 63 0.121 63 
L 0     
M 1 0.027 0   
N 1 0.053 0   
O 2 0.054 14 0.063 35 
P 2 0.073 0 0.060 7 
Q 2 0.112 35 0.111 77 
R 2 0.101 35 0.103 77 
S 2 0.151 56 0.124 63 
T 2 0.043 7 0.089 98 
 
Table 1. Inferred selective effects of beneficial haplotypes. The number of 
mutations inferred for a specific population is indicated in the 2nd column. W 
mut#1 and T mut#1 (3rd and 4th columns) indicate, respectively, the inferred 
fitness improvement and time of appearance (in generations) of the first mutant. 
W mut#2 and T mut#2 (5th and 6th columns) indicate the same inferred 
parameters for the second mutant. Shaded cells indicate a mutation inferred in 
the CFP background. 
 
Competitive fitness assays reveal two distinct strategies of pathoadaptation  
The changes in frequency of each fluorescent allele suggested a strong 
effect of the beneficial mutations that occurred. To support this inference and 
directly estimate the strength of these mutations, we performed competitive fitness 
assays, in the presence of macrophages, of evolved clones against the ancestral 
strain marked with a different fluorescence. Fig. 2 shows that all populations 
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exhibit a significant fitness increase and are therefore better adapted to the 
environment with macrophages. The mean competitive fitness increase observed 
was 7%, with a minimum of 5% and a maximum of 12% (Fig. 2, blue bars). These 
values are in close agreement with those estimated from the changes in marker 
frequency alone and assuming the simplest model of positive selection (mean of 
9% with a minimum of 4% and a maximum of 15% (see Table 1 and 
Supplementary Table 2). Although there is a slight overestimation of the fitness 
effects inferred by the marker deviations, they can be explained by a number of 
reasons. Firstly, and contrary to what is assumed by the model, selection in such 
complex environments might not be constant, leading to non-linear effects of 
beneficial mutations. Secondly, theoretical approaches are known to overestimate 
the effects of mutations when there is more than one mutation (i.e., cases of 
higher clonal interference) (Illingworth & Mustonen 2012; Moura de Sousa et al. 
2013). Finally, the AIC criteria (see methods) might be too stringent in selecting 
models that postulate an increased number of haplotypes, which will lead to 
stronger effect mutations. Nevertheless, both fitness measures are in agreement 
that the most likely form of selection taking place in this environment involves 
sweeps of beneficial mutations of strong effects. 
One possible trait that could be expected to evolve as an adaptation to the 
selective pressure imposed in this experiment would be an increased ability to 
grow in the abiotic environment external to the macrophages (RPMI). If a variant 
with increased fitness in RPMI would emerge, then its frequency outside 
macrophages could increase and dominate the population; a likely scenario if such 
a mutant did not have any cost inside macrophages nor in the external 
environment as it becomes conditioned by those cells. To determine whether the 
evolved populations increased in fitness in RPMI, i.e. in the absence of 
macrophages, we performed competitive fitness assays against the ancestor in 
the medium alone (Fig. 2, orange bars). The results show that in 3 out of 14 
populations there is, indeed, a significant fitness increase in the abiotic 
environment, suggesting that increasing growth in RPMI can be beneficial in the 
presence of macrophages. We note that during the evolution the abiotic 




Fig. 2. Fitness measures of evolved clones. In blue, the competitive fitness 
of evolved populations in the presence of MΦ: evolved clones (a sample of 30 
from each indicated population) were competed against the ancestral clone 
(1:1). In orange, competitive fitness assay in the absence of MΦ. Error bars 
correspond to 2SE.  
 
environment outside macrophages is likely to change, so a mutant which is 
beneficial in RPMI may change its advantage as this medium becomes 
conditioned by the presence of macrophages. The results also show a correlation 
between the changes in fitness in the absence of macrophages to the increase in 
fitness in their presence (Pearson r=0.688, P=0.0065, Fig. 2). In half of the 
populations (A,F,G,K,N, R and S) a clear trade-off was detected (Fig. 2). For these 
cases, accumulation of mutations with significant advantage in the presence of 
macrophages led also to a decreased competitive ability in their absence.  This 
indicates a specialization in the transition to intracellular life. Together, the results 
suggest different adaptive strategies adopted by similar bacteria adapting 
independently to the same environment, but with distinct genetic mechanisms 
evolved to cope with the same antagonistic interaction.  
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Genetic basis of the intracellular adaptation reveals common evolutionary 
paths 
Given the dynamics of neutral markers observed (see Fig. 1A and 1B), the 
short duration of the experiment (~175 generations) and the estimates of only a 
few of beneficial mutations being responsible for the adaptive process (see Table 
2), we predict that each population is dominated by a single clone with one or two 
mutations. In order to unravel the number of genetic changes that occurred and to 
reveal the underlying evolutionary paths taken by the populations, we performed 
whole genome sequencing of independently evolved clones. The evolved strains 
and their ancestor were sequenced to a minimum of 16x coverage on the Illumina 
Miseq platform. Table 2 shows the genetic changes detected and Fig. 3 their 
position along the chromosome. Overall, 25 different mutational targets were 
detected amongst the adapted clones. As expected, each clone carries an 
average of 2 mutations. Most of the mutations occurred in coding regions and 14 
out of 34 in total involved insertions of transposable elements IS1, IS5 and IS186. 
The first two have been found to transpose at higher rates than other elements 
(Sousa et al. 2013) and are therefore more likely to contribute to adaptation. 
Among the gene targets for the mutations detected, two occurred in 4 and 8 
clones (fhuA and rfaI, respectively) and one occurred in two independently evolved 
clones (tppB). Parallelism is a hallmark of adaptation since the probability that 
mutations in the same gene increase in frequency by random chance in at least 
two independent lines, over such a short period, is very low (Lang & Desai 2014; 
Adams & Rosenzweig 2014). Given the parallelism observed involving the gene 
targets rfaI and fhuA, we can safely assume that these changes are adaptive. 
Furthermore, the change hitting the coding region of tppB (either through an 
insertion or by a small deletion) in two independent clones, together with it being 
the sole detected mutation (B CFP and Q YFP) suggests that loss-of-function of 
tppB, coding for a proton-dependent transporter of di- and tri-peptides could be an 
important pathoadaptive mutation.  




Fig. 3. Genomic maps of the mutations detected in the sequenced evolved clones. 
Red inverted triangles represent insertions of IS elements, blue lines mark single 
nucleotide polymorphisms and green triangles denote small insertions (pointing 
downwards) or deletions (pointing upwards). All events have either the aminoacid 
changes associated (for SNPs), the IS element inserted or the small number of base 
pairs deleted or inserted. 
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Gene Mutation Annotation S  Tradeoff 
without Mfs 
A YFP (36x)  
2649245 yfjL/yfjM +GCACTATG intergenic (-258/+102 nt) 
7% Yes 3293960 panF T→G L395R (CTG→CGG) 
3689096 rfaI IS5 + 4bp coding (312/1020 nt) 
B CFP (35x) 1603229 tppB IS1 + 5 bp coding (378/1503 nt) 11% No 
C CFP (73x) 169014 fhuA G→A W511* (TGG→TAG) 12% No 
3722624 selC IS1 + 8bp non coding (47/95 nt) 
D YFP (20x) 
168462 fhuA +A coding (980/2244 nt) 
6% No 2039547 yegI Δ3 bp coding (1944-1946/1947 nt) 
3809621 gidB C→T R139H (CGC→CAC) 
E YFP (93x) 3070100 yqiC Δ1 bp coding (91/291 nt)     
168929 fhuA IS1 + 8bp coding (1447/2244 nt)     
F YFP (16x) 
3219882 ispB/sfs
B 
G→A intergenic (131/-197 nt) 
7% Yes 608471 glnS Δ5 bp coding (396-400/1665 nt) 
3689096 rfaI IS5 + 4bp coding (312/1020 nt) 
G CFP (40x) 3758025 dgoT A→C I21S (ATC→AGC) 7% Yes 
3689065 rfaI IS1 + 8bp coding (343/1020 nt) 
H YFP (20x) 2541599 hscA Δ3 bp coding 8% No 
3689096 rfaI IS5 + 4bp coding (312/1020 nt) 
I YFP (148x) 167493 fhuA IS1 + 8bp coding (11/2244 nt)     
3689096 rfaI IS5 + 4bp coding (312/1020 nt) 
J YFP (346x) 3971199 fdoG Δ6 bp coding (2311-2316/3051 nt) 7% No 
K YFP (28x) 3689096 rfaI IS5 + 4bp coding (312/1020 nt) 5% Yes 
N CFP (34x) 
75049 glnH/dps A→T intergenic (-295/+109 nt) 
5% Yes 4410884 yjgJ G→A M1I (ATG→ATA) 
1769910 yeaR IS186 + 10bp coding (122/360 nt) 
3688872 rfaI IS5 + 3bp coding (536/1020 nt) 
O CFP (35x) 1129729 cvrA Δ1 bp coding (296/1737 nt)     
3223632 yrbD IS1 + 11bp coding (9/522 nt) / intergenic 
(-1/+4) 
P CFP (29x) 
70580 araC T→C V65V GTT→GTC) 
7% No 1072984 ycfS G→A O180L (CCG→CTG) 
1247732 puuP C→T C110Y (TGT→TAT) 
3708996 spoT Δ6 bp coding (247-252/2115 nt) 
Q YFP (34x) 1602868 tppB Δ1 bp coding (17/1503 nt) 10% No 
S YFP (29x) 1404545 ydcU C→T P221L (CCG→CTG) 6% Yes 
3689096 rfaI IS5 + 4bp coding (312/1020 nt) 
T CFP (30x) 4546582 prfC A→C E221A (GAA→GCA)     
  Table 2. Mutations identified in the sequenced clones. Coverage for each clone is 
indicated in the first column. The 6th column (S) indicates the selective effect of the 
evolved clones in the presence of macrophages, compared to the ancestor, and the 7th 
column indicates whether there is a selective tradeoff (i.e., fitness in the absence of 
macrophages is lower than ancestor). 
 
 




Fig. 4. Invasion of an adaptive mutation at the rfaI locus. The blue line 
shows the selective sweep leading to the fixation of an IS5 insertion likely 
causing gene loss of function. In the inset an estimate of the selection 
coefficient (s) of this mutation is given. s is the slope of the logarithm of the ratio 
between the number of clones carrying the mutation and those with the wild-
type allele. 
Loss of rfaI leads to a strong selective sweep during adaptation to 
macrophages 
In 47% of the evolved populations, mutations in rfaI (all of them IS 
insertions presumably leading to gene inactivation) were detected, suggesting this 
to be a preferential target and, therefore, one with high beneficial effect. We 
followed the emergence of this adaptive mutation in one of the adapted 
populations (population I), by targeted PCR for the presence of IS5 element in rfaI, 
as this element had been identified in the evolved clone sequenced from this 
population. Fig. 4 shows that the mutation could be detected by day 6, with a 
frequency 4.1% (SE 0.04) and rapidly swept to fixation, being detected in all tested 
clones (n=60) at day 26. We could directly estimate its selective effect, from its 
initial change in frequency, to be 0.09 (see inset of Fig. 4).  
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We also found a strong correlation between the presence in a clone of a 
mutation in rfaI and a competitive tradeoff (i.e., benefit in the presence of 
macrophages, but disadvantage in their absence) of the populations where that 
clone mutation emerged (p<0.01, Pearson correlation). rfaI is a 
glycosyltransferase and part of the lipo-polysaccharide (LPS) synthesis machinery 
present in bacteria. LPS are unique and complex glycolipids that provide 
characteristic components in the outer membranes of bacteria and as such are a 
critical component of their interaction with cells from the immune system (Beutler & 
Rietschel 2003). The rfa locus itself is composed of 15 different genes, which are 
responsible for generating different parts of the LPS structure (Schnaitman & 
Klena 1993). rfaI is involved in the outer part of the core oligosaccharide, 
connecting the lipid A (inner part) and the O-antigen (outer part) of LPS. Since the 
strain used in this study is devoid of O-antigen, the outer part of the core is the 
LPS terminal section, and it is likely acting as one of the main interfaces between 
the bacterial cell and the cells from the immune system. Modifications in the LPS 
structure, and the outer core in particular, are known to modify the behavior of 
bacterial cells regarding adhesion to epithelial cells and biofilm formation in 
enterohemorrhagic E. coli (Torres & Kaper 2003; Torres et al. 2005), and 
intracellular invasion of different serovars of Salmonella enterica (Hoare et al. 
2006). Moreover, mutations in the outer core structure of Brucella abortus can 
induce pro-inflammatory responses and enhanced macrophage activation (Conde-
Álvarez et al. 2012). Interestingly, many genes in the rfa locus itself are a target for 
bacterial persistence in E. coli (Girgis et al. 2012), and the operon seems to be 
poorly conserved in a vast group of E. coli pathovars, with several pathogenic (and 
non-pathogenic) strains missing many of its genes (including rfaI) (see Analysis of 
rfaI conservation in other E. coli strains (section) in Material and Methods). This 
suggests that, in these strains, the rfa genes could be common mutational targets. 
Together, both our results and these observations seem to indicate an important 
role of the LPS structure both in the interaction with the immune system and in the 
transition to a pathogenic lifestyle, implying the changes in rfaI detected in 8 
independently evolving populations as a recurrent pathoadaptive target. 
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fhuA pathoadaptive mutant is beneficial under the combined pressure of 
iron limitation and oxidative stress  
The beta barrel protein FhuA is involved in the active transport of ferric 
siderophores across the outer membrane of Gram-negative bacteria (Ferguson et 
al. 1998). Iron homeostasis is crucial to the lives of both bacteria and 
macrophages therefore both cells have exquisite mechanisms to achieve 
physiological levels of iron and to keep it in a safe intracellular non-toxic form. 
Although oxidative stress can be generated by aerobic respiration, it is also one of 
the microbicidal pressures generated by the macrophages in the harsh 
phagosomal environment. Superoxide and hydrogen peroxide (O2- and H2O2) are 
moderately reactive oxygen species, however, upon interaction with iron, the 
highly reactive hydroxyl radical (OH-) can be created (Fenton reaction) (reviewed 
in (Andrews et al. 2003)).  Since phagocytosed bacteria can face high levels of 
oxidative stress inside macrophages we tested the survival of a fhuA mutant in 
different conditions regarding the presence/absence of H2O2 (2mM H2O2) and 
different concentrations of Ferrichrome plus Fe3+. Ferrichrome is a siderophore 
which binds iron III and enables it to be transported through the FhuA outer 
membrane transporter. We find that in the presence of Ferrichrome alone 
(100mM) or complexed with Fe3+ (100mM Fe3+, 1000mM Ferrichrome), survival of 
the fhuA mutant is indistinguishable from that of ancestral bacteria (Fig. 5A). A 
similar result was obtained in the presence of H2O2 (Fig. 5B).  A fitness advantage 
of the evolved clone was however detected in an environment comprising 
oxidative stress in conjunction with Ferrichrome, or with Ferrichrome and Fe3+. 
Under these conditions the survival of fhuA mutant clones is significantly increased 
in relation to that of ancestral bacteria (P=0.001 and P=0.008 respectively) (Fig. 
5C). The difference between the mutant and the ancestor is observed even in the 
absence of Fe3+ supplementation. This could be justified by the fact that bacteria 
are able to grow under limited amounts of this element, which is present under 
most biological conditions (Hartmann & Braun 1981). These results therefore 
indicate that this mutation may have evolved to decrease the amount of OH- inside 
the bacterial cells.  
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Fig. 5. Bacterial survival under iron and or oxidative stress. Log10(Number of 
bacteria after 1h)- Log10 (Number bacteria at 0h) in the environments: (A) Effect of 
Fe3+ depletion tested in minimal media supplemented with the indicated 
concentrations of Fe3+ and Ferrichrome; no significant difference between evolved 
and ancestral clones could be detected (T-test, P=0.8 and P=0.6, n=5) (B) Effect 
of H2O2 stress tested in minimal media supplemented 2mM of H2O2; no significant 
difference between evolved  and ancestral clones (T-test, P=0.8, n=10). (C) 
Fitness advantage of evolved clone is detected under both selective pressures, 
i.e. minimal media supplemented with the Fe3+, Ferrichrome and 2mM of H2O2 (T-
test, P=0.016, P=0.02, n=5). 
An in vitro evolved double mutant of rfaI and fhuA shows increased 
pathogenic potential in vivo  
We tested for increased virulence of one of the MΦ adapted clones. This 
clone carries two of the mutations that repeatedly emerged during the evolution: 
an insertion into rfaI and an insertion into fhuA (clone I Fig. 3). By infecting mice in 
the intra-peritoneal cavity with either the ancestral strain or the double mutant we 
find that, although mouse survival is similar for both strains, the weight loss 
caused by the infection of the evolved strain was significantly higher (P=0.046 for 
strain and P=0.003 for time, in a linear mixed effects model, with mouse as a 
random effect and strain and day of infection as factors, see Fig. S2). Given that 
the increased pathogenic potential of the double mutant was significant but not 
very strong we did not test each of the single mutants. Besides weight loss, a 
common phenotype to assay pathogenicity in vivo, we also measured 
temperature, but found no significant difference.  
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Pathoadaptation to macrophages can lead to metabolic tradeoffs 
Bacteria fully adapted to intracellular life tend to have small genomes 
(Moran 2002). Amongst the species of E. coli, Shigella strains have undergone a 
considerable amount of genome reduction (Hershberg et al. 2007). During its 
evolution from an extracellular inhabitant of the mammalian gut to an intracellular 
pathogen, Shigella accumulated a plethora of pseudogenes, with genes coding for 
carbon utilization, cell motility, transporter or membrane proteins more likely to 
become inactivated (Feng et al. 2011). While part of this gene loss may be the 
outcome of intensified genetic drift and inefficient selection, it can also be the 
result of positive selection for loss of anti-virulent functions, constituting adaptive 
losses in the intracellular niche (Andersson & Kurland 1998; Moran 2002). Such 
losses may entail antagonistic effects in extracellular environments. We tested the 
adapted clones for differences in their ability to grow on single carbon sources and 
found that some exhibited a strong metabolic trade-off when growing on either 
glucose or maltose (Fig. 6). We found that all the clones carrying the 
pathoadaptive loss of rfaI failed to reach high carrying capacity on minimal media 
with either of the sugars. In contrast, the mutants with pathoadaptive mutations in 
tppB, involved in the transport of peptides, showed increased growth in maltose 
(Fig. 6, red lines). Interestingly, subsequent mutations on the rfaI mutant 
background restore the ability to grow to similar levels as the ancestor, showing 
that the pleotropic effects of such pathoadaptation can be compensated to better 
grow on both poor and rich media.  
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Fig. 6. Growth curves of evolved populations and the ancestral strain in 
minimal media with maltose or glucose (0.4%). Each color on the growth 
curves represents similar patterns amongst the populations. 
 
Conclusions 
Characterizing the evolutionary and genetic mechanisms underlying the 
transition from commensal to pathogenic lifestyle is paramount in understanding 
the particularities of what makes pathogens dangerous and often fatal to their 
hosts. Here, we followed the evolution of a commensal strain of E. coli under the 
selective pressure imposed by the intracellular niche of MΦs to identify the most 
probable paths of this adaptation. All evolved populations show an increased 
ability to survive in the presence of macrophages, as the result of acquisition of 
strong beneficial mutations, which we estimate and measure to be around 7 to 
10%, on average. The characterization of their genetic basis unveiled mutation 
that were highly likely to be pathoadaptive mutations, namely those involving 
changes in LPS, crucial in the interaction with the immune system, and in iron 
metabolism, essential for both protecting against high levels of toxicity and to 
acquire the necessary resources to survive. Given the strong pressure imposed in 
our experimental system, our results show that commensal bacteria are able to 
acquire adaptations to increase their intracellular survival at a fast pace. 
Importantly, the adaptive mutations identified in this study suggest possible new 
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therapeutic targets to counteract pathogenic intracellular parasites. 
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Supplementary Figures and Tables 
 
 
Fig. S1. Inferred Evolutionary Dynamics. Simulated dynamics of the model of 
positive selection (Illingworth & Mustonen 2012) with the parameters that provide 
the best fit to the data of changes in marker frequencies (displayed as points). 
























































Fig. S2. rfaI and fhuA double mutants increase weight loss in mice. The 
change in weight of mice (as a percentage) after intra-peritoneal infection with 
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S1 Table. Increase in bacterial loads along the experiment. The majority of 
lines show a significant increase in bacterial loads. The slope of Log10(CFUs) 
along the 26 days of evolution, from a linear regression, is indicated in the 1st 
column and P value of slope indicated in the 2nd column. 
 
S2 Table. Correspondence between experimental and inferred fitness. The 
experimental values measured through competitive fitness assays are indicated 
with their errors (2SE), along with the fitness inferred through the marker dynamics 
of the respective population. In the majority of populations (with the exceptions of 
populations B, K and S), the two measures are either in agreement or the inferred 























A YFP [0.06 - 0.08] 0.1
B CFP [0.10 - 0.12] 0.05
C CFP [0.11 - 0.13] 0.11
D YFP [0.05 -0.07] 0.06
F YFP [0.05 - 0.09] 0.13
G CFP [0.06 - 0.08] 0.12
H YFP [0.07 - 0.09] 0.13
J YFP [0.06 - 0.08] 0.07
K YFP [0.03 - 0.07] 0.14
N CFP [0.04 - 0.06] 0.04
Q YFP [0.8 - 0.12] 0.11
R YFP [0.05 - 0.07] 0.1












Clonal interference is sufficient to explain the 
pathoadaptive phenotype emerging during 
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Clonal interference is sufficient to explain the pathoadaptive phenotype 




Antagonistic interactions are common in the microbial world, driving the adaptation 
of microorganisms. Here we aim to understand the importance of clonal 
interference in an experiment involving the adaptation of Escherichia coli under 
antagonistic interaction with macrophages during 30 days. Morphological diversity 
was observed to rapidly emerge from this adaptive process, generating small 
colony variants and large translucid mucoid colonies. Moreover, a remarkable 
genetic parallelism was detected at the end of the experiment, across 
independently evolving populations. We developed a theoretical model that 
attempts to explain the dynamics of frequency change of the mucoid phenotype, 
taking into account the mutational events observed. We show that a simple model 
of clonal interference is able to generate the complex dynamics observed during 
adaptation to the presence of macrophages. 
	  
Introduction	  
Emergence of morphological diversity in Escherichia coli adapting to the presence 
of macrophages 
	  
Macrophages are a key component of the host defense mechanisms 
against pathogens (Wynn et al. 2013) and thus provide a strong antagonistic 
interaction to which bacteria must adapt. In Chapter VI, we discussed an 
ecological scenario where bacteria adapted to inhabit the intracellular milieu of 
macrophages, prompted by the supplementation of media with an antibiotic to 
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which they were susceptible. However, adaptation to the presence of 
macrophages is not limited to adopt an intracellular lifestyle, since escape and 
avoidance strategies can also evolve from this interaction (Baxt et al. 2013). In 
(Miskinyte et al. 2013), E. coli was allowed to evolve under continuous selective 
pressure of macrophages, but without the application of gentamycin, thus allowing 
bacteria to survive by more efficiently escaping the predatory behaviours of 
macrophages. In order to assert the speed and genetic basis of adaptation to this 
antagonistic interaction, six independently evolved populations were followed for 
30 days, during which distinct colony morphologies emerged across the replicate 
populations and coexisted with the ancestral colony phenotype: small colony 
variants (SCVs) and large translucid mucoid (MUC) colonies. SCVs were 
observed in 5 out of the 6 populations, but only transiently and at low frequencies. 
In contrast, MUC clones, which were detected in all populations, rose in frequency 
and reached fixation in 5 out of the 6 populations, showing complex frequency 
dynamics (Figure 1). Both these phenotypes are known to emerge in clinical 
infections (Funada et al. 1978; Besier et al. 2008) and, therefore, it is important to 
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Figure 1. Emergency of morphological diversity in the bacterial populations 
adapting to MΦ. 
(A) Examples of the variability for colony morphology that emerged in E. coli 
populations adapting to MΦ, from left to right – ANC stands for morphology of 
ancestral, SCV for the small colony variants morphology and MUC for the mucoid 
colony morphology. (B) Dynamics of frequency change of the evolved phenotypes 
in each replicate evolving populations (M1 to M6): white squares indicate ANC, 
black triangles SCV, black circles MUC phenotypes.  
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Genetic basis of adaptation to macrophages  
In order to uncover the molecular basis of the MUC phenotype dynamics, 
whole genome sequencing was performed not only for the evolved clones at day 
30, for all populations, but also for one of the clones in population M3, at day 19. 
The mutations found are represented in Figure 2 and Table 1, and the frequency 
of transposon insertions (IS) along the experiment was detected by PCR (Figure 
2b). There is a high level of parallelism across the independently evolving 
populations, namely with the regulatory region of the yrfF gene being interrupted 
by an IS, in all six replicate populations. The homologue of yrfF in Salmonella 
(igaA) prevents the over-activation of the Rcs regulatory system, which controls 
the production of colanic acid capsule synthesis (Bernal & Pucciarelli 2004). This 
mutation is likely altering E. coli’s ability to produce colanic acid, in concordance to 
the MUC phenotype observed. To further understand the dynamics of adaptation 
in each independent evolved bacterial population, the frequency of the mutations 
found was assessed in mucoid clones sampled along the evolution experiment. 
Adaptation involved the competition between distinct haplotypes and the 
successive accumulation of beneficial mutations, mainly caused by IS insertions 
(Figure 2). Such haplotype dynamics is characteristic of clonal 
interference (Sniegowski & Gerrish 2010), where clones carrying distinct beneficial 
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Figure 2. Genetic characterization of adaptive mutations and the dynamics of 
their appearance. 
(A) Mutations identified in MUC1 to MUC6 clones isolated from M1 to M6 populations 
(evolved for 450 generations), represented along the E. coli chromosome. For 
simplicity, the genomes are represented linearly and are horizontally drawn. The 
types of mutations are represented in the following way: SNPs are shown as crosses, 
IS insertions as inverted triangles and deletions as triangles. Filled symbols represent 
mutation in the coding region of the gene and empty symbols in the regulatory region. 
(B) Emergence and spread of adaptive mutations in M1 to M6 populations. Dynamics 
of haplotype frequencies in evolving populations at different days of evolution 
experiment are represented by circles. The color and symbol (IS insertions are 
represented as circles and other mutations as crosses) of each sector represents 
different haplotypes and the area of the circle their frequency in the population. Grey 
area represents the frequency of clones in the population that were typed for existing 
mutations in the population and did not differ from ancestral haplotype. 
 
 





Table 1. Mutations acquired by evolved clones identified through whole 
genome re-sequencing (WGS). 
Mutations in intergenic regions have the two flanking genes listed (e.g., 
clpX/lon). SNPs are represented by an arrow between the ancestral and the 
evolved nucleotide. Whenever a SNP gives rise to a non-synonimous mutation 
the amino acid replacement is also indicated. The symbol Δ means a deletion. 
For intergenic mutations, the numbers in the “Mutation” row represent 
nucleotides relative to each of the neighboring genes, here + indicates the 
distance downstream of the stop codon of a gene – indicates the distance 
upstream of the gene, that is relative to the start codon. Insertions of IS 
elements are denoted by the specific IS element followed by the number of 
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Model and Results  
 
Model of clonal interference for the antagonistic interaction between bacteria and 
macrophages 
 
In order to understand whether clonal interference could reproduce the 
mucoid and ancestral-like frequency dynamics observed, we modeled this process 
within the basic ecological scenario of our experiment. We assume a simple model 




= B(r − B
K
+ amMΦe
−δt )  
Here, B represents the number of bacteria along time, r their growth rate, K their 
carrying capacity and am is the factor of bacterial death by macrophages (am<0); 
MΦ represents the number of macrophages and δ their death rate. For the initial 
conditions we used, in accordance with the experimental setup, MΦ=106 and 
B(0)=106. During a 24 hour period the infection dynamics expected under this 
model are similar to those obtained experimentally, with r=2.3 (per hour), K=108 
and δ=0.1 (per hour) (Figure 3). As in the experiments, every 24 hours bacterial 
population numbers are reduced to B(0) and macrophage numbers increased to 
MΦ.  
 




Figure 3: Infection dynamics of the ancestral strain.  
Variation in numbers of bacteria (A) and MΦ (B) during an infection with the 
ancestral clone (ANC) at MOI (1∶1). (C) Simulated dynamics of a population of 
ancestral bacteria (black line) dividing in the presence of MΦ (purple line) for 24 
hours, following the deterministic model, with the following parameter values: 
B(0) = 106; MΦ = 106; r = 2.3; K = 108; am = −3.7*10−6; δ = 0.1. We assume that MΦ 
decay at linear rate of 0.1 following the data of (B). 
 
Having these initial conditions, we then assume that new mutants arise and 
are not stochastically lost at a given rate. More specifically, the ancestral clone can 
mutate to two new types of adapted clones: one by transposition (upstream of 
yrfF) and another by point mutation. These mutations can have different rates 
(Sousa et al. 2013; Foster et al. 2015) and can also cause changes in both r and 
am, i.e., the growth rate of mutant bacteria (rmuc) can change and their ability to 
interact with macrophages (ammuc) can also change. We assume that mucoid 
bacteria will exhibit an increased ability to escape macrophages ammuc < am but 
also a decreased growth rate rmuc < r, due to the cost of producing 
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exopolysaccarides. While in some cases the mucoid haplotype displays an 
apparently simple phenotypic sweep (see, for instance, M2 or M6 in Figure 1B), in 
other instances the frequencies of the morphologies have a higher degree of 
complexity (M4 as an extreme cases in Figure 1B). This seems to indicate that 
the level of clonal interference could be different amongst the populations. 
Therefore, and in order to model different orders of clonal interference under an 
antagonistic interaction, we start with the following equations in order to describe 
the frequencies of the ancestral background and a derived mucoid haplotype: 
Eq. 2a: dB
dt








( −UisB  
Eq. 3a: dMuc
dt










Here Uis is the rate of occurrence of successful transpositions leading to the 
mucoid haplotype. B represents the number of bacteria with the ancestral 
genotype and Muc of the mucoid genotype that emerges. From the experimental 
data, we know that the non-mucoid (or ancestral-like) phenotypes sometimes 
increase in frequency and are maintained in the populations (white squares in 
Figure 1B and grey areas in Figure 2B). Therefore, to simulate some of the 
dynamics in Figure 1B, we postulate that a phenotype derived from ancestral type 
(B’), which is non-mucoid, can emerge in the population at rate U, with growth r’ 
and macrophage interaction amb. Note that both U and Uis are the spontaneous 
rate of mutation times the probability that such mutation is not lost by drift. 
Eq. 2b: dB
dt








( −UB −UisB  
Eq. 4a: dB '
dt
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Moreover, because successional mutations are acquired in the background of the 
mucoid phenotype (Figure 2B), we also postulate that subsequent mucoid 
haplotypes can originate from the first one, at a rate Uis’ and with growth r’m and 
macrophage interaction ammuc’. The complete set of equations for a model 
















= Muc rm −








( −Uis 'Muc +UisB  
Eq. 4b: dB '
dt









Eq. 5: dMuc '
dt
= Muc ' r 'm−








(+Uis 'Muc  
In this model of clonal interference, we make the simplifying assumption 
that two traits, growth rate (r) of bacteria and their ability (am) to escape MΦ, are 
the most important for bacterial fitness in this environment. Both these traits can 
evolve, as it is evident from the emergence of new morphologies (in particular 
mucoid morphs) and phenotypic tests of the evolved clones. Figure 4 shows 
simulations of adaptive dynamics over the period of the experiment (30 days), 
where the frequencies of mucoid (MUC) phenotypes are plotted and can be 
compared to those observed in the experiments (Figure 1B). The solutions for the 
equations were obtained in Mathematica v8.0 (the full script can be found as 
supplementary material in (Miskinyte et al. 2013)). These parameters were chosen 
because they depict the initial infection dynamics of the ancestral strain (Figure 1) 
and its relation with the derived evolved clones. We are able to find conditions that 
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can reproduce the observed dynamics of morphs under a scenario of intense 
clonal interference and accumulation of multiple beneficial mutations (see Figure 
5). The parameters used to obtain these dynamics, which are indicative of the 
rates and strength of mutations that drive this clonal interference process, are 
shown in Table 1. For some of the dynamics, further haplotypes, both mucoid and 
non-mucoid, were required to explain the dynamics, and the parameters for these 
are shown in Table 2. The model is able to reproduce the observed changes in 
frequency of the mucoid and non-mucoid phenotypes, if we assume that distinct 
beneficial mutations occur and change each of the two fitness traits in both 
morphs. Specifically, we assume that a successful beneficial mutation occurs, 
which produces the first mucoid morph. Such mutation is assumed to increase the 
ability of bacteria to escape MΦ, but also carry a cost in that it diminishes the 
growth rate (see Figure 6 for the conditions under which such a mutation can 
invade). This mucoid morph can acquire further beneficial mutations that alter 
those traits values, such that a new derived mucoid haplotype can have a reduced 
cost of producing colanic acid and/or an increased ability to escape macrophages. 
Importantly, we also assume that clones with ancestral colony morphology can 
acquire beneficial mutations that increase their growth rate. Under these 
assumptions, and with the direct evidence that several distinct clones are 
segregating in the populations, complex dynamics are to be expected (Figures 4 








Figure 4. Predictions of model of clonal interference for changes in mucoid 
frequencies with time. 
Simulations of the adaptive dynamics over the period of the experiment (30 days). 
The frequencies of mucoid phenotypes are plotted and can be compared to those 
observed in the experiments (Figure 1B). The values of parameters used are 
shown in Tables 1 and 2 and the dynamics of haplotypes that compete for fixation 
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Figure 5. Dynamics for the different haplotypes under the model of 
clonal interference.  
Simulated frequencies of the different haplotypes that result in the frequencies 
of the mucoid phenotypes of Figure 4. r = 2.3, am = −3.7×10−6 and the other 
parameters used are shown in Table 1. In this table, the cases where more 
haplotypes were assumed to reproduce the experimental dynamics are 
marked with *, and the additional parameters are in Table 2. 
  



















M1 3 4 2.1758 -3.23 12 2.369 -3.7 2.2171402 -3.23 
M2 0.96 4.45 2.21122 -3.2 3.84 2.392 -3.7 2.2554444 -3.2 
M3* 0.43 4 2.185 -3.24 1.72 2.3609 -3.7 2.2724 -3.24 
M4* 0.1 10 2.1988 -3.2 5 2.4104 -3.7 2.2691616 -3.2 
M5* 0.43 6.94 2.180768 -3.28 0.107 2.346 -3.7 2.180768 -2.86 
M6 3 4 2.1758 -3.23 12 2.3736 -3.7 2.2247555 -3.23 
 
Table 1. Parameters used in modeling the dynamics of the different 
haplotypes. Parameters used for the dynamics in Figure 5. Cases where more 
haplotypes were assumed to reproduce the experimental dynamics are marked 
with *, and the additional parameters are in Table 2. 
 
 





M3* 4.3 x 10-8 2.47309513 -3.7 1.72 x 10-7 2.3428444 -3.24  
M4* 1 x 10-8 2.494764 -3.7 1 x 10-8 2.3202177
4 
-2.99  
M5* 4.3 x 10-8 2.482068 -3.7    
 
Table 2. Parameters for the additional haplotypes for the modelled 
dynamics. Parameters in the additional haplotypes required to obtain the 
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Figure 6. Region of parameter space theoretically expected for the invasion 
of first mucoid morph. Colored areas show the parameter region (rm/r and 
ammuc/am) where a mucoid genotype (mimicking the IS insertion upstream of yrfF 
in the experiment) that has emerged is able to increase in frequency so that it can 
survive the bottleneck imposed every 24 hours in the experiment. The equations 
for these simulations are:  
 
 
with initial conditions Muc(0)=1, B(0)= 106 and the other parameter values as in 
Figure 3: M0=106; r=2.3; K=108; am= 3.7*10-6; d=0.1. Note that the escape 
parameter is negative (according to the mathematical model) and, therefore, a 
value lower than 1 indicates a higher ability to escape predation. Warmer colors 
show higher frequency of the mucoid genotype in the population after 24 hours of 
its emergence as a single copy. The yellow dot indicates the value of rm and 
ammuc, of the first mucoid haplotype assumed to emerge in the 6 models that 
produced the dynamics in Figures 4 and 5. 
 




The complex adaptive dynamics driving the pathoadaptive process of E. 
coli in the presence of macrophages are difficult to disentangle in an environment 
that poses antagonistic biotic interactions and the generation of multiple 
phenotypes and haplotypes, as shown by the genetic analysis. One of the drivers 
of this process is clonal interference. Here we studied if clonal interference alone 
could explain the dynamics of the morphologies emerging during the evolution, 
under specific parameter values for the rate and effects of mutations causing the 
observed phenotypes. One of the strongest assumptions of the model, regarding 
the existence of only two main phenotypic traits (growth and escape from 
predation), might be too simplistic, even in this simple ecological setup. Other 
traits and environmental conditions that we did not consider might play a role. 
These include the structure of the environment, differential variation in the cell 
densities, or the possibility of frequency dependent selection emerging from the 
secreted expolysaccharide potentially becoming a public good. Therefore, it is 
important to note that we cannot exclude the possible occurrence of other forms of 
selection during the evolution experiment. Indeed it is known that even in simple 
abiotic environments adaptive diversification, involving frequency dependent 
selection can repeatedly evolve (Lenski et al. 1991; Maddamsetti et al. 2015). It is 
generally difficult to distinguish this form of selection from simple clonal 
interference. However, if strong negative frequency dependent selection would 
have occurred in our lines, it would have led to the maintenance of distinct 
lineages along the evolutionary process. Such expectation seems inconsistent at 
least with the fixation of the IS insertion upstream of yrfF and the observed fixation 
of the mucoid phenotype in the majority of the lines, but could explain further 
diversification across replicate populations and the complex dynamics observed in 
some of them.  
Whilst our model of clonal interference, can reasonably describe the 
complex dynamics of the evolved phenotypes, we should stress the considerable 
amount of sensitivity in the assumed model. Indeed, a minor change in one of the 
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parameters results in very different haplotype dynamics. The sensitivity of the 
model to slight changes in parameter values is expected under intense clonal 
interference, but it is also suggests that the assumptions to generate the 
competition between the haplotypes might be an oversimplification of the real 
system. Nevertheless, the lack of theoretical approaches that are able to model 
selection under clonal interference and antagonistic interactions requires an initial 
analysis under the most basic scenarios of adaptation, before invoking other forms 
of selection. This is fundamental in order to distinguish cases where clonal 
interference cannot explain certain observations. Here we have shown that such a 
simple model, where distinct haplotypes carrying new transposon insertions and 
other mutations, increase in frequency and compete for fixation, can reasonably 
explain the adaptive dynamics, indicating that clonal interference might be the 
main driver of pathoadaptation in our basic ecological scenario. Nevertheless, 
further experiments in the lab involving competitions between mucoid and 
ancestral phenotypes suggest that frequency-dependent selection may have also 
played a role. Models that consider both forms of selection might therefore be 
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Understanding the dynamics involved in the exploration of adaptive 
spaces, as well as the evolutionary parameters that drive this process, is essential 
not only for understanding adaptation, but also for predicting, preventing and 
reversing diverse pathologies inflicted by microbial infections. The studies 
presented in this thesis, as well as recently published research (e.g., (Strelkowa & 
Lässig 2012; Lang et al. 2013; Maharjan et al. 2015; Maddamsetti et al. 2015; 
Wilson et al. 2016; Barroso-Batista et al. 2014; Comas et al. 2012; Lieberman et 
al. 2014)), establish the influence of clonal interference in adaptation across a 
range of increasingly complex ecological scenarios and organisms. We started by 
developing tools and algorithms for estimating evolutionary parameters from 
experimental evolution studies that use neutral markers to track adaptive events. 
Both our method and ones developed by other groups (Hegreness 2006; Barrick 
et al. 2010; Illingworth & Mustonen 2012) were used to analyze the outcomes of 
evolving Escherichia coli populations. We studied how the genetic background 
affects adaptation, using compensation of single and multiple antibiotic resistant 
bacteria as a model. We also studied adaptation across different environmental 
contexts, including antagonistic interactions with cells of the immune system in an 
attempt to uncover likely paths of acquisition of pathogenic traits. Understanding 
how adaptation proceeds in these clinically relevant cases, using theoretical 
methods to infer important parameters, is paramount to quantify the strength of 
selection for new mutations that might lead to pathoadaptation. 
Determining, from the entire spectrum of new variants, the rate, fraction 
and shape of the distribution of beneficial mutations is quite difficult to do 
experimentally, because many of these will be lost before reaching detectable 
frequencies. However, these evolutionary parameters underlie the adaptive paths 
that microorganisms can follow. It is thus important to understand whether strong 
effect mutations are rare (e.g., if new mutations are exponentially distributed) or if, 
on the other hand, they are the most likely, or the only expected mutations to 
occur. In Chapter II, we showed that the assumption that all mutations have a 




(Hegreness 2006; Barrick et al. 2010), might mislead the inference of the 
beneficial mutation rate (U) and the mean effect of mutations (E(S)), 
underestimating the former and overestimating the latter. Since there is 
experimental evidence that beneficial mutations have a considerable variation in 
their fitness effects (Kassen & Bataillon 2006), wrongly estimating the selective 
effects can mislead the interpretation of evolutionary outcomes. This is important, 
for instance, in studies addressing the evolvability of a genetic background 
(Barrick et al. 2010; Woods et al. 2011). We proposed a method to infer the 
underlying distribution of effects of arising beneficial mutations, as well as the rate 
at which they arise in an evolving population, by tracking two neutral markers and 
the population fitness over time. With the technological advances and the 
increasing widespread use of dozens or even hundreds of replicate populations in 
experimental evolution studies (Maisnier-Patin et al. 2002; Lenski et al. 2015; Lang 
et al. 2013; Barroso-Batista et al. 2014), methods that use direct measures from 
the adaptive dynamics are needed to extract important quantitative parameters 
from experimental data. The methodology we propose to estimate these 
evolutionary parameters is, like the work of other groups (Hegreness 2006; Barrick 
et al. 2010; Illingworth & Mustonen 2012), simple and relatively inexpensive to 
use, since it uses data routinely acquired during experimental evolution. Across all 
these methods, the difficulty in accurately assessing these parameters is strongly 
dependent on the magnitude of clonal interference (Sniegowski & Gerrish 2010), 
as well as in assumptions of frequency independent effects (Maddamsetti et al. 
2015) and an additive effect of mutations (i.e., that no epistasis occurs, but see 
(Wiser et al. 2013) for an example of an underlying model that assumes epistasis 
to infer the dynamics of fitness increase in the LTEE). Moreover, there is a 
limitation imposed by the use of only two markers, since once one of these 
markers reaches fixation, new mutations cannot be detected. This problem can be 
alleviated by using additional information, such as the fitness of populations, as 
considered in our method, but the information given by the marker dynamics is 
lost. This is especially problematic for stronger effect mutations leading to rapid 
marker fixation. Alternative methods have been proposed in order to tackle the 
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question of determining the distribution of arising beneficial mutations, which 
involve single cell barcoding of the population (Levy et al. 2015). These methods 
allow for an exquisite level of resolution of the generation of diversity within a 
population but are, however, still technologically demanding. A possible tradeoff 
can be reached with experimental systems that use several neutral markers (such 
as microsatellites (Imhof & Schlotterer 2001; Perfeito et al. 2007), although an 
appropriate model for how these mutate is needed, as well as theoretical methods 
that allow the simulation of such data. 
With the power and increasing accessibility of NGS data, the dynamics of 
adaptation are now being studied by following individual mutations and their fate in 
evolving populations. Recent experimental data disclosing these dynamics 
corroborate the idea that beneficial alleles generally do not segregate alone and 
are, instead, associated with further allelic modifications (Lang et al. 2013; 
Maddamsetti et al. 2015; Maharjan et al. 2015). More than simply competing 
against each other, these variants aggregate in cohorts, forming phenotypes that 
hide complex genetic compositions (Maharjan et al. 2015). Recently, these 
dynamics have also been tracked and comparatively studied between sexual and 
asexual Saccharomyces cerevisiae populations, showing the magnitude of linkage 
in segregating mutations across backgrounds (McDonald et al. 2016). In Chapter 
III we use a classical model of adaptation, Fisher’s Geometric Model (FGM), to ask 
if these dynamics are commonly observed during the evolutionary ascent of a 
fitness peak in haploid populations. We observe that the patterns observed 
experimentally, the formation of cohorts and their “interference”, can be 
reproduced under the simplest version of FGM, pointing to the ubiquity of these 
types of adaptive dynamics. Moreover, we were able to define a range of 
parameters where we expect these cohorts to have a higher prevalence. It would 
be interesting to test experimentally the dynamics of individual mutations in 
different environments, or in backgrounds with increased mutation rates, to test 
the predictions of the model. Since FGM can lead to epistasis (Weinreich & Knies 




simply passenger mutations, hitchhiking with beneficial alleles, from those that are 
composed of synergistic beneficial mutations. In principle, this could be tested by 
separately testing the vector change caused by the different mutations in an 
ancestral genotype. It has recently been proposed that, under FGM, epistasis is 
expected to be more prevalent closer to the optimum (Blanquart et al. 2014). 
Therefore, it would be interesting to ask if the fraction of cohorts with synergistic 
mutations is dependent also on the distance to a fitness peak. Moreover, although 
the model we considered assumes that only competitive interactions occur, the 
dynamics and coexistence of different cohorts have been proposed to be also a 
consequence of frequency dependent interactions (Maddamsetti et al. 2015; 
Maharjan 2006). Since both processes can drive these dynamics, it is important to 
develop methods that can account for both processes, and that are able to 
distinguish their relative roles in the dynamics of cohorts of mutations.  
The dynamics of beneficial mutations studied in Chapters II and III show 
that distinct evolutionary parameters lead to very different adaptive dynamics. 
Importantly, different genotypes (due to epistatic interactions) or environments 
(due to specific selective pressures) might entail distinct evolutionary trajectories 
caused, for instance, by different underlying distributions of arising beneficial 
effects. One very relevant scenario, in which it is crucial to disclose these 
fundamental aspects of adaptation, is the acquisition and maintenance of antibiotic 
resistant traits, a prevalent clinical problem (World Health Organization 2014; 
Hughes & Andersson 2015). While stabilization of single resistances through 
compensation has been extensively studied (see, for instance, (Levin et al. 2000; 
Reynolds 2000; Maisnier-Patin et al. 2007; Qi et al. 2016)), compensation of 
multidrug resistances, particularly when there are epistatic interactions between 
the resistance alleles (Hall & MacLean 2011; Trindade et al. 2009; Durão et al. 
2015), has been far less explored. In Chapter IV we described the compensatory 
process in a multi-resistant E. coli, resistant to both rifampicin and streptomycin. 
Our initial hypothesis was that, since the two resistance alleles display strong 
negative synergistic epistasis, the pattern of compensation might be distinct from 
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the ones observed in the single resistance alleles. Indeed, our results show that 
the double resistant background followed an evolutionary path that seems to 
deviate from the ones pursued by the single resistances and, consequently, the 
observations acquired from studies of the latter might not be entirely transferrable 
to cases of multi-resistant strains. Evidence for the compensation of the epistatic 
interaction comes from a particular mutation (rpoCQ1126K) that, while beneficial in a 
RifRStrR background (where it emerged), confers a deleterious effect upon allelic 
reconstruction in the single RifR ancestral background. An alternative explanation 
that is currently being tested is whether this particular allele is beneficial in the StrR 
ancestral background, a result that would be surprising (since rpoC is a traditional 
target for compensation of rifampicin resistance (Brandis et al. 2012; De Vos et al. 
2013; Comas et al. 2012)) but with important clinical implications. However, under 
the assumption that a subset of mutations is compensating specifically the genetic 
interactions between the resistance alleles, other questions arise. For instance, 
what is the fraction of this subset of compensatory mutations? Is it the majority? 
And how would these patterns of compensation look like in bacteria with 
resistance alleles that either a) are non-epistatic or b) display positive epistasis? 
Would an increased overlap of allelic targets be observed between these multi-
resistant strains and their correspondent single resistant backgrounds? Or, on the 
other hand, are we really far from exhausting the compensatory targets for a given 
resistance allele? As in our study, the mutational targets identified in experiments 
involving compensatory adaptation allow further understanding of the mechanisms 
driving epistasis. Testing specific mutations that emerge during the compensatory 
process, and measuring relevant parameters, such as the speed of transcription 
and translation (for the particular resistance mutations we used in our work), could 
elucidate how these two fundamental cellular mechanisms interact. Another 
important question regards the types of compensatory targets that can be 
expected. Many studies so far have focused on genes that are known to be targets 
for compensatory adaptation, such as rpoA, rpoB or rpoC for the case of 
compensation to rifampicin resistance (Brandis & Hughes 2013) or genes coding 




However, the availability of NGS allows uncovering in further detail the genomic 
basis of compensation, both in laboratory (Qi et al. 2016) and clinical (Comas et al. 
2012; Zhang et al. 2013; Lieberman et al. 2014) settings. In a recent study, the 
group of Craig MacLean has observed that compensation to rifampicin in P. 
aeruginosa occurs through mutations in the expected RNA polymerase genes 
when the resistance mutations are costly, but when the resistances are of low 
cost, adaptation occurs through mutations in the lasR gene, which is a highly 
pleiotropic regulator (Qi et al. 2016). Studying these alternative targets, and 
whether they have a direct relationship with the cellular mechanism of resistance, 
will further increase our knowledge of compensatory adaptation.  
Whilst many compensatory mutations have been detected to segregate in 
clinical populations, especially for cases of infection by M. tuberculosis (e.g., 
(Comas et al. 2012; Zhang et al. 2013)), translating the studies of compensatory 
adaptation in the laboratory to both clinical and in vivo studies has not been 
straightforward (MacLean & Vogwill 2015). One of the reasons might be the one 
tackled in Chapter IV, but other factors might play an important role. For instance, 
the fitness cost of a resistance in vitro needs not to be the one expressed in vivo 
(Björkman et al. 2000; Martinez & Baquero 2000; Luangtongkum et al. 2012) or be 
similar across different environments (Trindade et al. 2012; Gifford et al. 2016); the 
usage of sub-lethal doses of antibiotics might lead to different resistance 
mechanisms (Andersson & Hughes 2014); or the compensation of resistance 
genes encoded in plasmids or other MGE, which typically have lower fitness costs 
(Vogwill & MacLean 2014), might occur through different processes. In Chapter V, 
we argue that ecology, through the coexistence of several resistance alleles within 
a population, might also play a role. The simple question we asked was whether 
the initial relative fitness cost of the resistances is predictive of its long-term fate. 
Should the more costly resistances be extinct or, on the other hand, can this 
disadvantage be overcome by an increased evolutionary potential to acquire 
compensatory mutations? To answer this question, we performed long-term 
competitions between E. coli subpopulations with different resistance alleles. This 
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is a scenario of standing genetic variation that is uncommonly studied in 
compensatory adaptation, even though it mimics ecological conditions that are 
much closer to a clinical infection (Wilson et al. 2016; Lieberman et al. 2014). The 
surprising outcome, for the 3 different combinations of resistant alleles we studied, 
is that the initial relative fitness cost is a poor predictor of the long-term 
maintenance of these alleles, as the more costly populations rarely got extinct, due 
to their evolvability. It would be interesting to study larger poly-resistant bacterial 
populations, in order to understand if evolvability plays a more outstanding role 
whenever there are more than 2 backgrounds in competition. Because 
compensation in different resistance alleles might occur within the same bacterial 
population, clonal interference will occur between the beneficial variants of either 
background. If their distributions of beneficial mutations are significantly distinct 
(for instance, due to epistasis with the resistance allele), then the outcome of 
clonal interference might bias the selection of beneficial variants from the 
background with a distribution with higher mean selective effect. Such a scenario 
would be unnoticed in the compensation of each of the resistant backgrounds 
alone. Whilst in the cases studied here, the evolutionary potential seems to play a 
major role in the maintenance of resistance, the coexistence of multiple resistant 
strains gives rise to plenty of opportunities for interactions to occur, and therefore 
shaping the composition of clinical infections. This is particularly likely for 
resistances that act through the production of public goods (Lee et al. 2010) and 
infections occurring in highly structured environments, such as cystic fibrosis 
(Lieberman et al. 2014; Winstanley et al. 2016). One interesting observation, that 
seems to point in this direction, is the apparent lack of transitivity in the fitness 
costs of the resistances we tested, where the cost against a sensitive ancestral is 
not transferrable to the competitions between the resistances. Why this lack of 
transitivity is observed (and what is its extent) is something that begs to be 
understood. Nevertheless, our results highlight the importance of measuring 
important evolutionary parameters in populations within contexts analogous to the 
one observed in clinically relevant scenarios (Eldholm et al. 2014), and thus closer 




Ecology and environmental context seem then to be crucial in assessing 
adaptive dynamics in bacteria. An additional way to bridge the gap between real 
world microbial environments and the laboratory is through the study of adaptation 
in environments where biotic interactions are key to get closer to the conditions a 
given microbe is likely to encounter (Meyer & Kassen 2007; Gordo et al. 2014). 
The presence of cells from the innate immune system is one of the most relevant 
contexts for microbial evolution (Wynn et al. 2013; Schmid-Hempel 2008). The 
antagonistic interactions between these immune defenses and bacteria provide a 
strong environmental pressure and adaptation to withstand antimicrobial activity 
leads to severe pathogenic phenotypes (Sokurenko et al. 1999; Bokil et al. 2011; 
Brunke et al. 2014). Moreover, the ability of bacteria to survive in intracellular 
environments is also used as a strategy to avoid exposure to antibiotics, as in the 
case of S. aureus (Garzoni & Kelley 2011). What is, then, the genetic basis that 
leads to these pathogenic traits? In Chapter VI we studied the initial adaptive 
steps that might lead to the transition from commensalism to pathogenicity, by 
evolving E. coli in the intracellular environment of macrophages. Strong effect 
mutations, that increased the survival of evolved bacteria within macrophages 
relative to the ancestral, were acquired very rapidly, but this advantage was, in 
some cases, accompanied by a tradeoff in their absence. Adaptation to this 
environment was driven mostly by mutations in genes that code for two very 
relevant traits in the survival of E. coli in the presence of macrophages, the 
lipopolysaccharide structure and an iron transporter. Interestingly, clonal 
interference did not seem to be particularly prevalent here, and these few strong 
effect mutations dominated the adaptive process, possibly due to the lower 
effective population sizes resulting from the intracellular environment. However, in 
the conditions studied in Chapter VII, clonal interference was paramount in 
generating variation in the frequency of the emergent phenotypes. In the design of 
that study, we let both the bacteria and macrophages co-exist in the same 
environment and allow for mutations that could increase intracellular survival 
and/or extracellular fitness.  The dominant mucoid phenotype only swept to 
fixation in 2 out of 6 replicate populations, while in the others its frequency varied 
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greatly along time. A model postulating clonal interference between haplotypes 
showed that the fast input of genetic mutations could, indeed, drive the dynamics 
observed in the frequencies of the morphologies. It is important to be able to 
distinguish whether clonal interference can explain the observed data, since 
several factors could account for a mode of selection that involves interactions 
between the evolved cells. Both the existence of spatial structure (Xavier & Foster 
2007; Libberton et al. 2015) (through a static environment and the surface 
proportioned by macrophages) and the increased production of public goods (Lee 
et al. 2010)  (colanic acid exopolysaccharides, in our study) could lead to 
frequency-dependent selection and the coexistence of several haplotypes and 
phenotypes (Stein et al. 2013; Maddamsetti et al. 2015; Cordero & Polz 2014). 
Moreover, in both our studies we detected single mutational events that increased 
the pathogenic traits in E. coli. Others studies that follow have observed similar 
patterns, namely in the fungi Candida albicans, where a single SNP can lead to a 
hypervirulent strain that is able to escape phagocytes (Brunke et al. 2014). In a 
clinical context, Lieberman and colleagues have studied the evolution of 
Burkholderia dolosa in cystic fibrosis, both across and within patients (Lieberman 
et al. 2011; 2014), identifying targets of pathoadaptive mutations recurrently 
acquired by this pathogen in vivo. Their results indicate the coexistence of different 
lineages within a single individual, but also genetic records of adaptation that 
include antibiotic resistance across individuals (Lieberman et al. 2014). However, 
the study of Pseudomonas aeruginosa in a similar cystic fibrosis context has 
indicated high levels of genetic convergence (Yang et al. 2011; Marvig et al. 
2014), suggesting different evolutionary paths. These observations, both from our 
studies and others, show that the experimental evolution setup we used might be 
particularly suited to understand these important adaptive dynamics, and may 
contribute to anticipate the likely paths in the transition from commensal to 
pathogenic lifestyles. 
Overall, the research explored in this thesis reinforces something fairly well 




simple environments, uncoupled from diversity and ecology, and, therefore, their 
adaption should also be studied under those more realistic scenarios. 
Experimental evolution has been, and still is, an invaluable tool to evolutionary 
biology, and has been key in recreating adaptive processes in increasingly 
complex ecological scenarios. The results we present and discuss here indicate 
that one of the fundamental characteristics of adaptation, the distribution of effects 
of beneficial mutations, depends on both the genetic background and the 
environmental context. Nonetheless, our studies are still very much abstractions of 
the real environments encountered by microbes, and further work to create 
conditions that are closer to the real world of microorganisms are necessary. In 
parallel, theoretical models used in the estimation of evolutionary parameters also 
need to be improved. Technological advances leading to the streamlining of data 
acquisition allows using further information from experimental studies, such as 
measures of population fitness, as we propose, or even data from whole genome 
sequencing of populations or clones. Simultaneously, using models that are 
considerably more complex, by taking into account epistasis between mutations 
(Hall & MacLean 2011; Wiser et al. 2013) or interactions between co-existing 
haplotypes that go beyond competitions (Maddamsetti et al. 2015; Stein et al. 
2013), will be very useful to simulate data that can be compared with experimental 
observations. 
Ultimately, an integrative approach to study adaptation – including 
experimental evolution, the assessment of genomic data at different time points 
and ecologically complex environments and theoretical approaches – is key to 
understand what is arguably the most essential process in biology. Evolutionary 
biology depends on the harmonious integration of these different approaches and 
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